General

Exam Map

• ATLS Hemorrhage Classification: Memorize the hemodynamic shifts. Blood pressure only drops at Class III (30–40% loss, 1500–2000 mL). Classes I & II feature normal blood pressure with increasing tachycardia.
• Hemodynamic Profiling: You must be able to differentiate shock types. High CO + Low SVR = Septic/Distributive; High CVP/PCWP + Low CO = Cardiogenic; Hypotension + Bradycardia + Warm Skin = Neurogenic.
• Sepsis-3 & SOFA Criteria: Know the 6 exact systems of SOFA (Respiratory, Liver, Kidneys, Brain, Cardiovascular, Platelets—there is no RAAS/endocrine component). Septic shock strictly requires vasopressors to maintain MAP ≥ 65 and Lactate > 2 mmol/L despite fluid resuscitation.
• Trauma Primary Survey Decision Points: Airway/Intubation (GCS ≤ 8) trumps all other operative interventions (including severe maxillofacial fractures). For abdominal trauma, FAST is strictly for the unstable patient; CT is the gold standard for the stable patient.
• Surgical Site Infection (SSI) Rules: Prophylactic antibiotics must be given within 60 minutes of incision, re-dosed during prolonged surgeries, and definitively stopped within 24 hours. Exam trap: Continuing Abx for 2–3 days post-op is always wrong and promotes C. diff.
• SSI Wound Classification: Classify to determine Abx need. Herniorrhaphy = Class I (Clean/No Abx unless mesh is used); Elective Cholecystectomy = Class II (Clean-contaminated); Ruptured Diverticulitis = Class IV (Dirty).
• Post-Operative Fever Timeline: Strictly apply the "6 Ws". Fever at 24–48h = Atelectasis (Wind); Day 3 = UTI (Water); Days 5–7 = SSI (Wound) or DVT (Walking).
• Fluid & Acid-Base Traps: Upper GI losses (Vomiting/NGT) cause hypochloremic metabolic alkalosis (Treat: NS + KCl). Lower GI losses (Diarrhea) cause normal anion gap metabolic acidosis (Treat: Ringer's Lactate).
• Transfusion Complications: Platelets carry the highest risk of bacterial contamination because they are stored at room temperature. Massive PRBC transfusions predictably cause Hypocalcemia (due to citrate toxicity) and Dilutional Thrombocytopenia.
• Metabolic Substrates & Healing: The brain and RBCs are obligatory glucose users (requiring ~100g/day); cardiac muscle relies on free fatty acids. Vitamin C is highly tested as the mandatory cofactor for the hydroxylation of proline/lysine in collagen synthesis.
• Preoperative Risk: Decompensated congestive heart failure is universally tested as the single highest predictor of perioperative mortality, surpassing a recent MI or advanced age.

Trauma management

Core Concepts

• Trimodal Distribution of Trauma Deaths:
  • Peak 1 (Immediate - 50%): Seconds to minutes (e.g., massive brain/spinal cord injury, cardiac/great vessel rupture).
  • Peak 2 (Early - 30%): Minutes to hours. Known as the "Golden Hour" (e.g., epidural/subdural hematoma, hemopneumothorax, ruptured spleen/liver). Rapid trauma care yields the greatest impact here.
  • Peak 3 (Late - 20%): Days to weeks (e.g., sepsis, multi-organ failure).
• Mechanisms of Injury:
  • Blunt: Involves compression (crushing tissues), shear (acceleration/deceleration tearing the aortic isthmus), and overpressure (blow-out of closed spaces like the diaphragm or bladder).
  • Penetrating: Small bowel is the most commonly injured organ in high-velocity penetrating trauma transversing the mid-abdomen (umbilicus).
• Hemostasis following Vascular Injury: The immediate, first response is reflex vasoconstriction, which slows blood flow to allow primary (platelet) and secondary (coagulation cascade) hemostasis.
• Metabolic Response to Trauma:
  • Induces a profound hypermetabolic and catabolic state driven by counter-regulatory hormones (catecholamines, cortisol, glucagon).
  • Promotes massive lipolysis, hypercatabolism, and glycogenolysis/gluconeogenesis, reliably producing hyperglycemia (never hypoglycemia).
  • Skeletal muscle is the primary source of protein for catabolism.
  • Note: Severe major burns (>40-50% TBSA) induce the most massive increase in basal metabolic needs, surpassing multi-trauma or severe pancreatitis.

Diagnosis / Clinical Features

• Tension Pneumothorax: Diagnosed clinically by the triad of hypotension, tachycardia, and a hyper-resonant lung field, often with absent breath sounds and tracheal deviation. If intubated, presents with sudden high airway pressures.
• Cardiac Tamponade: Presents with Beck's triad (hypotension, distended neck veins/elevated JVP, and muffled heart sounds), frequently accompanied by pulsus paradoxus.
• Flail Chest: Results from fractures of ≥2 ribs in ≥2 places. Presents with paradoxical chest wall movement (sinks inward on inspiration) and underlying pulmonary contusion.
• Hypovolemic/Hemorrhagic Shock:
  • The venous system is the primary capacitance reservoir, holding 60-70% of resting blood volume.
  • Tachycardia (HR > 100) is the earliest sign.
  • A palpable femoral pulse implies SBP > 80 mmHg; radial implies SBP > 90 mmHg; carotid implies SBP > 60 mmHg.
• Acute Compartment Syndrome:
  • Most frequently affects the fascial compartments of the lower leg following a tibial fracture.
  • Classic hallmark: Excruciating progressive pain out of proportion to injury, unresponsiveness to IV narcotics, pain on passive stretch, and a tense/swollen limb.
• Abdominal Compartment Syndrome (ACS): Defined strictly as a sustained intra-abdominal pressure (IAP) > 20 mmHg directly accompanied by new-onset organ dysfunction (e.g., oliguria).

Investigations

• Focused Assessment with Sonography for Trauma (FAST):
  • Evaluates 4 dependent regions: RUQ (Morrison's pouch), LUQ (Splenorenal recess), Sub-xiphoid (pericardial space), and Pelvic (Rectovesical/Pouch of Douglas).
  • Excellent for rapidly identifying free fluid (blood) at the bedside without patient transport. Can be repeated easily.
  • Major limitation: It cannot reliably identify the specific solid organ that is injured.
• Computed Tomography (CT): The absolute gold standard imaging modality for definitive evaluation and grading of solid organ injury in a hemodynamically stable patient.
• Emergent Radiography: Standard initial films include AP Chest (look for widened mediastinum >8 cm indicating aortic tear), AP Pelvis, and C-spine.

Management

• Primary Survey (ABCDE) Principles:
  • Must be performed strictly in order. If a patient is hypotensive, conscious, and communicative, Airway and Breathing are stable; immediately move to Circulation and establish large-bore IVs for fluid resuscitation.
  • Airway: Secure a definitive airway (intubation) for GCS ≤ 8, severe flail chest/respiratory distress, or severe tracheal edema.
  • Breathing:
    • Tension Pneumothorax: Immediate life-saving needle thoracostomy followed by definitive tube thoracostomy. Waiting for an X-ray is fatal.
    • Stable Pneumothorax: Direct chest tube thoracostomy; needle decompression is unnecessary if stable.
  • Circulation:
    • Cardiac Tamponade: Pericardiocentesis is a temporary bridge; median sternotomy is the definitive incision for broad access to the heart/great vessels.
    • Hemorrhage: Stop external bleeding, apply pelvic binder for open-book fractures, give warm IV fluids/blood products.
• Secondary Survey: A comprehensive head-to-toe evaluation performed only after the primary survey is complete and resuscitation is underway.
• Splenic Trauma (Non-Operative Management - NOM): Hemodynamic stability is a prerequisite. A dropping hemoglobin requiring multiple/frequent transfusions indicates ongoing hemorrhage and signifies NOM failure, requiring surgery/embolization.
• Acute Limb Ischemia: The absolute first medical step prior to OR transfer is systemic anticoagulation with an IV bolus and continuous infusion of unfractionated heparin.
• Maxillofacial Trauma: Definitive repair of facial fractures is not immediately life-saving and should be delayed until the airway is secured, the C-spine is cleared, and the patient is hemodynamically stable.

Relevant Guidelines

• Indications for Thoracotomy in Chest Trauma:
  • Initial blood drainage of >1500 ml upon chest tube insertion.
  • Continuous bleeding of >200 ml/hr for 2-4 consecutive hours.
  • Note: Merely >200 ml over 24 hours is NOT an indication.
• NEXUS Criteria for Cervical Spine Clearance:
  • Alert and oriented; No focal neurological deficits; Not intoxicated; No midline spinous tenderness; No distracting injuries.
• qSOFA Score (Sepsis screening):
  • Includes exactly 3 components: Altered mental status (GCS < 15 or new confusion), Respiratory rate ≥ 22, and Systolic BP ≤ 100 mmHg. (Tachycardia is SIRS, not qSOFA).
• Glasgow Coma Scale (GCS):
  • Minimum score = 3; Maximum score = 15. A lower score correlates with higher mortality.
  • Eye Opening (1-4): Spontaneous (4), Verbal (3), Pain (2), None (1).
  • Verbal Response (1-5): Oriented (5), Confused (4), Inappropriate words (3), Incomprehensible (2), None (1).
  • Motor Response (1-6): Obeys commands (6), Localizes pain (5), Withdraws (4), Abnormal flexion (3), Extension (2), None (1).

Operative / Procedural Notes

• Chest Decompression:
  • Needle Thoracostomy: 2nd intercostal space, midclavicular line.
  • Tube Thoracostomy: 5th intercostal space, anterior axillary line. Dissect over the superior rib margin to avoid the neurovascular bundle.
• Tracheostomy: Typically considered after 10-14 days (2 weeks) of prolonged mechanical ventilation to prevent tracheal stenosis and vocal cord damage.
• Fasciotomy: Emergent 4-compartment fasciotomy of the lower leg is the definitive, limb-saving treatment for compartment syndrome.
• Nasogastric Tube (NGT): Absolute contraindications include suspected/confirmed esophageal rupture, stricture, and severe maxillofacial trauma. Note: A foreign body in the esophagus requires caution but is not an absolute contraindication.

Complications / Prognosis

• Persistent Air Leak: Failure of a pneumothorax to resolve after 3-5 days of chest tube management indicates surgical intervention (VATS bleb excision and mechanical pleurodesis).
• Hypothermia: Causes trauma-induced coagulopathy; impairs the coagulation cascade, increasing hemorrhagic mortality.

Past-Paper High Yield

• Primary Survey Priority Trap: If a trauma patient has severe facial fractures or airway compromise, airway management overrides all other structural repairs.
• Tension Pneumothorax vs. Tamponade: Tension PTX presents with hyperresonance and absent breath sounds; Tamponade presents with Beck's triad and pulsus paradoxus. Neither requires a CXR prior to life-saving intervention.
• Anatomy & General Surgery Integrated High-Yields:
  • Hernias:
    • Femoral: Has a narrow, rigid neck (lateral border = femoral vein) with a 40% strangulation rate. Originates inferior to the inguinal ligament.
    • Inguinal: Ilioinguinal nerve is the most commonly injured during anterior repair. The cremasteric muscle derives from the internal oblique.
  • Canal of Nuck: Normal embryological pouch of peritoneum extending into the labia majora.
  • Median Umbilical Ligament: Fibrous remnant of the urachus.
  • Thyrohyoid Muscle Innervation: Uniquely innervated by C1 'hitchhiking' on CN XII, explicitly bypassing the ansa cervicalis.
  • Ulnar Nerve: Tested clinically by abducting the fingers against resistance (dorsal interossei).
  • Torticollis: Caused by spasm/injury to the Sternocleidomastoid muscle.
  • Bell's Palsy: The most common cause of lower motor neuron facial nerve palsy.
  • Abdominal Aortic Aneurysm (AAA): Most commonly located in the infrarenal aorta.
  • Parotid Mass: Fine-needle aspiration (FNA) is the initial diagnostic step; incisional/excisional biopsies are strictly contraindicated due to facial nerve risk.
  • Inflammation/Infection: Tumor Necrosis Factor (TNF) is a central mediator of septic shock and is highly pro-coagulant. Trench foot is a non-freezing cold injury. Cellulitis from superficial excoriation does not typically cause osteomyelitis.
  • Oncology: Testicular cancer is NOT strongly associated with DNA viruses (unlike Burkitt's/EBV, Cervical/HPV, HCC/HBV).

Memory Pearls

• "Blood on the floor and 4 places more": Key areas for massive hemorrhage (Chest, Abdomen, Retroperitoneum, Pelvis, Bilateral Femurs).
• GCS ≤ 8: Intubate.
• 45/45/45 Rule for Pericardiocentesis: Subxiphoid insertion, 45-degree angle to the skin, pointing 45 degrees left and 45 degrees cephalad toward the left scapula.

Preoperative assessment of surgical patients & risk evaluation

Core Concepts

• Primary Goals: Improve the outcomes of surgery and anesthesia, detect unrecognized diseases/risk factors, quantify risk, and plan perioperative care (e.g., HDU/ICU beds).
• Contraindications to Major Elective Surgery: Must be actively screened for. Standard reasons to delay elective surgery include:
  • Recent myocardial infarction (<6 months).
  • Recent stroke (<4 months).
  • Severe hypokalemia (e.g., K⁺ of 2.5 mmol/L on diuretics).
  • Active or resolving upper respiratory tract infections.
  • Note: A previous heart valve replacement (e.g., mitral valve) is not a contraindication; it solely requires bridging anticoagulation and endocarditis prophylaxis.
• Surgical Site Infection (SSI) Risk: Independently increased by advanced age (>70), chronic malnutrition, long-term steroid use (immunosuppression), and remote body site infections. While uncontrolled diabetes is a major risk factor, well-controlled diabetes mitigates SSI risk significantly.
• Prophylactic Antibiotics: Must be given as a single preoperative dose to attain high tissue levels at the time of incision. They should be narrow-spectrum (targeted against specific flora likely encountered), not broad-spectrum. Late administration (>3 hours post-incision) renders them ineffective.

Diagnosis / Clinical Features

• Surgical Risk Factors (History & Physical):
  • Age: Not a sole criterion to withhold surgery, but associated with comorbidities, frailty, and malnutrition.
  • Social History: Smoking increases short-term myocardial oxygen demand and decreases long-term mucociliary clearance.
  • Family History: Screen for malignant hyperthermia, pseudocholinesterase deficiency, and bleeding disorders.
• Clinical Assessments Specific to General Surgery:
  • Peripheral Arterial Disease (PAD): Classic presentation is intermittent claudication (e.g., calf pain after walking 200m). First initial step in evaluation is the Ankle-Brachial Index (ABI).
  • Diabetic Foot: The most appropriate tool for assessing protective sensation (neuropathy) is the 10-gram Semmes-Weinstein monofilament.
  • Femoral Hernias: Present as a bulge inferior to the inguinal ligament. Due to the rigid, narrow defect bounded by the lacunar ligament and femoral vein, they carry an exceptionally high risk of incarceration and strangulation (up to 40% present emergently). They must be repaired, never observed.

Investigations

Targeted preoperative testing should be based on patient age, comorbidities, and surgical grade rather than broad, unselective screening.

• Full Blood Count (FBC): Indicated for all emergencies, all elective cases >60 years, all adult females, cases with expected significant blood loss, or suspicion of anemia/CKD.
• Urea and Electrolytes (U&E): Indicated for patients >65 years, cardiopulmonary disease, diuretic/steroid use, renal/liver/endocrine disease, malnutrition, or IVF therapy >24 hours.
• Random Blood Glucose: Indicated for acute abdomen, known DM, malnutrition, obesity, or age >60.
• Coagulogram (PT, APTT, INR): Indicated for known liver disease, heavy alcohol use, bleeding history, anticoagulant therapy, and specific high-risk surgeries (vascular, cardiothoracic, craniotomy).
  • Note: Warfarin effect is profoundly amplified by liver disease due to impaired synthesis of Vitamin K-dependent factors (II, VII, IX, X).
• Liver Function Tests (LFTs): Upper abdominal pain, jaundice, alcoholism, or Hepatitis B/C screening.
• Amylase: Perform in all adult emergency admissions with abdominal pain prior to surgery.
• Chest X-Ray (CXR): Elective cases >60 years, thoracic/cervical/abdominal trauma, respiratory symptoms, thoracic surgery, malignancy, perforated viscus, TB, or goiter (to check for retrosternal extension/tracheal deviation).

Management

• Perioperative Cardiac Management:
  • If a patient has had a recent MI or PCI with stenting, elective surgery should be postponed for 4–6 weeks.
  • Optimization may require initiation of medical therapy (e.g., beta-blockers) prior to surgery.
• Vascular & General Procedural Management:
  • Superficial Femoral Artery (SFA) Occlusion: For short-segment occlusions (e.g., 3 cm) causing claudication, endovascular angioplasty is the most appropriate, least invasive initial treatment.
  • Abdominal Aortic Aneurysm (AAA): A large AAA (>5.5 cm) requires repair. In patients with severe comorbidities (e.g., COPD, CAD) who are high-risk for open surgery but have favorable vascular anatomy (good iliac caliber), Elective Endovascular Aneurysm Repair (EVAR) is the definitive treatment of choice.

Relevant Guidelines

ASA Physical Status Classification

Clinical Predictors of Increased Cardiovascular Risk (ACC/AHA)

• Major Predictors: Acute/recent MI (<30 days), unstable/severe angina, strongly positive stress test, decompensated heart failure, severe valvular disease, significant arrhythmias.
• Intermediate Predictors: Mild angina, previous MI (history or Q waves), compensated heart failure, diabetes mellitus, renal insufficiency (Cr > 2.0 mg/dl).
• Minor Predictors: Advanced age, abnormal ECG (LVH, LBBB, ST changes), low functional capacity, history of stroke, uncontrolled systemic hypertension.

Surgery-Related Risk (Cardiac Event Rate)

• High Risk (>5%): Emergent major surgery (especially in elderly), aortic/major vascular, peripheral vascular, prolonged procedures with large fluid shifts/blood loss.
• Intermediate Risk (<5%): Carotid endarterectomy, endovascular AAA repair, head & neck surgery, intraperitoneal/intrathoracic surgery, orthopedic, prostate surgery.
• Low Risk (<1%): Endoscopic, superficial, cataract, breast surgery.

Goldman Cardiac Risk Index Points are assigned to estimate cardiac complication risk:

• S3 gallop or JVD: 11
• Recent MI (< 6 months): 10
• Nonsinus rhythm or PACs on ECG: 7
• >5 PVCs/minute: 7
• Age > 70 years: 5
• Emergency operations: 4
• Poor general medical condition: 3
• Intrathoracic, intraperitoneal, or aortic surgery: 3
• Important valvular aortic stenosis: 3
• Risk Stratification: 0–5 pts = 1%; 6–12 pts = 7%; 13–25 pts = 14%; >26 pts = 78% complication rate.

Revised Cardiac Risk Index (RCRI / Lee's Index) Independent predictors (1 point each): Ischemic heart disease, Congestive heart failure, Cerebrovascular disease (Stroke/TIA), High-risk surgery, Preoperative insulin use, Preoperative Creatinine >2 mg/dL.

Nutritional Risk Index (NRI)

• Formula: NRI = (15.19 × Serum Albumin g/dL) + (41.7 × [Present weight / Usual weight])
• Threshold: NRI < 83% indicates significantly increased mortality.

Past-Paper High Yield

• Highest Perioperative Mortality: Severe, decompensated congestive heart failure—especially when exacerbated by severe anemia (e.g., Hb 7)—carries a higher perioperative mortality risk than a recent MI, severe aortic stenosis, or advanced age >70.
• C. difficile Infection: Risk factors include broad-spectrum antibiotics, prolonged hospitalization, advanced age, and PPI use (flora disruption). Dietary habits (e.g., being vegetarian) are NOT risk factors.
• Hidradenitis Suppurativa: Primarily affects APOCRINE sweat glands (axilla/groin), not eccrine glands. It occurs post-puberty, is more common in Black populations, and chronic tracts require wide surgical excision. Malignant transformation can occur in chronic cases.
• Scleroderma: Systemic sclerosis is universally and classically associated with Raynaud's phenomenon, famously forming part of the CREST syndrome (Calcinosis, Raynaud's, Esophageal dysmotility, Sclerodactyly, Telangiectasia).
• Soft Tissue Sarcomas: Most spread hematogenously, but Malignant Fibrous Histiocytoma uniquely has a highly recognized propensity for lymphatic metastasis.
• Technetium-99m Bone Scans: Carries a negligible/extremely low risk of anaphylaxis (it is non-iodine). It is highly sensitive for osteoblastic activity (metastases) but notoriously lacks specificity.

Memory Pearls

• "Decompensated CHF tops the risk list": Always select decompensated heart failure as the highest predictor of perioperative mortality when compared to isolated older MIs or age.
• Femoral Hernia Anatomy = High Risk: Femoral hernias are Female-predominant, Inferior to the inguinal ligament, and have a Frightening strangulation risk.
• Prophylactic Abx Rule: Narrow spectrum, Now (at incision), Not later (>3 hrs is useless).

Metabolism & nutrition in surgical patients

Core Concepts

Metabolic Response to Injury (Stress Metabolism)

• Ebb Phase (Shock Phase): Brief, initial period immediately following injury or surgery.
• Flow Phase: Prolonged hypermetabolic state lasting weeks to months. Characterized by intense hypermetabolism, protein catabolism, insulin resistance, and adverse nutritional depletion.
• Hormonal Shift: Major surgery triggers a massive release of counter-regulatory hormones (glucagon, cortisol/glucocorticoids, catecholamines) and a reduction in insulin.
  • Result: Glycogenolysis, gluconeogenesis, sodium/water retention, and systemic hyperglycemia (not hypoglycemia).
• Catabolic Phase: Dramatic increase in metabolic demand, marked by high urinary nitrogen excretion (protein depletion). Muscle breakdown yields amino acids for hepatic gluconeogenesis.
• Early Anabolic Phase (Corticoid Withdrawal Phase): Marked by positive nitrogen balance and a rapid, progressive gain in weight and muscular strength.
• Late Anabolic Phase: Final recovery period; adipose stores replenish gradually, nitrogen balance equilibrates, and weight gain slows.

Macronutrients and Energy Yields

• Carbohydrates (30–40% of diet):
  • Enteral formulations provide 4 kcal/g; parenteral formulations (hydrated) provide 3.4 kcal/g.
  • Obligatory Glucose Users: Brain, red blood cells, renal medulla, and bone marrow rely exclusively on glucose.
  • Protein-Sparing Effect: Administration of approximately 100 grams of glucose per day provides minimum needs for obligatory users, suppressing hepatic gluconeogenesis and preventing muscle protein breakdown.
• Lipids (25–45% of diet): Provide 9 kcal/g.
  • Cardiac muscle primarily relies on free fatty acids for energy (especially at rest) and can utilize ketone bodies. It is not an obligatory glucose user.
• Proteins: Provide 4 kcal/g. Complete absorption is typically achieved by the mid-jejunum.
  • Glutamine: A conditionally essential amino acid during stress; highly utilized by rapidly dividing cells. It serves as crucial fuel for enterocytes and improves immune function.

Wound Healing Basics

• Phases: The proliferative phase (angiogenesis, collagen deposition, granulation, epithelialization) begins 2 to 3 days post-injury.
• Vitamin C (Ascorbic Acid): An essential cofactor for prolyl hydroxylase and lysyl hydroxylase, enzymes responsible for the hydroxylation of proline and lysine residues. This is a mandatory step for stabilizing the collagen triple-helix. Deficiency causes scurvy and poor wound healing.
• Holistic Healing: While individual vitamins are essential biochemically, a balanced nutritional diet (adequate protein, calories, vitamins, minerals) is the most comprehensive and critical factor for optimal wound healing.

Diagnosis / Clinical Features

Nutritional Assessment

• Subjective Global Assessment (SGA): A comprehensive clinical examination and history (assessing muscle wasting, fat loss, and dietary changes). It is the most reliable, validated, and best overall indicator of a patient's nutritional status—superior to isolated lab values.
• High-Risk History Markers:
  • Unintentional weight loss of 5% in the last month or 10% over 6 months.
  • Current weight ≤ 80–85% of ideal body weight.
  • Energy intake ≤ 50% of estimated requirements for ≥ 5 days.
• Physical Exam: Thenar/temporal muscle wasting, loss of subcutaneous fat (loose skin), peripheral edema/ascites (hypoproteinemia).

Types of Malnutrition

Investigations

Laboratory Markers of Nutrition

• Prealbumin: Has a very short half-life (2–3 days). It is the best and most sensitive indicator of recent changes in nutritional status.
• Albumin: Has a long half-life (20 days); a poor marker for acute changes.
• Note: Both markers (and transferrin) vary with inflammation and should be interpreted cautiously alongside CRP and WBC counts.

Energy Measurement

• Indirect Calorimetry: The gold standard for measuring energy expenditure (measures CO2 production and O2 consumption).
• Harris-Benedict Equation: Used to predict Basal Energy Expenditure (BEE), adjusting for height, weight, age, and sex.
• Respiratory Quotient (RQ): Ratio of expired CO2 to consumed O2.
  • RQ = 1.0 indicates carbohydrate (glucose) oxidation.
  • RQ = 0.8 indicates protein utilization.
  • RQ = 0.7 indicates fat metabolism.

Management

Return of Bowel Function Post-Op Following laparotomy or laparoscopy, bowel motility returns sequentially:

1. Small intestine: Recovers first (within hours).
2. Stomach: Recovers next (24–48 hours).
3. Colon: Recovers last (48–72 hours).

Enteral Nutrition (EN)

• Benefits: Highly beneficial, physiologic, and prevents the translocation of gut bacteria by maintaining mucosal integrity.
• Formulas: A "half-strength" enteral feeding formula means the standard formula is diluted by exactly half (50% formula mixed with 50% free water).
• Contraindications: Intestinal obstruction, upper GI bleeding, severe diarrhea resistant to therapy, intractable vomiting, and high-output enterocutaneous fistulas.
  • High-Yield Exception: Mild acute pancreatitis is NOT a contraindication to enteral feeding. Early EN is actually highly recommended to maintain gut integrity and is safer than TPN.
  • Note: Enteral feeding does not treat or prevent gallstones.

Parenteral Nutrition (PN)

• Indications: Patients who cannot meet needs via oral/enteral routes and have contraindications to EN (e.g., short gut syndrome, high-output fistula, prolonged ileus).
• Central vs. Peripheral:
  • Peripheral Parenteral Nutrition (PPN) is strictly limited to an osmolarity of 900 mOsm to avoid phlebitis.
  • Total Parenteral Nutrition (TPN) solutions utilizing highly concentrated dextrose (e.g., 20% Dextrose) are extremely hyperosmolar and must strictly be administered via a central venous line to prevent severe chemical phlebitis/sclerosis.
• Discontinuation: Discontinue when the patient can consistently meet 60% of caloric/protein needs orally or enterally.

Relevant Surgical Pharmacology & Medical Management

• Antibiotics:
  • Vancomycin: Targets bacterial cell wall synthesis by binding tightly to D-alanyl-D-alanine.
  • Carbapenems: Exceptionally broad-spectrum beta-lactams covering gram-positive, gram-negative, and anaerobic bacteria.
  • Metronidazole: Exerts bactericidal effect by causing DNA strand breakage (distinct from clindamycin, which inhibits 50S ribosomes).
  • **C. difficile Infection: Oral vancomycin** (or fidaxomicin) is the first-line therapy. IV vancomycin does not penetrate the gut lumen. Anti-motility agents (loperamide) are contraindicated.
• Post-Dural Puncture Headache: Treated with bed rest, analgesics, oral hydration, epidural blood patch, and caffeine (causes cerebral vasoconstriction, which actively treats the headache).

Operative / Procedural Notes

• Feeding Tubes (Aspiration Risk): A jejunostomy tube delivers feeds post-pylorically into the jejunum, significantly reducing the risk of reflux. A gastrostomy tube carries a higher risk of aspiration compared to a jejunostomy.
• Pneumoperitoneum (Laparoscopy): A major physiological disadvantage of using CO2 gas is that it is highly soluble, rapidly crossing the peritoneum into the bloodstream, causing systemic hypercarbia and respiratory acidosis.

Complications / Prognosis

• Enteral Feeding Complications:
  • GI side effects such as abdominal cramps and diarrhea are common, often due to hyperosmolar formulas or rapid infusion rates.
  • Tracheobronchial aspiration (mitigated by head elevation and jejunal placement).
• Parenteral Nutrition Complications:
  • Cholestasis / Gallstones: Common metabolic complication of long-term TPN due to a lack of enteral stimulation for gallbladder contraction, leading to biliary stasis.
  • Hyperglycemia: Standard complication. Target blood glucose is <180 mg/dL.
  • Occult Sepsis: If a patient previously stable on TPN suddenly becomes glucose intolerant, it is a classic clinical hallmark of occult sepsis (though standard exam keys may also point to underlying Diabetes Mellitus as a cause of TPN hyperglycemia).
• Refeeding Syndrome: A potentially lethal complication in severely malnourished patients upon feeding reintroduction. Marked by dangerous shifts (depletion) of phosphate, potassium, magnesium, and thiamine.
• Fluid & Electrolyte Shifts:
  • Severe catabolism breaks down cellular structures, decreasing effective total body water.
  • Primary hyperaldosteronism (Conn's syndrome) promotes renal excretion of magnesium, causing hypomagnesemia (not hypermagnesemia).

Past-Paper High Yield

• Transplant Oncology: Kaposi sarcoma is a highly prominent and the most common cancer in immunocompromised post-organ transplant patients.
• Wound Healing Trap: While cross-linking of collagen requires copper, the hydroxylation of proline/lysine strictly requires Vitamin C.
• Fuel Sources Trap: The brain and RBCs are obligatory glucose users; cardiac muscle is not (it uses free fatty acids).
• Vasculitis Trap: Giant cell (temporal) arteritis is the most common primary systemic vasculitis in adults, but leukocytoclastic (hypersensitivity) vasculitis is the most common vasculitis overall.
• Dermatology/Laser Trap: Scleroderma is a systemic fibrotic autoimmune disease; localized laser therapy has no role in its treatment (unlike port wine stains or hair removal).
• Mechanism of Action Trap: Metronidazole covers anaerobes via DNA strand breakage; it does not share a mechanism with clindamycin.

Memory Pearls

• Prealbumin = Present: Short half-life (2-3 days), tells you the nutrition status right now.
• Vitamin C = Collagen Hydroxylase: No C = no cross-linkable collagen = scurvy.
• 100g Glucose: The magic number daily to feed the brain/RBCs and stop muscle breakdown.
• Bowel Wake-up: Small Bowel (hours) -> Stomach (1-2 days) -> Colon (2-3 days).
• CO2 in Laparoscopy: Highly soluble -> Hypercarbia -> Respiratory acidosis.
• Vanco for C. diff: Must be ORAL. IV vancomycin will not reach the colon lumen.

Fluid management of surgical patients

Core Concepts

• Total Body Water (TBW) Compartments: Accounts for ~60% of total body weight.
  • Intracellular Fluid (ICF): 2/3 of TBW (~40% of body weight, ~28 L in a 70 kg adult). Primary ions are Potassium (K⁺), Magnesium (Mg²⁺), phosphates, proteins, and sulfate.
  • Extracellular Fluid (ECF): 1/3 of TBW (~20% of body weight, ~14 L). Primary ions are Sodium (Na⁺), Chloride (Cl^-), and Bicarbonate (HCO₃^-).
    • Interstitial fluid: 3/4 of the ECF (~10.5 L).
    • Intravascular fluid (Plasma): 1/4 of the ECF (~3–3.5 L).
• TBW Demographics & Variation:
  • Age: TBW decreases steadily with age due to progressive loss of muscle mass and increased adipose tissue.
  • Infants/Neonates: Have the highest physiological percentage of TBW (70–80%), giving them the lowest reserve against dehydration.
  • Sex & Body Habitus: Females and obese individuals have a lower TBW percentage because adipose tissue holds significantly less water than highly aqueous muscle tissue.
• Daily Fluid Balance:
  • Average input and output is 30–35 mL/kg/day (approx. 2.4 L/day).
  • Losses: Urine (500–1500 mL), Skin (500–700 mL), Lungs (400 mL), Stool (100–200 mL).
  • Fever: Water requirements increase by 100 to 150 mL/day for each 1°C elevation in body temperature.
• Osmolality vs. Osmolarity:
  • Osmolality (mOsm/kg): Normal plasma is 275–295 mOsm/kg. Calculated as: 2 × Na + fracGlucose18 + fracBUN2.8.
  • Effective Osmolality (Tonicity): Derived by omitting freely permeable BUN (2 × Na + fracGlucose18).
• Acid-Base Buffer System:
  • The normal physiological ratio of bicarbonate (HCO₃^-) to carbonic acid (H₂CO₃) is 20:1.
  • In uncompensated respiratory acidosis, retained CO₂ rapidly converts to carbonic acid, dropping the ratio below 20:1 until the kidneys slowly compensate by retaining bicarbonate.
  • In metabolic alkalosis, the primary respiratory compensation is hypoventilation (retention of CO₂ to increase PCO₂ and lower pH).

Management

• Maintenance Fluid Calculation (100-50-20 Rule):
  • 100 mL/kg for the first 10 kg.
  • 50 mL/kg for the next 10 kg.
  • 20 mL/kg for every remaining kg.
  • Example 1 (35 kg child): 1000 + 500 + (15 × 20) = 1800 mL/day.
  • Example 2 (22 kg child): 1000 + 500 + (2 × 20) = 1540 mL/day (note: some exam keys loosely accept 1550 mL).
• Intravenous Fluids (Crystalloids):
  • 0.9% Normal Saline (NS): Contains 154 mEq/L Na⁺ and 154 mEq/L Cl^-. Major extracellular expander. Avoid large volumes in pre-eclampsia, CHF, and cirrhosis.
  • Ringer’s Lactate (RL): Considered the most physiological crystalloid. Contains 131 mEq/L Na⁺, ~109–112 mEq/L Cl^-, 5 mEq/L K⁺. Lactate is metabolized in the liver to bicarbonate, providing buffering capacity.
  • 5% Dextrose in Water (D5W): Contains 50 grams of glucose per liter. Supplies roughly 200 kcal/L, which is vastly insufficient to meet basic nutritional requirements for fasting patients. Used to prevent starvation ketosis and correct hypernatremia.
• Intravenous Fluids (Colloids):
  • Large molecular weight substances that stay in the intravascular space. 3 times more potent than crystalloids (1 mL blood loss = 1 mL colloid = 3 mL crystalloid).
  • Albumin: 5%, 20%, 25% formulations. Avoid in severe anemia/cardiac failure.
  • Dextrans: Inhibits platelet aggregation and improves microcirculatory flow.
  • Gelatins (Haemaccel): Does not interfere with blood grouping/cross-matching.
  • Hydroxyethyl Starch (Hetastarch): Rapid amylase-dependent breakdown.
• Condition-Specific Management:
  • Gastric Outlet Obstruction / Severe Vomiting: Causes massive loss of gastric fluid (rich in HCl and Na⁺). Results in hypochloremic hypokalemic metabolic alkalosis. Resuscitate with isotonic 0.9% NS supplemented with Potassium Chloride (KCl) to correct volume and ion deficits. Do not use RL (worsens alkalosis).
  • Severe Diarrhea: Profound loss of bicarbonate from the lower GI tract leads to normal anion gap metabolic acidosis (never alkalosis), hypokalemia, and dehydration. RL is the fluid of choice, especially in pediatrics.
  • Hypernatremia with Hypovolemia: If hemodynamically unstable, initial volume resuscitation must be done with isotonic (0.9%) Normal Saline despite the high serum sodium. Do not avoid NS merely due to hypernatremia.

Relevant Guidelines

• COCHRANE Collaboration (Critically Ill Patients):
  • There is no evidence from RCTs that resuscitation with colloids reduces the risk of death compared with crystalloids in patients with trauma or burns after surgery.
  • Recommendation: Crystalloids are recommended as the initial fluid of choice for resuscitating patients from hemorrhagic shock.

Operative / Procedural Notes

• Laparoscopic Pneumoperitoneum:
  • Carbon dioxide (CO₂) is the standard gas used.
  • It is non-flammable, has a low water content, and is highly soluble in blood (critical to prevent fatal air embolisms).
  • Consequence: Systemic absorption causes hypercarbia leading to respiratory acidosis, not alkalosis.
• Peripheral IV Potassium Administration:
  • To prevent severe phlebitis, vascular sclerosis, and extreme pain, the maximum safe concentration of potassium infused through a peripheral vein is standardly limited to 20 mEq/L. Higher concentrations mandate a central venous catheter.
• Pre-/Post-op Bowel Management (Laxative Pharmacology):
  • Osmotic laxatives: Macrogol (polyethylene glycol) retains water in stool.
  • Stimulant laxatives: Senna, Bisacodyl.
  • Bulk-forming: Psyllium.
  • Surfactant/Stool softener: Docusate sodium.
• Caustic Ingestions (GI Endoscopy Context):
  • Strong Alkalis (Lye, drain cleaner): Cause severe, deep, full-thickness liquefactive necrosis of the esophagus by saponifying fats and dissolving tissue barriers.
  • Strong Acids (Battery acid, toilet cleaner): Cause superficial coagulative necrosis (forms a tough protective eschar that limits deep penetration).

Complications / Prognosis

• Hypernatremia Overcorrection: Rapidly lowering serum sodium and osmolality causes massive fluid shifts into the brain, resulting in fatal cerebral edema. The aim is a gradual decrease; correction should not exceed 0.5 mmol/L/hr. Aiming for 10 mOsm/hour is excessively fast and dangerous.
• Excessive Normal Saline (NS): Infusing large volumes leads to hyperchloremic metabolic acidosis because of the non-physiological high chloride load (154 mEq/L).
• Colloid-Specific Complications:
  • Dextrans: Can cause acute renal failure and uniquely interfere with blood grouping and cross-matching.
  • Hetastarch: Increases serum amylase concentrations (can falsely mimic pancreatitis) and impairs coagulation (decreases fibrinogen, VWF, factor VIII, and platelet aggregation).
• Hypermagnesemia: High magnesium levels act as a profound central and peripheral nervous system depressant. It classically causes diminished or absent (never exaggerated) deep tendon reflexes, generalized muscle weakness, and in severe cases, cardiac arrest.

Past-Paper High Yield

• 1/4 ECF Rule: Intravascular plasma makes up exactly 25% (1/4) of the extracellular fluid.
• Chloride Concentrations: Normal Saline has 154 mEq/L Cl^-. Ringer’s Lactate has approx. 109 mEq/L Cl^- (statements asserting RL has 130 mEq/L Cl^- are highly tested as FALSE).
• Vomiting vs. Diarrhea Acid-Base traps:
  • Vomiting / Gastric suction = Metabolic Alkalosis (treat with NS + KCl).
  • Diarrhea = Metabolic Acidosis (treat with RL).
• Hypovolemic Hypernatremia Trap: Never withhold 0.9% Normal Saline in a hemodynamically unstable, volume-depleted patient just because they are hypernatremic.
• D5W Nutrition Trap: 5% Dextrose in Water does not provide adequate caloric/nutritional support for fasting patients; it only contains 50g of sugar (~200 kcal).
• Hypermagnesemia DTRs: Often tested as a false positive trait. Reflexes are diminished/absent, not exaggerated.
• Metabolic Alkalosis Compensation: Driven strictly by respiratory hypoventilation (CO₂ retention).
• Gas used in Laparoscopy: Always CO₂. Remember it is used precisely because it is highly soluble in blood, mitigating embolism risk.

Surgical site infection

Core Concepts

• Definition: Surgical Site Infections (SSIs) occur within 30 days post-operation (or within 1 year if an implant is left in place). They are a major cause of nosocomial (hospital-acquired) infections (>48 hours post-admission).
• Anatomical Depth of SSI:
  • Superficial Incisional: Involves only skin and subcutaneous tissue.
  • Deep Incisional: Involves deep soft tissues (fascia and muscle layers).
  • Organ/Space: Involves any anatomical compartment (other than the incision) opened or manipulated during the operation.
• Pathogen Sources:
  • Endogenous (Most common): Patient’s own flora (skin, mucous membranes, GI tract) or seeding from a distant focus. Example: Skin flora (S. aureus, S. epidermidis) is the primary source of SSI in clean elective surgeries like hernia repairs.
  • Exogenous: Surgical personnel (soiled attire, hand hygiene breaks), OR environment/ventilation, or contaminated instruments.
• Microbiology Trends: Staphylococcus aureus is universally the most common overall SSI pathogen. MRSA rates are highly significant, increasing morbidity, 90-day mortality (3.4x), length of stay, and hospital costs.

Diagnosis / Clinical Features

• Timing of Presentation:
  • 1st 24 Hours Post-Op: Rapid, devastating necrotizing infections. Classically caused by Group A Beta-hemolytic Streptococcus (S. pyogenes) or Clostridium perfringens.
  • Days 5–7 Post-Op: Standard SSI presentation, typically caused by staphylococcal or enteric organisms.
• Gas Gangrene (Clostridial Myonecrosis):
  • Caused by Clostridium perfringens (Gram-positive anaerobe).
  • Rapidly progressive with severe pain out of proportion to exam, crepitus (gas in tissues), and profound, rapid systemic toxemia.
  • Pathology: Aggressively invades and destroys muscle tissue (stating that it "spares muscles" is a classic exam trap and is WRONG).
• Necrotizing Fasciitis (Type 1):
  • The most common form; it is a polymicrobial infection (aerobic and anaerobic bacteria).
  • Progresses with extreme rapidity; the underlying muscle may initially be spared but the fascial destruction is catastrophic.
• Fournier’s Gangrene:
  • Necrotizing fasciitis specifically of the perineum. Primarily affects older patients with multiple comorbidities (e.g., diabetes) and is polymicrobial.
  • Key Trap: The testes are typically spared because their blood supply originates from the aorta (testicular arteries), distinct from the perineal fascial supply. Routine orchiectomy is incorrect unless frankly necrotic.
• Specific Wound Infections:
  • Fight Bites (Clenched-fist injury): While Eikenella corrodens is the classic "buzzword", Staphylococcus aureus remains the most common overall bacterial cause of septic arthritis and infection in these wounds.
  • Central Line Infections: Coagulase-negative staphylococci (Staphylococcus epidermidis) are the most common cause due to their ability to form resilient biofilms on indwelling plastics.

Management

• Antimicrobial Prophylaxis Timing:
  • Must be given within 60 minutes prior to surgical incision (knife to skin). Exception: 120 minutes for vancomycin and fluoroquinolones.
  • Intra-operative Redosing: Required if the surgery exceeds the antibiotic's half-life (e.g., >3 hours).
  • Discontinuation: Must be stopped within 24 hours after surgery end time (48 hours for cardiac surgery). Continuing for 2-3 days is a common exam distractor—it provides no benefit and promotes antibiotic resistance and C. difficile colitis.
• Treatment of Specific Infections:
  • Gas Gangrene / Necrotizing Fasciitis: The most important life-saving step is immediate, aggressive surgical debridement. Antibiotics alone are insufficient. (Gas gangrene specifically requires high-dose penicillin).
  • Anaerobic Intra-abdominal Infections: Metronidazole is the gold standard for severe anaerobic infections below the diaphragm (e.g., Bacteroides).
  • Mild, Localized Hidradenitis Suppurativa (Hurley Stage I): Topical clindamycin 1% is the standard first-line therapy.
  • Incarcerated Hernia: Painful, non-reducible mass with a negative cough impulse requires urgent surgical exploration (do not manually reduce or give isolated antibiotics/analgesia).
  • Snake Bites: Routine prophylactic IV antibiotics are NOT required unless secondary infection is clearly evident. Management relies on antivenom, tetanus toxoid, and compartment syndrome observation.

Relevant Guidelines

SSI Wound Classification (Heavily Tested)

Target Antimicrobial Prophylaxis Regimens

• Biliary Tract / Cholecystectomy: Cefazolin (1st generation cephalosporin).
• Orthopedic & Vascular: Cefazolin or Cefuroxime or Vancomycin.
• Colorectal: Oral Neomycin + Erythromycin base OR Oral Metronidazole.
• Head & Neck: Clindamycin + Gentamicin OR Cefazolin.
• Genitourinary: Ciprofloxacin.

CDC Prevention Strategies

• Core Preoperative:
  • Do NOT remove hair unless necessary; if necessary, use clipping/depilatory agents (never use razors).
  • Treat remote infections prior to elective operation.
• Core Intraoperative: Keep OR doors closed.
• Core Postoperative:
  • Control blood glucose to <200 mg/dL on POD#1 and #2.
  • Discontinue antibiotics within 24 hrs post-op.
• Supplemental Strategies: Decolonize S. aureus nasal carriers with mupirocin (cardiac/ortho/neuro implants); redose abx at 3 hr mark; weight-adjust dosing for obesity (BMI >30).

NNIS Risk Stratification (Predicting SSI Risk)

3 independent variables (1 point each):

1. Contaminated or Dirty/Infected wound class.
2. ASA score > 2.
3. Length of operation > 75th percentile for the specific procedure.

Operative / Procedural Notes

• Surgical Technique to Minimize SSI: Essential steps include removing devitalized tissue, maintaining meticulous hemostasis, gentle tissue handling, eradicating dead space, and avoiding inadvertent viscus entry.
• OR Ventilation Parameters:
  • Temperature: 68º–73ºF (20º–22.7ºC).
  • Humidity: 30%–60%.
  • Air Changes: ≥ 15 total per hour (≥ 3 outdoor air).

Complications / Prognosis

• Inhibitors of Wound Healing: Tissue hypoxia, active infection, Vitamin C deficiency (scurvy), and uncontrolled diabetes mellitus profoundly inhibit wound healing. (Note: Low systemic free fatty acids do not independently impair wound healing).
• Risk Factors for SSI: Obesity (BMI >30 or 20% over ideal weight), chronic malnutrition, uncontrolled diabetes mellitus, immunosuppression, prolonged preoperative stay, and smoking. (Note: Hypercholesterolemia is a cardiovascular risk factor, but NOT an independent acute SSI risk factor).

Past-Paper High Yield

• Prophylactic Antibiotic Rules: Give within 60 minutes prior to incision, redose during long surgeries, and stop within 24 hours. Never continue for 2-3 days post-op (promotes C. difficile).
• Gas Gangrene Trap: Gas gangrene destroys muscle. If an option says "muscles are spared", it is FALSE.
• Wound Classification Differentiators:
  • Elective upper GI or cholecystectomy = Class II (Clean-contaminated).
  • Diverticulitis with an abscess (Hinchey II) or perforation = Class IV (Dirty).
  • Hernia repair = Class I (Clean). If using primary tissue suture (herniorrhaphy), no abx are needed. If using mesh (hernioplasty), give abx.
• Organism Associations:
  • Fight bites: Staphylococcus aureus is most common (despite Eikenella association).
  • Central line: S. epidermidis (biofilm).
  • First 24 hours post-op: Group A Strep (S. pyogenes) or C. perfringens.
  • Intra-abdominal anaerobes: Treat with Metronidazole.
  • Chlamydia: Obligate intracellular, urogenital/ocular, NOT gastrointestinal flora.
• Hand Hygiene: Alcohol-based gels kill vegetative bacteria (Staph, Strep, E. coli, Pseudomonas) but CANNOT kill Clostridioides difficile spores (requires soap and water).
• Skin Infections & Osteomyelitis: Superficial skin infections do NOT reliably indicate underlying osteomyelitis in asymptomatic patients; deep testing is needed.
• Fournier’s Gangrene: Testicles are spared (supplied by aorta).
• Needlestick Transmission ("Rule of 3s"): Hepatitis B (~30%), Hepatitis C (~3%), HIV (~0.3%).

Memory Pearls

• Rule of 3s for Needlesticks: 30% (HBV) > 3% (HCV) > 0.3% (HIV).
• Early vs. Late SSIs: First 24h = "Strep or Clostridium". Days 5-7 = "Staph or Enterics".
• Spermatic Cord Anatomy Link: The internal spermatic fascia originates from the transversalis fascia (a classic anatomy fact relevant to inguinal hernia exploration).
• Chronic Inflammation Histology: Characterized by mononuclear cells (lymphocytes, macrophages, multinucleated giant cells), tissue destruction, and fibrosis. Eosinophilia is strictly for allergies/parasites, not typical chronic inflammation.
• Hydatid Cyst Transmission: Echinococcus granulosus is strictly transmitted via the fecal-oral route (ingestion of eggs from dog feces).

Surgical complications and outcome in surgical patients

Core Concepts

• Postoperative Care Phases:
  • Immediate postoperative care (Recovery phase).
  • Care in the ward prior to discharge.
  • Continued care post-discharge.
• Risk Reduction Strategies: Optimization of co-morbidities/nutrition, minimizing preoperative hospital stay, early mobilization, and meticulous surgical technique.
• Complications of Prolonged Immobility (Chronically bed-ridden patients):
  • Decreased bone density (osteoporosis) due to increased osteoclastic activity from lack of weight-bearing stress.
  • Rapid skeletal muscle atrophy.
  • Significantly increased risk of deep vein thrombosis (DVT), pressure ulcers, pulmonary atelectasis, and pneumonia.
• General Categorization of Complications: Wound, thermal, infectious (fever), pulmonary, cardiac, gastrointestinal, metabolic, and neurological.

Diagnosis / Clinical Features

Wound Complications

• Fascial Dehiscence: Classically presents on postoperative days 7–10 with a sudden, painless discharge of copious salmon-pink (serosanguinous) fluid from the wound without surrounding erythema or purulence. This is a pathognomonic sign of fascial failure.
• Evisceration: Complete disruption of all abdominal wall layers with protrusion of viscera (e.g., bowel loops) outside the incision.
• Seroma: Benign collection of liquefied fat, serum, and lymphatic fluid. Presents as a soft, non-erythematous, non-tender bulge. Associated with mastectomies and axillary/groin dissections.
• Hematoma: Abnormal blood collection due to imperfect hemostasis. Presents with purplish discoloration of wound edges and blood leaking through sutures.
• Necrotizing Fasciitis / Surgical Site Infections:
  • Clostridial myonecrosis: Sudden onset of severe pain, crepitus, marked edema, tense skin, and hemorrhagic bullae following abdominal surgery.
  • Group A β-hemolytic streptococcal gangrene: Often follows penetrating wounds.
  • Polymicrobial necrotizing infections are highly associated with Diabetes Mellitus (DM) and Peripheral Vascular Disease (PVD).

Postoperative Fever & Pulmonary Complications

• Early postoperative fever (first 24–72 hours) is typically non-infectious, stemming from the inflammatory response to trauma or pulmonary atelectasis.
• Atelectasis: Peripheral alveolar collapse.
  • Mechanism: Decreased functional residual capacity (FRC) from diaphragmatic stunning and shallow breathing (incisional pain), combined with impaired mucociliary clearance of thick secretions due to anesthetic gases.
• Foreign Body Aspiration (Pediatrics): Acute chest X-ray findings include unilateral hyperinflation (ball-valve effect) or unilateral atelectasis (complete obstruction). Increased anterior-posterior (AP) diameter is not an acute finding (associated with chronic COPD).

Thermal Regulation Complications

• Hypothermia: A drop below 35°C leads to coagulopathy and platelet dysfunction. It increases the risk of cardiac events (3x), surgical site infections (3x), and blood loss/transfusion requirements.
• Malignant Hyperthermia: Rare autosomal dominant condition triggered by anesthesia. Presents with fever, tachycardia, rigidity, and cyanosis.

Gastrointestinal Complications

• Postoperative Ileus: Lack of bowel function without mechanical obstruction. Prolonged by extensive manipulation, small bowel injury, narcotic use, abscess, and pancreatitis. X-ray shows diffuse gaseous distension without a transition point.
• Small Bowel Obstruction (SBO): Hernias are the second leading cause of SBO worldwide (trailing only intra-abdominal adhesions). Imaging shows dilated centrally located loops, prominent valvulae conniventes, and a classic "stepladder" pattern of air-fluid levels.
• Pseudomembranous Colitis (C. difficile): Superinfection due to altered normal flora. Toxic colitis is a surgical emergency carrying a 20–30% mortality rate. CT shows severe colonic wall thickening, mucosal edema ("accordion sign"), and hyperemia.
• GI Bleeding: E.g., Cushing’s ulcer (incidence reduced with routine PPI use).

Vascular & General Surgical Pathology

• Acute Limb Ischemia: Sudden onset of complete cessation of arterial flow, often due to an embolus from a cardiac source (e.g., lodging in the brachial artery).
• Saphena Varix: Dilatation of the saphenous vein at the saphenofemoral junction. Presents as a painless, soft groin swelling that disappears when lying down and has a positive cough impulse.

Management

• Fascial Dehiscence / Evisceration: Evisceration is a surgical emergency. The immediate step is covering the bowel with sterile, saline-moistened dressings followed by urgent return to the operating room for washout and closure. Dehiscence requires urgent surgical evaluation to prevent evisceration.
• Urinary Retention post-Anorectal Surgery: E.g., post-hemorrhoidectomy, retention is frequently caused by pain-induced reflex spasm of the pelvic floor/sphincter. First step: Ensure proper analgesia before considering catheterization. Trigger for catheter replacement is >500 mL retention.
• Malignant Hyperthermia: Administer Dantrolene 1 to 2 mg/kg initially, up to a total of 10 mg/kg until symptoms subside.
• C. difficile Colitis: Treatment requires stopping the offending antibiotic and administering targeted oral therapy (Vancomycin, Fidaxomicin, or historically Metronidazole). Systemic steroids are contraindicated.
• Immune Thrombocytopenic Purpura (ITP): Platelet transfusions are generally ineffective (donor platelets are rapidly destroyed by autoantibodies) and do not provide sustained benefit. They are reserved strictly for catastrophic bleeding.
• Hernia Repair: Hernioplasty (using a mesh) is the gold standard surgical treatment for inguinal hernias in adult men.

Investigations

• Fever Work-up (> 48 hours):
  • History and Physical Exam
  • Blood cultures, Urinalysis/Urine culture, Sputum culture
  • Chest X-ray
• Metabolic Evaluation (Adrenal Insufficiency): Suspect in sudden cardiovascular collapse with hypotension, fever, confusion, and abdominal pain.
  • Test: Cosyntropin (ACTH) stimulation test (baseline cortisol, then at 30 mins and 60 mins post-hydrocortisone administration).
• Acute Renal Failure (Oliguria < 0.5 cc/kg/hr): Differentiate via Fractional Excretion of Sodium (FeNa): Pre-renal (FeNa < 1), Intrinsic/Post-renal (FeNa > 1).

Complications / Prognosis

• Cardiac Complications: Ischemia and infarction are the leading causes of death in any surgical patient. Prevention is the cornerstone of management. Arrhythmias require correcting underlying electrolytes (Keep Mg > 2, K > 4).
• Renal Transplant: The most common cause of death following a renal transplant is Infection, secondary to mandatory, life-long powerful immunosuppression.
• Internal Jugular Cannulation: Left internal jugular vein cannulation carries a uniquely specific risk of thoracic duct injury (chylothorax), as the duct ascends and empties at the junction of the left internal jugular and left subclavian veins.
• Hemorrhage Timeline:
  • Immediate: Inadequate hemostasis, unrecognized vessel damage.
  • Early Postoperative: Defective anastomosis, coagulopathy (usually requires re-exploration).
  • Secondary: Occurs several days postoperatively due to infection eroding a blood vessel (treat the infection).

Past-Paper High Yield

• Hernia Anatomy & Demographics:
  • Direct inguinal hernias are medial to the inferior epigastric vessels and rarely descend into the scrotum.
  • Indirect hernias are the most common in both males and females.
  • Femoral hernias are more common in females than males (though still a rare presentation overall compared to indirect) and carry a significantly higher risk of strangulation than inguinal hernias.
  • Inguinal hernias appear above and medial to the pubic tubercle.
• Eponymous Hernias: A hernia containing a Meckel's diverticulum is a Littre's hernia. A Richter's hernia involves only the anti-mesenteric bowel wall. A sliding hernia is often difficult to reduce.
• Acute Limb Ischemia: Classic presentation is the "6 Ps": Pain, Pallor, Pulselessness, Paresthesia, Paralysis, and Poikilothermia (cold).
• Early Post-Op Fever Trap: Fever within 24-48 hours is atelectasis, not pneumonia, wound infection (days 5-7), or DVT (days 5-7). Ascending cholangitis requires evidence of biliary obstruction.

Memory Pearls

• The "6 Ws" of Postoperative Fever:
  • Wind: Atelectasis (POD 1-2), Pneumonia (POD 3-4)
  • Water: UTI (POD 3)
  • Walking: DVT/PE (POD 5-7)
  • Wound: Surgical site infection (POD 5-7)
  • Waste: Intra-abdominal Abscess (POD 5-7+)
  • Wonder drugs: Medication-induced fever

Shock - dr. Amjad

Core Concepts

• Definition: A physiologic state in which systemic reduction in tissue perfusion results in decreased tissue oxygen delivery (DO₂). It is fundamentally a mismatch where Oxygen Demand > Oxygen Delivery.
• Key Principle: Falling blood pressure is a LATE sign of shock. Normal blood pressure does not equate to normal microvascular perfusion (vessel dropout occurs despite normal BP).
• Oxygen Delivery (DO₂):
  • DO₂ = Cardiac Output (CO) × O₂ Content
  • O₂ Content = (1.34 × Hb × SaO₂) + (0.023 × PaO₂)
  • Clinical correlate: Hemoglobin and oxygen saturation are the primary drivers of blood oxygen content; dissolved oxygen (PaO₂) contributes minimally.
• Mean Arterial Pressure (MAP):
  • MAP - CVP = CO × Systemic Vascular Resistance (SVR)
  • CO = Heart Rate (HR) × Stroke Volume (SV)
• Cellular Pathophysiology (Hypoxia):
  • Cells transition from efficient aerobic metabolism (38 ATP) to inefficient anaerobic glycolysis (2 ATP + Lactic acid).
  • ↓ ATP production leads to:
    1. Failure of Na⁺/K⁺ pump: Influx of Ca²⁺, Na⁺, and H₂O → cellular edema, ER swelling, loss of microvilli.
    2. Increased anaerobic glycolysis: ↑ Lactic acid → ↓ intracellular pH → nuclear chromatin clumping.
    3. Detachment of ribosomes: ↓ Protein synthesis.
  • Progression leads to lysosomal membrane rupture (enzyme release) and mitochondrial death.

Diagnosis / Clinical Features

• General Manifestations:
  • Altered mental status (agitation, confusion, lethargy).
  • Delayed capillary refill time (CRT > 2 seconds).
  • Oliguria/Anuria (< 0.5 mL/kg/hr) due to ↓ GFR.
  • Tachypnea (compensating for metabolic acidosis).
• Compensatory Responses:
  • Sympatho-adrenal: Baro/chemoreceptors sense ↓ BP → sympathetic activation → epinephrine/norepinephrine release → severe peripheral vasoconstriction (↑ SVR) and ↑ HR/contractility.
  • Neuroendocrine (RAAS): Renin → Angiotensin II (potent vasoconstrictor) → Aldosterone (Na⁺/H₂O retention). ADH/Vasopressin release.
• Type-Specific Clinical Findings:
  • Hypovolemic: Cold/clammy skin, flat neck veins, tachycardia, narrow pulse pressure.
  • Cardiogenic: Cold/wet skin, elevated Jugular Venous Pressure (JVP), pulmonary crackles, S₃ gallop.
  • Distributive (Early Septic): Warm/flushed extremities, bounding pulses, widened pulse pressure (hyperdynamic state).
  • Obstructive: Distended neck veins, muffled heart sounds (Beck's triad in tamponade), absent breath sounds (tension pneumothorax).
  • Neurogenic: Hypotension + Bradycardia + Warm extremities (due to loss of sympathetic tone and unopposed vagal tone).

Investigations

• Non-Invasive / Bedside:
  • POCUS / RUSH Protocol (Rapid Ultrasound in Shock and Hypotension): Evaluates "Pump, Tank, and Pipes" (Heart, IVC/abdomen, Aorta/DVT) to determine the etiology of non-traumatic shock (broader than eFAST, which focuses on trauma).
• Invasive Monitoring (Swan-Ganz / Pulmonary Artery Catheter):
  • Hypovolemic: ↓ CVP, ↓ PCWP, ↓ CO, ↑ SVR
  • Cardiogenic: ↑ CVP, ↑ PCWP, ↓ CO, ↑ SVR
  • Distributive (Septic): ↓ CVP, ↓/normal PCWP, ↑ CO, ↓↓ SVR
  • Obstructive: ↑ CVP, ↑ PAP (if PE), ↓ CO, ↑ SVR

Management

• General Principles: Individualize treatment. Shock states frequently coexist. Recognize and treat during the compensatory phase; mortality doubles for every hour of delay.
• Type-Specific Interventions:
  • Distributive: IV fluids, vasopressors, source control (antibiotics/surgery).
  • Hypovolemic: Crystalloids, packed RBCs, surgical hemostasis.
  • Cardiogenic: Inotropes (dobutamine), vasodilators (sodium nitroprusside), intra-aortic balloon pump (IABP), diuresis.
  • Obstructive: Heparin/thrombolysis (PE), needle decompression (PTX), pericardiocentesis.

Relevant Guidelines

• Diagnostic & Hemodynamic Pathway of Circulatory Shock (Slide Algorithm):
  • Step 1: Arterial hypotension + signs of hypoperfusion = Circulatory Shock.
  • Step 2: Estimate CO or SvO₂.
    • If High CO → Distributive Shock.
    • If Low CO → Assess CVP.
  • Step 3: Evaluate CVP in Low CO states.
    • Low CVP → Hypovolemic Shock.
    • High CVP → Echo required (Cardiogenic vs. Obstructive).
• Stages of Shock Classification:
  • Stage I (Compensated / Nonprogressive): Perfusion to vital organs maintained. BP preserved via ↑ HR and mild vasoconstriction. ATP Supply = Demand.
  • Stage II (Uncompensated / Progressive): Decreased microvascular perfusion, end-organ dysfunction begins, clinical hypotension ensues.
  • Stage III (Irreversible): Refractory organ dysfunction, severe cellular acidosis, cell death.

Operative / Procedural Notes

• Pneumoperitoneum Physiology (12-15 mmHg): Creation of a CO₂ pneumoperitoneum predictable causes a transient decrease in urine output due to physical compression of renal veins and parenchyma (↓ GFR). It also causes ↓ CO, ↑ SVR, and ↓ FRC.
• Cardiogenic Shock Contraindication: Pneumatic antishock garments (PASG) are contraindicated because they compress the lower body, massively increasing SVR and venous return, which fatally overloads a failing heart.

Complications / Prognosis

• Inflammatory Mediators & Prognosis:
  • Interleukin-6 (IL-6): Best predictor of prolonged recovery and Multiple Organ Dysfunction Syndrome (MODS). Stimulates acute-phase reactants (causes hyperferritinemia).
  • TNF-α: Causes severe hypotension and lactic acidosis.
  • iNOS (inducible Nitric Oxide Synthase): Overexpressed in sepsis, producing toxic free radicals and causing hyperdynamic vasodilation.
• Prolonged shock leads to Shock-induced cardiomyopathy (impaired contractility) and acute tubular necrosis (ATN).

Past-Paper High Yield

• Septic Shock Hemodynamics: Early septic shock is classically a hyperdynamic state characterized by normal or elevated cardiac output and profoundly low systemic vascular resistance (SVR).
• Bowel Perforation Sequence: A missed small bowel perforation or colonic rupture leads directly to massive fecal peritonitis → severe sepsis → widespread systemic vasodilation → distributive shock (↑ CO, ↓ SVR).
• Cardiogenic Shock Hemodynamics: Refractory hypotension with a history of MI + high PCWP + high CVP + low ScvO2 confirms primary pump failure.
• Hemorrhagic Shock Classes:
  • Class II (20% blood loss): Compensatory mechanisms maintain BP and urine output is typically still maintained (no frank oliguria yet).
  • Class III (1700 mL loss): Corresponds to massive sympathetic output → ↑ SVR to maintain BP, narrowed pulse pressure, ↓ CO, and frank oliguria.
• Neurogenic Shock Triad: Absolute hallmark in a trauma patient is profound hypotension + bradycardia + warm, flushed extremities. (Do not pick tachycardia; vagal tone is unopposed).
• Hidden Hemorrhage Sites: The abdomen, retroperitoneum, pelvis, and femurs can hide massive blood volumes. The intracranial space cannot harbor enough blood to cause systemic hypovolemic shock before fatal brain herniation occurs.
• Necrotizing Soft-Tissue Infections: Highly aggressive, rapidly progressive, and life-threatening (they do not have a gradual/chronic course). Require immediate surgical debridement, usually polymicrobial, produce "dishwater pus", and S. pyogenes can cause concurrent toxic shock syndrome.
• Cellular Biology: Lymphocytes (B and T cells) mediate adaptive immunity and are NOT phagocytic. (Neutrophils, macrophages, microglia, and Kupffer cells are phagocytes).
• Surgical Anatomy Tested with Shock:
  • The dorsalis pedis artery is a direct continuation of the anterior tibial artery.
  • An aberrant/replaced right hepatic artery most commonly arises from the Superior Mesenteric Artery (SMA) and courses posterior to the portal vein.

Memory Pearls

• Low SVR + High CO = Distributive / Early Sepsis.
• High CVP + High PCWP + Low CO = Cardiogenic (Pump Failure).
• Bradycardia + Hypotension + Warm Skin = Neurogenic.
• IL-6 = Predictor of MODS and causes HYPERferritinemia.
• RUSH = Medical shock ultrasound (Pump/Tank/Pipes) neq eFAST (Trauma).

Hypovolemic shock - dr. Khaled

Core Concepts

• Definition of Shock: A life-threatening state of circulatory failure resulting in inadequate oxygen delivery to tissues, leading to cellular hypoxia, organ dysfunction, and ultimately multiorgan failure (MOF) if unreversed.
• Key Hemodynamic Equations:
  • Cardiac Output (CO) = Stroke Volume (SV) × Heart Rate (HR)
  • Blood Pressure (BP) = CO × Total Peripheral Resistance (TPR)
• Pathophysiological Cascade: Hypovolemia → ↓ Venous Return → ↓ Preload → ↓ Cardiac Output → Hypotension → Tissue Hypoxia.
• Categories of Hypovolemic Shock:
  • Hemorrhagic: Intravascular volume loss due to bleeding (Trauma, GI varices/ulcers, ruptured ectopic, ruptured aortic aneurysm, hemorrhagic pancreatitis).
  • Non-Hemorrhagic: Intravascular volume loss from fluids other than blood:
    • GI Losses: Diarrhea, vomiting, fistulas/external drainage.
    • Renal Losses: Diuretics, osmotic diuresis, salt-wasting nephropathy.
    • Skin Losses: Burns, heat stroke, excessive sweating (can exceed 1–2 L/hr).
    • Third Spacing: Extravascular fluid shift (e.g., crush injuries, intestinal obstruction, acute pancreatitis, post-operative state, cirrhosis).

Diagnosis / Clinical Features

• Classic Signs & Symptoms: Tachycardia, narrow pulse pressure, hypotension, tachypnea, oliguria, altered mental status (agitation to lethargy), cool/clammy skin, dry mucous membranes.
• Tissue Perfusion Indicators: Weak peripheral pulses, prolonged capillary refill (>2 seconds).
• Renal Perfusion (Exam Pearl): The standard metric for minimum acceptable urine output in an adult to ensure adequate renal perfusion is 0.5 mL/kg/hour (e.g., 35 mL/hour for a 70 kg patient).

Investigations

• FAST (Focused Assessment with Sonography for Trauma): Early diagnostic ultrasound looking for hemopericardium and intra-abdominal bleeding in 4 windows: Heart (pericardial), Liver/Kidney (Morison's pouch), Spleen (perisplenic), and Bladder (pelvic).
• CT Scan: Indicated for identifying retroperitoneal bleeding or solid organ injury, but strictly reserved for hemodynamically stable patients.
• Laboratory: Baseline labs, blood typing, and cross-matching for PRBCs.

Relevant Guidelines

• American College of Surgeons (ACS) Classes of Acute Hemorrhage:
  • Class I (<15% / <750 mL): Pulse <100, BP Normal, Pulse Pressure Normal/↓, Cap Refill <2s, RR 14–20, UOP ≥30 mL/hr. Mentation: Slightly anxious.
  • Class II (15-30% / 750-1500 mL): Pulse >100, BP Normal, Pulse Pressure ↓, Cap Refill 2-3s, RR 20–30, UOP 20-30 mL/hr. Mentation: Mildly anxious.
  • Class III (30-40% / 1500-2000 mL): Pulse >120, BP Decreased (hypotension begins here), Pulse Pressure ↓↓, Cap Refill 3-4s, RR 30–40, UOP 5-10 mL/hr. Mentation: Anxious & confused.
  • Class IV (>40% / >2000 mL): Pulse >140, BP Severely Decreased, Pulse Pressure ↓↓, Cap Refill >5s, RR >40, UOP Negligible. Mentation: Confused/Lethargic.
• Assessment of Blood Consumption (ABC) Score: Predicts the need for massive transfusion based on 4 parameters (assessed upon ED arrival):
  1. Penetrating mechanism of injury.
  2. Positive FAST examination.
  3. Systolic Blood Pressure (SBP) ≤ 90 mmHg.
  4. Heart Rate ≥ 120 bpm.

Management

• Initial Priorities (ATLS): Control hemorrhage, establish/protect airway (with C-spine precautions), maximize oxygenation, and gain IV access (Intraosseous lines can be used if IV access fails; targets include humeral head, sternum, proximal tibia, distal femur).
• Fluid Resuscitation:
  • Use balanced crystalloids (Lactated Ringer's) initially.
  • Caveats: Large volumes of Isotonic Saline (0.9% NaCl) cause non-anion gap hyperchloremic metabolic acidosis. Large volumes of Lactated Ringer's can cause metabolic alkalosis.
  • Rhabdomyolysis specific: Aggressive volume resuscitation with IV crystalloids is the cornerstone of early management following a crush injury to flush myoglobin and prevent AKI.
• Delayed Fluid Resuscitation (Permissive Hypotension):
  • Target early IV fluid resuscitation only to an SBP of 70–90 mmHg.
  • Prevents the "popping" of newly formed clots, dilution of clotting factors, and hypothermia associated with aggressive normotensive fluid replacement.
• Blood Transfusion Principles:
  • Transfuse products early in a 1:1:1 ratio (PRBC : FFP : Platelets). Whole blood is also acceptable.
  • Type O RhD-negative is the universal donor.
  • Transfusion Threshold: Give blood to patients exhibiting symptomatic anemia (e.g., Hb of 8 g/dL experiencing tachycardia/dyspnea) to improve oxygen delivery. A minor drop or asymptomatic chronic anemia (e.g., ESRD with Hb 7) generally does not mandate immediate transfusion.
• Massive Transfusion Protocol (MTP):
  • Defined as requiring ≥10 units PRBCs/24h, ≥4 units/1h, or ≥10 units/6h.
  • Delivered in batches: 6 units PRBCs + 6 units FFP + 6 units random donor platelets (or 1 unit apheresis platelets).
• Adjuncts in Resuscitation:
  • Tranexamic Acid (TXA): Antifibrinolytic; must be administered within 3 hours of injury.
  • Calcium: Administer to counteract citrate toxicity (chelates calcium) from massive blood product administration.
  • Temperature Control: Maintain normothermia (≥ 35.5^°C) using fluid warmers and forced-air blankets to prevent coagulopathy.

Operative / Procedural Notes

• Hemorrhage Control Techniques:
  • Direct pressure is primary. Clamping is acceptable only under direct visualization (blind clamping is contraindicated).
  • Tourniquets: Used for severe extremity injury/amputations. The maximum recommended safe inflation time to prevent irreversible ischemic nerve and muscle damage is 2 hours (120 minutes). When possible, release periodically (e.g., every 45 mins).
  • Scalp Lacerations: Bleeding can be managed via running sutures, Raney clips, or local injection of lidocaine + epinephrine.
  • Pelvic Fractures: Open-book fractures require immediate circumferential pelvic binder or tied sheet for stabilization.
• Surgical Hemorrhage Classification:
  • Primary: Bleeding during the surgery.
  • Reactionary: Bleeding within the first 24 hours post-op (e.g., caused by a slipped surgical ligature once blood pressure normalizes).
  • Secondary: Bleeding 7–14 days post-op (almost exclusively caused by infection eroding a vessel wall).
• Anesthesia in Shock: Use agents with minimal hemodynamic effects; reduce standard induction doses. Avoid high Positive End-Expiratory Pressure (PEEP) as it increases intrathoracic pressure, decreases venous return, and worsens cardiac output.
• Intraoperative Temperature Regulation: Core body temperature is directly affected by cold IV fluids, ambient OR air, cold/humidified ventilator air, and muscle relaxants (which halt shivering). Note: The patient's O2 saturation level is a measure of oxygenation, not a physical variable that alters body temperature.

Complications / Prognosis

• Tissue Ischemia Sensitivity: Nerve tissue is the most sensitive to ischemia, followed by muscle. Skin is highly resistant and tolerates ischemia much longer than muscle or nerve. Ischemia-reperfusion injury is mediated by oxygen free radicals.
• Limb Viability: Rigid muscles indicating rigor mortis in a limb is a definitive sign of irreversible tissue necrosis, implying the limb is no longer viable and invariably requires amputation. (Loss of pulses or sensation indicates severe ischemia but may still be reversible with emergent revascularization).
• Coagulopathy & DIC: Prolonged shock leads to Disseminated Intravascular Coagulation (DIC), characterized by widespread clotting cascade activation → microthrombi formation → consumption of platelets/coagulation factors → significant hemorrhage, ↓ fibrinogen, ↓ platelets, and prolonged PT/PTT.

Past-Paper High Yield

• Antibiotic Prophylaxis: Hernioplasty strictly requires Abx prophylaxis because it involves placing a prosthetic mesh (a foreign body), carrying a risk of devastating mesh infection. Abx should be given before anesthesia, tailored to the site, and re-dosed in prolonged surgeries.
• Pharmacology of Anticoagulants: Heparin's mechanism of action is binding to and activating Antithrombin III, which rapidly inactivates thrombin and Factor Xa. (Warfarin = Vit K epoxide reductase inhibitor; Rivaroxaban = direct Xa inhibitor; Dabigatran = direct thrombin inhibitor).
• Tracheostomy Bleeding: Minor, self-resolving bright red bleeding from a tracheostomy site a few weeks (e.g., 2 weeks) post-procedure is most commonly due to friable granulation tissue at the stoma. (A tracheoinnominate fistula causes catastrophic, massive hemorrhage, not self-resolving bleeding).
• Laparoscopy Arrhythmias: The most common arrhythmia during laparoscopy is sinus bradycardia (caused by rapid CO2 insufflation stretching the peritoneal membrane, triggering a vagovagal reflex).
• Dermis Anatomy: The dermis is the thick, highly vascularized inner layer of skin that contains sensory nerve endings and appendages (hair follicles, sweat glands, sebaceous glands). The epidermis is avascular.
• Hypercalcemia Management: Calcitonin quickly lowers serum calcium, but patients rapidly develop tachyphylaxis (tolerance) within 48–72 hours. It is for acute, short-term management only, not life-long treatment.
• Soft Tissue Sarcoma Metastasis: Retroperitoneal and abdominal soft tissue sarcomas primarily metastasize via the hematogenous route to the LUNGS (not the liver). Lymphatic spread is rare.
• Cadaveric Organ Donation: Strictly requires that the donor has suffered irreversible brain injury meeting legal and clinical criteria for brain death.
• Surgical Lasers: Not all lasers cause superficial corneal damage. Safety and depth of tissue/corneal interaction depend strictly on the specific wavelength (e.g., CO2 lasers damage the cornea, but Nd:YAG lasers pass through the cornea and damage the retina). Appropriate wavelength-specific safety glasses must be worn.
• Diabetic Foot Infections: The 'probe-to-bone' test is the most reliable bedside method to diagnose osteomyelitis in a diabetic foot ulcer. If a sterile probe touches hard, gritty bone, osteomyelitis is highly likely.

Memory Pearls

• Shock Classes by BP Drop: BP does not drop until Class III (30-40% blood loss).
• MTP Ratio: 1 : 1 : 1 (PRBC : FFP : Platelets).
• DIC Labs: ↓ Platelets, ↓ Fibrinogen, ↑ PT/PTT, Bleeding + Clotting.
• Urine Output Target: 0.5 mL/kg/hr.
• Reactionary Bleeding: <24 hrs (slipped tie); Secondary Bleeding: 7-14 days (infection).

Sepsis

Core Concepts

• Sepsis (Sepsis-3 Definition): Life-threatening organ dysfunction caused by a dysregulated host response to infection.
• Septic Shock: A subset of sepsis where circulatory, cellular, and metabolic abnormalities are profound enough to significantly increase mortality (often >40%).
• Pathophysiology: Sepsis represents a loss of homeostasis triggered by an infection:
  • Pro-inflammatory State: Cytokine storm (TNF, IL-1, IL-6) leads to massive inflammation and endothelial dysfunction.
  • Endothelial Dysfunction: Causes excessive vasodilation, relative hypovolemia, and capillary leakage (tissue edema).
  • Pro-coagulant State: Inflammation and endothelial injury stimulate tissue factor expression and inhibit fibrinolysis (e.g., via inactivation of Protein C). This leads to microvascular thrombosis, impaired tissue perfusion, and potential Disseminated Intravascular Coagulation (DIC).
  • Metabolic Impact: Severe systemic inflammatory response syndrome (SIRS), such as that caused by peritonitis, throws the body into a severe hypermetabolic state, drastically increasing caloric and energy requirements.
• Tumor Necrosis Factor (TNF): A highly pro-thrombotic mediator in sepsis; it promotes coagulation and inhibits natural anticoagulant pathways. It is not an anticoagulant.

Diagnosis / Clinical Features

• General Presentation:
  • Tachypnea is the most common and earliest clinical sign (present in ~99% of cases). Do not rely solely on the presence of a fever to suspect sepsis.
  • Tachycardia, altered mental status, and oliguria are also highly prevalent.
• Body's Response to Shock:
  • Sympathetic Activation: Release of epinephrine/norepinephrine causes tachycardia and vasoconstriction.
  • RAAS and ADH Activation: Promotes sodium and water retention to preserve intravascular volume.
  • Blood Flow Redistribution: Shunts blood away from the skin, GI tract, and kidneys to preserve the brain and heart, leading to pallor, delayed capillary refill, and oliguria.
• Common Sources & Pathogens:
  • Respiratory (35%) and Urinary Tract (35%) are the most common primary sources.
  • Gram-Negative Sepsis: The urinary tract is the most common source of Gram-negative sepsis in the elderly. Escherichia coli is overwhelmingly the most common causative organism for septic shock originating from the GI or urinary tracts.
• Surgical Risk Factors: Advanced age, immunosuppression (steroids, chemotherapy), emergency operations, prolonged procedures, contaminated fields (bowel perforation), and indwelling devices (central lines, catheters).

Investigations

• Serum Lactate: A critical marker of tissue hypoperfusion and anaerobic metabolism.
  • < 1 mmol/L: Normal
  • > 2 mmol/L: Abnormal / Diagnostic threshold for shock
  • ≥ 4 mmol/L: Severe tissue dysoxia; triggers immediate aggressive resuscitation bundle
• Blood Cultures: Must be obtained before starting antimicrobial therapy, provided this does not delay antibiotics by more than 45 minutes. Note: Cultures are frequently negative in 30-50% of patients with severe sepsis or septic shock.
• ScvO2 (Central Venous Oxygen Saturation): Reflects the balance between oxygen delivery and oxygen consumption. Target > 70%. If low, interventions include fluids, packed red blood cells (target Hct > 30%), or inotropes (dobutamine).

Management

• Hour-1 Resuscitation Bundle: ("Time Zero" = time of presentation/recognition)
  1. Measure lactate level (re-measure if initial is > 2 mmol/L).
  2. Obtain blood cultures prior to administering antibiotics.
  3. Administer broad-spectrum IV antibiotics (ideally within 1 hour; delaying significantly increases mortality).
  4. Rapid IV fluid resuscitation: Give 30 mL/kg of crystalloid fluids for hypotension or if lactate is ≥ 4 mmol/L.
     • Fluid note: Ringer's Lactate contains Sodium, Chloride, Potassium, Calcium, and Lactate. It does NOT contain Magnesium.
  5. Apply vasopressors if hypotensive during or after fluid resuscitation to maintain a MAP ≥ 65 mmHg.
• Source Control: Anatomic source control (e.g., draining an abscess, resecting ischemic bowel, removing an infected device) must be achieved as rapidly as possible. It must never be delayed to "stabilize the patient."
• Vasopressor Therapy: Norepinephrine is the first-line vasopressor for fluid-refractory septic shock. Dopamine is not recommended as first-line due to arrhythmia risks.
• Corticosteroids: Administer IV hydrocortisone only if adequate fluid resuscitation and vasopressor therapy are unable to restore hemodynamic stability.
• Glucose Control: Target an upper blood glucose level of ≤ 180 mg/dL to prevent hypoglycemia while avoiding severe hyperglycemia.

Relevant Guidelines

• Sepsis-3 Definitions & Pathways:
  • Clinical Criteria for Sepsis: Suspected or documented infection plus an acute change in the SOFA score of ≥ 2 points. (A SOFA score of ≥ 2 reflects an overall mortality risk of ~10% in a general hospital population).
  • qSOFA (Quick SOFA): A prompt used outside the ICU to identify patients at high risk of poor outcomes (Score ≥ 2 is positive). Includes:
    1. Systolic BP < 100 mmHg
    2. Altered Mental Status (GCS < 15)
    3. Tachypnea (Respiratory Rate ≥ 22 breaths/min)
  • Clinical Criteria for Septic Shock:
    1. Persisting hypotension requiring vasopressors to maintain a MAP ≥ 65 mmHg AND
    2. Serum lactate level > 2 mmol/L
    3. Despite adequate fluid resuscitation.
• The SOFA (Sequential Organ Failure Assessment) Score: Evaluates exactly six organ systems.
  1. Respiratory: PaO2/FiO2 ratio
  2. Coagulation: Platelet count
  3. Liver: Bilirubin levels
  4. Cardiovascular: MAP or dose of vasopressors required
  5. Central Nervous System: Glasgow Coma Scale (GCS)
  6. Renal: Creatinine levels or Urine Output
  • Crucial Distinction: The Renin-Angiotensin System is NOT part of the SOFA score.

Complications / Prognosis

• Multiple Organ Dysfunction Syndrome (MODS): Represents a continuum of progressive physiological derangements. The mortality rate is extremely high and directly correlates with the number of organ systems failing (e.g., 1 organ = ~22% mortality; 4+ organs = >70% mortality). Aggressive antibiotic use does not make this a "low mortality" condition.
• DIC (Disseminated Intravascular Coagulation): Widespread microvascular clotting consumes platelets and clotting factors, drastically increasing bleeding risk.

Past-Paper High Yield

• Diagnostic Thresholds: Under Sepsis-3, organ dysfunction is clinically identified by an acute change in the total SOFA score of ≥ 2 points (NOT ≥ 4 points).
• SOFA Components: The SOFA score explicitly evaluates the respiratory, coagulation, liver, cardiovascular, central nervous system, and renal systems. It does NOT evaluate the renin-angiotensin system.
• Definition of Septic Shock: True septic shock strictly requires both the need for vasopressors to maintain MAP ≥ 65 mmHg and a serum lactate > 2 mmol/L despite adequate fluid resuscitation.
  • Legacy Classification Trap: If a patient presents with severe hypotension that normalizes completely and remains stable after a rapid fluid bolus, they have Severe Sepsis (under historical Sepsis-2 criteria) but do not meet the criteria for Septic Shock, as they did not require vasopressors.
• First-line Pressor: If a patient receives 30 ml/kg of crystalloid fluids and remains hypotensive (e.g., BP 80/60 mmHg), they have fluid-refractory shock. The immediate next step is to initiate a norepinephrine infusion. (Dopamine is incorrect).
• Antibiotic Timing: Broad-spectrum antibiotics MUST be administered within 1 hour of recognition. Delaying them up to 6 hours to obtain cultures is completely incorrect and universally increases mortality.
• Source Control: Source control must be prioritized alongside resuscitation and should NOT be delayed to stabilize the patient.
• Microbiology: Escherichia coli is the most overwhelmingly common causative organism for septic shock originating from the GI or urinary tract, particularly in the elderly. Furthermore, it is false to claim that 90% of patients have positive blood cultures; up to 30-50% will have negative cultures.
• Fluid Composition: Ringer's lactate solution contains Sodium, Chloride, Potassium, Calcium, and Lactate. It does NOT contain Magnesium.
• Metabolism: SIRS/Sepsis (e.g., from peritonitis) causes a hypermetabolic state that drastically increases energy requirements. (Do not select answers suggesting energy requirements decrease).
• Cytokines: TNF is highly pro-thrombotic (it is NOT a systemic anticoagulant).
• Miscellaneous General Surgery Exam Trivia (Mapped to this block):
  • Therapeutic Radiation: Toxic to rapidly dividing bone marrow cells, causing lymphopenia (NOT lymphocytosis). Chronic effects include tissue fibrosis, necrosis, telangiectasia, and secondary malignancies.
  • Hemorrhoids: Second-degree hemorrhoids (prolapse with straining but reduce spontaneously) should initially be managed conservatively with diet (fiber/water) and topical agents.

Memory Pearls

• Sepsis-3 Septic Shock = MAP < 65 (requiring pressors) + Lactate > 2 (despite fluids).
• Hour-1 Sepsis Bundle = Lactate → Cultures → Antibiotics → 30ml/kg Fluids → Vasopressors.
• SOFA = 6 Systems (Lungs, Liver, Kidneys, Brain, Heart/Vessels, Platelets). No endocrine or RAAS components.

Bleeding and blood transfusion

Core Concepts

• Rationale for Transfusion: Improving oxygen-carrying capacity of the blood to prevent tissue hypoxia (organs most sensitive are the heart and brain).
• Oxygen Delivery (O2 Flux): Cardiac Output × (Hemoglobin × Oxygen Saturation).
• Blood Components and Preparation: Prepared via differential centrifugation in a closed system.
  • First Centrifugation (Soft Spin): Separates heavier RBCs from platelet-rich plasma (PRP).
  • Second Centrifugation (Hard Spin): Separates PRP into Platelet Concentrate and Platelet-Poor Plasma (FFP).
• Storage and Composition:
  • Whole Blood: Stored at 4°C for up to 35 days. Platelets and coagulation factors become inactive after 3–5 days. Must be ABO identical.
  • Packed Red Blood Cells (PRBCs): Stored at 4°C for up to 42 days. One unit (10 cc/kg) increases Hb by ~2.5 g/dL. Must be ABO compatible.
  • Platelets: Stored at 20–24°C (room temperature) for up to 5 days. Contains donor leukocytes and cytokines. One unit/10 kg increases platelet count by 50,000/μL. Donor/recipient must be ABO identical.
  • Fresh Frozen Plasma (FFP): Contains all coagulation factors. Stored at -18°C for up to 12 months. Requires ABO compatibility, but Rh compatibility is not required (lacks RBCs).
  • Cryoprecipitate: Precipitate formed when FFP is thawed at 4°C; refrozen and stored up to 1 year. Rich in Fibrinogen, von Willebrand Factor, Factor VIII, and Factor XIII.

Diagnosis / Clinical Features

• Acute Hemolytic Transfusion Reaction (AHTR):
  • Triggered by ABO/Rh incompatibility (usually due to a labeling or clerical error).
  • Pathophysiology: Pre-formed recipient antibodies activate complement, causing rapid intravascular hemolysis. Can occur with just 1–2 cc of RBCs.
  • Awake patient: Fever, chills, severe back/flank pain, dyspnea, hypotension, dark urine (hemoglobinuria), and pallor.
  • Anesthetized patient (in the OR): Classic symptoms are masked. The most reliable signs of AHTR under general anesthesia are unexplained hypotension and sudden, diffuse microvascular bleeding/oozing from the surgical field (due to acute DIC).
• Febrile Non-Hemolytic Transfusion Reaction (FNHTR):
  • Defined by a temperature rise of >1°C.
  • Caused by recipient alloantibodies directed against donor HLA antigens/leukocytes and accumulated cytokines.
• Allergic Reaction: Ranges from mild urticaria/wheezing to anaphylaxis. Classically occurs in IgA-deficient patients receiving blood products containing IgA.
• Transfusion-Related Acute Lung Injury (TRALI):
  • ARDS-like pulmonary syndrome occurring 1–6 hours post-transfusion.
  • Caused by donor WBC antibodies inducing pulmonary leukostasis. Carries high mortality.

Investigations

• Blood Bank Workup for Hemolytic Reactions:
  • Direct Antiglobulin Test (DAT/Coombs test) – positive in AHTR.
  • Visual check of plasma for free hemoglobin (hemoglobinemia).
  • Urine analysis for hemoglobinuria.
  • Repeat crossmatch and blood group typing.
  • Baseline coagulation panel (PT, PTT, Fibrinogen, D-dimer) to assess for DIC.
• Viscoelastic Whole-Blood Assays (TEG® / ROTEM®):
  • Provides continuous graphic display of clot initiation, strength, and lysis.
  • Allows targeted transfusion:
    • Prolonged R-time (clotting time): Indicates coagulation factor deficiency → Give FFP.
    • Decreased Alpha-angle/K-time: Indicates poor fibrinogen/fibrin polymerization → Give Cryoprecipitate.
    • Decreased MA (Maximum Amplitude): Indicates poor clot strength → Give Platelets (or Cryoprecipitate).
    • Elevated Ly30: Indicates hyperfibrinolysis → Give Tranexamic Acid (TXA).

Management

• AHTR Management:
  • IMMEDIATELY STOP the transfusion.
  • Assess ABCs, maintain IV access, and vigorously hydrate with normal saline or Lactated Ringer's to maintain urine output.
  • Administer diuretics to protect renal tubules from free hemoglobin.
  • Return remaining blood and tubing to the blood bank.
• FNHTR Management: Stop transfusion; administer antipyretics (and corticosteroids for severe reactions). Future transfusions should use leukoreduced products.
• Management of Massive Hemorrhage:
  • Hemostatic Resuscitation: Early use of balanced ratios (1:1:1 of PRBC : FFP : Platelets). High FFP-to-RBC and Platelet-to-RBC ratios significantly reduce mortality and multi-organ failure.
  • Do not rely solely on hemoglobin triggers during active hemorrhagic shock; initiate rapid replacement to prevent dilutional coagulopathy.
  • Administer Tranexamic Acid (TXA) early (1 g loading dose, followed by 1 g over 8 hours).
• Specific Reversals & Scenarios:
  • Warfarin Toxicity with Active Bleeding: Administer FFP (or Prothrombin Complex Concentrate) + Vitamin K.
  • Hemophilia A: FFP is contraindicated for volume or routine replacement; specific recombinant Factor VIII or Cryoprecipitate is required.
  • Upper GI Bleed in Cirrhosis: Target restrictive Hb (7–8 g/dL). Over-transfusion (>9 g/dL) directly increases portal venous pressure and exacerbates variceal rebleeding.

Relevant Guidelines

• American Association of Blood Banks (AABB) Transfusion Triggers:
  • Hb < 7 g/dL: Transfusion recommended.
  • Hb 7–8 g/dL: Restrictive strategy; consider transfusion only if symptomatic (chest pain, orthostatic hypotension, tachycardia unresponsive to fluid, CHF).
  • Hb 8–10 g/dL: Transfusion generally not indicated (unless specific active ischemia or massive ongoing bleeding).
  • Hb > 10 g/dL: Transfusion NOT indicated.
• Massive Transfusion Protocol (MTP) Activation & Targets:
  • Activation Criteria: Actual or anticipated need for ≥ 4 units RBC in < 4 hours + hemodynamic instability; OR replacement of >50% blood volume within 3 hours; OR loss of one total blood volume (~70 mL/kg) in 24 hours.
  • Laboratory Targets during MTP:
    • Hemoglobin > 8–10 g/dL
    • Platelets > 50,000/μL (>100,000/μL for head trauma)
    • PT / PTT < 1.5 × control
    • Fibrinogen > 1.0 g/L (treat with Cryoprecipitate if lower)
• ATLS Classification of Hemorrhage (Adults):
  • Class I: Blood loss up to 15% (<750 mL). Normal HR, BP, Pulse Pressure.
  • Class II: Blood loss 15–30% (750–1,500 mL). Tachycardia (>100), Normal BP, Decreased Pulse Pressure.
  • Class III: Blood loss 30–40% (1,500–2,000 mL). Tachycardia (>120), Decreased BP, Confused mental status.
  • Class IV: Blood loss >40% (≥ 2,000 mL). HR >140, Decreased BP, Lethargic/negligible urine output.

Complications / Prognosis

• The Lethal Triad of Trauma: A self-reinforcing, deadly cycle comprising:
  1. Hypothermia (<35°C): Decreases enzymatic activity of coagulation factors (by 50% at 34°C) and prevents platelet activation (almost eliminated at 30°C).
  2. Acidosis (Base Deficit ≥ 6): Interferes with the assembly of coagulation factor (Xa/Va) complexes. Contributes more to coagulopathy than hypothermia and is harder to reverse.
  3. Coagulopathy (ACOT): Driven by hemodilution (crystalloids/PRBCs replacing whole blood) and consumption (DIC).
• Massive Transfusion Metabolic Complications:
  • Hypocalcemia: Citrate anticoagulant in stored blood rapidly chelates serum calcium. Presents with hypotension, narrow pulse pressure, and prolonged QT interval. Treat with slow IV 10% calcium gluconate.
  • Hyperkalemia: Potassium leaks from stored RBCs. Exacerbated by concurrent hypothermia and acidosis.
  • Dilutional Thrombocytopenia: Massive PRBC transfusion (which lacks platelets) drastically dilutes circulating platelets.
• Transfusion-Transmitted Infections:
  • Bacterial Contamination: Platelets are the most common source because they are stored at room temperature (20–24°C), favoring Gram-positive (Staph/Strep) growth.
  • Cytomegalovirus (CMV): Intracellular virus residing in donor leukocytes. Risk is virtually eliminated by leukoreduction filters.
  • Viral risks are now exceptionally low (HIV 1:1.8M, HCV 1:1.6M) due to Nucleic Acid Testing (NAT). The most common serious hazard (53%) is administrative labeling errors (wrong blood).
• Heparin-Induced Thrombocytopenia (HIT):
  • Immune-mediated IgG response against Heparin-PF4 complexes.
  • Causes paradoxical severe arterial and venous thrombosis.
  • Platelet counts drop by ~50% from baseline but rarely drop below 20,000/μL.
  • Stop all heparin immediately and initiate a direct thrombin inhibitor.

Past-Paper High Yield

• Most common reaction: Febrile non-hemolytic transfusion reaction (FNHTR) is the single most common adverse reaction, caused by recipient antibodies against donor leukocytes/cytokines.
• Platelet storage & infection: Because platelets are stored at room temperature, they are highly conducive to bacterial growth and are the most common source of transfusion-transmitted bacterial infections.
• FFP indications & limitations: FFP is indicated for rapid reversal of warfarin in active bleeding (provides all coagulation factors). It is never indicated for routine volume repletion. FFP contains no platelets; thus, it is completely useless for a patient with a prolonged bleeding time (which indicates a primary hemostasis/platelet defect).
• Massive Transfusion definition traps: Massive transfusion is defined quantitatively (volume/speed of RBC replacement). Although FFP is needed to treat the resulting coagulopathy, the need for FFP is not part of the diagnostic definition of massive transfusion.
• Citrate Toxicity: Causes HYPOcalcemia (not hypercalcemia) due to calcium chelation.
• Dilutional effect: Transfusion of PRBCs decreases platelet count via dilutional thrombocytopenia.
• Chemotherapy limits: Severe hematological suppression (myelosuppression causing neutropenia/thrombocytopenia) is the most frequent condition forcing alteration or delay of chemotherapy regimens.
• Transplant prerequisites: ABO blood group compatibility is the most absolute, critical initial barrier for cadaveric organ transplants to prevent hyperacute rejection.
• CMV transmission: Occurs specifically via donor WBCs.
• Hemolytic reaction in the OR: Classic signs (flank pain, chills, fever) are masked under anesthesia. Sudden, unexplained hypotension and diffuse microvascular oozing (DIC) are the classic presentations.

Memory Pearls

• Bacteria love Platelets (Stored at Room Temp).
• CMV lives in the Cells (White blood cells).
• Citrate Chelates Calcium → Hypocalcemia (Long QT).
• Transfusing PRBCs massively drops Platelets (Dilutional Thrombocytopenia).
• Lethal Triad: Hypothermia, Acidosis, Coagulopathy (HACk). Acidosis is the most detrimental to the coagulation cascade.

Gastrointestinal

Exam Map

• Gold Standard Imaging Paradigms: Endoscopic Ultrasound (EUS) is universally tested as the most accurate modality for T-stage (mural depth) and N-stage in GI malignancies (Esophageal, Gastric). CT Abdomen/Pelvis with contrast is the definitive next step for acute mechanical obstructions, diverticulitis, and equivocal appendicitis.
• Strict Clinical Contraindications: Diagnostic colonoscopy and barium enema are absolutely contraindicated during acute diverticulitis (perforation risk). Percutaneous drainage without scolicidal agents is contraindicated in hydatid cysts (anaphylaxis/seeding), and routine drainage is avoided in amebic liver abscesses (managed medically).
• Abscess & Peritonitis Algorithms: Localized collections (Hinchey II diverticulitis, appendiceal/psoas abscesses) mandate image-guided percutaneous drainage + IV antibiotics. Diffuse purulent/fecal peritonitis (Hinchey III/IV) requires emergent surgery (Hartmann’s procedure).
• IBD Operative Decision Points: Acute severe Ulcerative Colitis management hinges on the "Day 5 Rule" (failure of IV steroids by day 5 mandates Subtotal Colectomy or rescue biologics). Crohn's disease surgery is explicitly reserved for complications (strictureplasty, fistulas) to preserve bowel length.
• Obstruction & Volvulus Management: Sigmoid volvulus allows initial endoscopic decompression (flexible sigmoidoscopy) followed by elective resection. Cecal volvulus explicitly mandates primary surgical resection (Right Hemicolectomy).
• Scoring Systems & Criteria: High-yield exam traps involve exclusions in common scores. Ranson's criteria (Pancreatitis) excludes Amylase/Lipase. Child-Pugh score (Cirrhosis) uses PT/INR, not PTT or AST/ALT. Alvarado score guides appendicitis management (CT imaging for equivocal scores of 4-6).
• Perioperative Priorities: Elective splenectomy requires vaccinations against encapsulated organisms (SHiN) 2 to 4 weeks prior to surgery. Elective colorectal surgery prophylaxis must cover both Gram-negative bacilli and anaerobes (never monotherapy with a cephalosporin).
• Bariatric Surgical Physiology: Roux-en-Y gastric bypass causes dumping syndrome (useful for "sweet eaters"), cures GERD, but uniquely risks internal hernias. Sleeve gastrectomy removes ghrelin, cannot cause internal hernias, but worsens GERD.
• Lower GI Bleed Distinctions: Massive, acute, painless arterial bleeding = Diverticulosis or Angiodysplasia (not uncomplicated CRC). Painless, bright red dripping blood = Internal hemorrhoids (visceral innervation). Severe tearing pain with minimal blood = Anal fissure.
• Surgical Oncology Genetics: FAP (APC gene mutation) mandates prophylactic total proctocolectomy. Diffuse gastric cancer (linitis plastica) is linked to CDH1/E-cadherin and blood type A. MEN-1 differentiates a standard Gastrinoma (ZES) from one presenting with concurrent hypercalcemia.

GERD, hiatal hernia & achalasia

Core Concepts

• Gastroesophageal Reflux Disease (GERD) Definition: A condition developing when the retrograde flow of gastric contents into the esophagus causes troublesome symptoms and/or complications. It represents an imbalance between injurious refluxed material and physiological defensive mechanisms.
• Anti-Reflux Defensive Mechanisms:
  • Lower Esophageal Sphincter (LES): The primary barrier to reflux. It is a high-pressure zone created by:
    • Intrinsic Smooth Muscle Tone: The competence of the LES is primarily maintained by the intrinsic myogenic resting tone of the sphincter's smooth muscle (not merely by extrinsic intra-abdominal pressure).
    • Extrinsic Factors: The diaphragmatic crura act synergistically as an external sphincter (the 'pinchcock' effect) to increase pressure during inspiration.
    • Anatomical Factors: Angle of His, clasp and sling fibers, and an adequate length of intra-abdominal esophagus.
  • Clearance & Buffering: Esophageal peristalsis, gravity, salivary production (buffering acid), and epithelial barrier function (tight junctions).
  • Gastric Factors: Normal fundic compliance and proper gastric emptying.
• Pathophysiology of Reflux:
  • Transient LES Relaxations (TLESRs): The primary physiological mechanism for GERD. TLESRs are triggered by gastric fundus distention (e.g., after eating large meals), which actually increases the likelihood of acid reflux.
  • Mechanically Defective LES: Defined manometrically by one or more of the following:
    • Resting LES pressure < 6 mmHg
    • Overall sphincter length < 2 cm
    • Intra-abdominal esophageal length < 1 cm
• Physiological Modulators of LES Tone:
  • Increases tone: Gastrin (prevents reflux during gastric digestion), upright posture, weight loss.
  • Decreases tone: Alcohol, high-fat meals, peppermint, calcium channel blockers.
• GERD Phenotypes:
  • Non-Erosive Reflux Disease (NERD): Most common (60-70%).
  • Erosive Esophagitis (EE): Occurs in ~30%.
  • Barrett's Esophagus (BE): Occurs in 6-15%.

Diagnosis / Clinical Features

• Typical GERD Symptoms: Heartburn, acid regurgitation, dysphagia, odynophagia, hypersalivation (water brash).
• Atypical GERD Symptoms: Chest pain, cough, adult-onset asthma (50% of adult asthma patients have esophagitis or abnormal acid exposure), chest infections/lung fibrosis, otitis, laryngitis, sinusitis, dental erosions.
• Alarming Symptoms: Anemia, weight loss, dysphagia/odynophagia.
• Achalasia Presentation: Progressive, severe dysphagia to both solids and liquids, frequent regurgitation of undigested food, and weight loss.
• Esophageal Cancer Presentation: Progressive dysphagia to solid foods is the hallmark symptom. The vast majority present with advanced, late-stage disease (Stage III or IV) because the esophagus lacks a serosa and has a rich lymphatic supply.

Investigations

• Proton Pump Inhibitor (PPI) Trial: Standard first-line diagnostic and therapeutic approach for typical GERD symptoms. Routine 24-hour pH monitoring is not required before initiating empiric PPI therapy.
• Endoscopy (EGD) with Biopsy:
  • Initial diagnostic evaluation tool for structural abnormalities; mandatory before anti-reflux surgery.
  • Most patients (~60-70%) with classic GERD symptoms will have entirely normal esophageal mucosa on endoscopy (NERD).
  • Required in suspected achalasia strictly to rule out pseudoachalasia (malignancy).
• 24-Hour pH Impedance Study:
  • The most precise test to quantify reflux (measures total time, supine/upright time, number of episodes).
  • Probe is placed 5 cm above and 5 cm below the LES.
  • Indications: Atypical symptoms, absence of esophagitis on EGD, atypical/refractory response to medical treatment.
  • Preparation: Stop H2 blockers 3 days prior and PPIs 14 days prior.
• High-Resolution Esophageal Manometry:
  • GERD: Mandatory preoperatively to assess sphincter status and tailor the wrap according to esophageal pump function.
  • Achalasia: The definitive, gold standard, and most sensitive diagnostic test. Definitively shows absence of peristalsis (aperistalsis) in the esophageal body and incomplete relaxation of a hypertensive LES.
• Barium Swallow:
  • Used to assess hiatal hernia size/type and esophageal peristalsis.
  • In GERD, it demonstrates reflux in only 40% of cases (a negative test does not exclude GERD).
  • In Achalasia, shows a dilated esophagus with classic tapering "bird's beak" appearance at the GE junction (suggestive, but manometry is still required for confirmation).

Management

• Medical Therapy:
  • Intensive PPI therapy (2-3 months) plus lifestyle modifications (avoiding large/fatty meals, weight loss). PPIs reduce gastric acidity by 80-90%.
  • Limitation: 80% of patients experience recurrent symptoms 6 months after stopping treatment.
• Surgical Indications for GERD:
  • Complications of reflux not responding to medical treatment.
  • Symptoms interfering with lifestyle despite medical therapy.
  • Presence of a hiatal hernia.
  • Patient preference to avoid lifelong medical therapy (e.g., young age).
  • Markedly hypotensive LES on manometry.
• Pre-Operative Prerequisites: All patients must receive an intensive medical trial (2-3 months), and both endoscopy and esophageal manometry are mandatory before considering surgery.

Relevant Guidelines

• Diagnostic Pathway Based on Symptoms:
  • No Alarm Symptoms: Initiate a 6-week empiric trial of PPIs + lifestyle modifications. If no improvement, proceed to endoscopy.
  • Alarm Symptoms Present (Anemia, Weight Loss, Dysphagia): Immediate endoscopy is indicated.
• Los Angeles (LA) Grading System of Esophagitis:
  • LA-A: ≥ 1 mucosal break, ≤ 5 mm, does not extend between mucosal folds.
  • LA-B: ≥ 1 mucosal break, > 5 mm, does not extend between mucosal folds.
  • LA-C: Mucosal breaks extending between folds, involving < 75% of the circumference.
  • LA-D: Mucosal break(s) involving > 75% of the esophageal circumference.
• Hill Grading System of Hiatal Hernia (Endoscopic Retroflexion):
  • Hill I: Normal tissue fold tightly approximated around the endoscope.
  • Hill II: Slight opening and mild laxity of the tissue fold.
  • Hill III: Marked reduction in muscular collar with a clear opening around the endoscope.
  • Hill IV: Absolute absence of a muscular fold; wide open GE junction; endoscope sits in a large hiatal hernia cavity.

Operative / Procedural Notes

• Principles of Anti-Reflux Surgery:
  • The primary goal is to preserve the anti-reflux valve while maintaining the patient’s ability to swallow normally and belch (to relieve gaseous distension).
  • Ensure the wrap is placed over the sphincter, not the gastric body.
  • Only use the gastric fundus for the wrap (normal swallowing triggers vagally mediated relaxation of both the LES and fundus; using the fundus ensures the wrap relaxes appropriately).
  • Avoid injury to the vagus nerve (can cause failure of the sphincter to relax).
• Basic Surgical Steps:
  1. Restore intra-abdominal esophageal length.
  2. Excise the hernial sac.
  3. Posterior Cruroplasty (suturing the diaphragmatic crura posterior to the esophagus).
  4. Wrap the intra-abdominal esophagus with the fundus (tension-free).
• Types of Fundoplication:
  • Nissen: Complete 360^° wrap (associated with 90% long-term success but higher risk of post-op dysphagia/gas bloat).
  • Toupet: Partial 270^° posterior wrap.
  • Dor: Partial 180^°-200^° anterior wrap.
• Collis-Nissen: An esophageal lengthening procedure utilized if the patient has a foreshortened esophagus.

Complications / Prognosis

• Barrett's Esophagus (BE): Replacement of normal squamous epithelium with columnar epithelium (intestinal metaplasia). Premalignant condition requiring regular endoscopic follow-up.
  • Risk of dysplasia/cancer is 0.2%–0.5% per year (40x higher than the general population).
  • Virtually all esophageal adenocarcinomas arise from BE. 1/3 of patients with BE present with malignancy.
• Esophageal Cancer Prognosis: Overall survival remains exceedingly poor. The 5-year survival rate generally hovers around 20% (not 60%). Lymph node metastasis frequently involves the celiac nodes for distal tumors.
• Complications of Fundoplication:
  • Dysphagia: Very common early post-op (19-90%), but persists long-term in only 5-10%.
  • Gas Bloating Syndrome: Inability to belch. Occurs if the surgical valve is too tight, preventing retrograde venting during physiological gastric fundus distention.
  • Intrathoracic migration of the wrap (herniation).
  • Failure of the procedure (5-10%).

Past-Paper High Yield

• LES Pathophysiology: The intrinsic myogenic tone of the smooth muscle is the primary mechanism for resting LES competence.
• Gastric Distension Trap: Gastric fundus distension (eating large meals) does not decrease reflux; it actively INCREASES it by triggering TLESRs.
• Medical Management of GERD: Routine 24-hour pH monitoring is FALSELY claimed to be required before starting PPIs. An empiric PPI trial is standard care.
• Endoscopy Findings in GERD: It is FALSE that esophagitis is found in >90% of GERD endoscopies. Approximately 60-70% have NERD with a completely normal mucosal appearance.
• Achalasia Diagnostics: While a barium swallow showing a 'bird beak' is classic, high-resolution esophageal manometry is the definitive, gold standard, and most sensitive diagnostic test. You must select manometry if asked for the diagnostic confirmation.
• Esophageal Cancer Survival: Do not be tricked by optimistic numbers; 5-year survival is ~20% (poor prognosis), usually presenting late with solid food dysphagia.
• Substances Modulating Tone: Gastrin increases LES tone. Alcohol, fatty foods, peppermint, and CCBs decrease LES tone.

Memory Pearls

• Endoscopy pre-op: Can't cut without an EGD and a Manometry first.
• Typical GERD without alarm signs: Pop a PPI for 6 weeks, no scope needed yet.
• Achalasia: "Bird's beak" on barium = think it. Manometry (aperistalsis + failed LES relaxation) = confirm it. Endoscopy = rule out cancer.
• The Wrap: Nissen = 360^° (full circle). Toupet = 270^° (two-thirds, posterior). Dor = 180^° (half, anterior door). Use the fundus only!

Esophageal cancer

Core Concepts

• Pathophysiology of Spread: Local lymph node invasion occurs exceptionally early and rapidly because esophageal lymphatics are located within the lamina propria (unlike the rest of the GI tract where they are deep in the submucosa).
• Squamous Cell Carcinoma (SCC):
  • Location: Predominantly in the midportion of the esophagus.
  • Epidemiology: Dominates (90% of cases) in the high-risk "esophageal cancer belt" (Northern Iran to North-Central China) and Southern/Eastern Africa. Male-to-female ratio is 3:2.
  • Risk Factors: Smoking, excessive alcohol, dietary factors (high-temperature beverages, red meat, low folate/zinc, N-nitrous compounds, aflatoxin, pickled vegetables), achalasia, caustic strictures, atrophic gastritis, tylosis, and poor oral hygiene.
• Adenocarcinoma (ACA):
  • Location: Majority located near the gastroesophageal junction (GEJ).
  • Epidemiology: Male-to-female ratio is 10:1.
  • Risk Factors: GERD, Barrett’s metaplasia, smoking, alcohol, obesity, and Helicobacter pylori infection.

Diagnosis / Clinical Features

• Presentation: Early intramucosal cancers are often asymptomatic or present with subtle, transient "sticking" of solid foods or retrosternal burning.
• Advanced Symptoms:
  • Progressive solid food dysphagia.
  • Weight loss (due to dysphagia, diet changes, and tumor-related anorexia).
  • Regurgitation of saliva/food uncontaminated by gastric acid.
  • Hoarseness (recurrent laryngeal nerve involvement).
  • Chronic GI blood loss and aspiration pneumonia.
• Red Flag: Tracheobronchial fistula formation is a terminal complication; life expectancy is less than 4 weeks following its development. Massive upper GI hemorrhage indicates erosion into the aorta.

Investigations

• Upper Endoscopy (EGD) & Biopsy: Gold standard for diagnosis. Detects subtle plaques/nodules (early) or ulcerated/circumferential masses (advanced). Note: 17% of endoscopically "benign" looking lesions prove malignant on biopsy.
• Chromoendoscopy: Uses stains during EGD to highlight abnormal mucosa.
  • Lugol’s Iodine: Normal squamous mucosa (rich in glycogen) stains dark brown. Neoplastic/dysplastic tissue remains unstained ("Lugol-voiding" areas).
• Barium Esophagram: Demonstrates mucosal lumen narrowing, stricture length, and classic "apple-core" filling defects in advanced circumferential carcinoma. Cannot assess mural depth.
• Endoscopic Ultrasound (EUS):
  • Gold standard for T-staging (mural depth) and local N-staging.
  • Capable of fine needle aspiration (FNA) of suspicious regional lymph nodes.
  • Visualizes 5 distinct sonographic layers: (1) Balloon/mucosa interface [hyperechoic], (2) Mucosa/lamina propria/muscularis mucosae [hypoechoic], (3) Submucosa [hyperechoic], (4) Muscularis propria [hypoechoic], (5) Adventitia [hyperechoic].
  • Limitations: Poor at assessing tracheobronchial invasion, unable to pass through tight stenoses, cannot detect distant metastases.
• PET/CT Scan: Recommended for staging systemic disease. 78% sensitivity for identifying nodal disease and distant metastasis.

Management

• Nutritional Optimization: Required prior to treatment.
  • Crucial Pre-operative Caveat: Percutaneous Endoscopic Gastrostomy (PEG) tubes must be avoided if the stomach is planned as a surgical conduit. PEG placement risks injuring the right gastroepiploic artery, which is the vital vascular pedicle for the gastric pull-up. Use NG or jejunal feeding tubes instead.
• Endoscopic Resection (EMR/ESD): For highly selected superficial lesions (e.g., ≤ 15 mm, well-differentiated, < 500 µm submucosal invasion, negative margins, N0).
• Primary Surgery: Indicated for strictly early-stage disease (Stage 0, I, IIa / T1-T2, N0, M0).
• Neoadjuvant Therapy + Surgery: Standard of care for locally advanced, resectable disease (Stage IIB and III / T3 or node-positive, selected T4a).
• Primary/Definitive Chemoradiation: For Stage IV disease, unresectable tumors (T4b), or patients who are poor surgical candidates/refuse surgery.
• Endoscopic Palliation:
  • Stents: Self-expanding metal stents (SEMS); covered stents (silicone/polyurethane) are specifically beneficial for sealing tracheoesophageal fistulas. 95% effective for dysphagia.
  • Photodynamic Therapy (PDT): Injection of a photosensitizing agent activated by targeted laser light, causing selective tumor necrosis.
  • Other: Nd-YAG laser photoablation, thermal ablation, dilation, sclerotherapy.

Relevant Guidelines

• TNM Staging (Slide-derived criteria):
  • T1: Invades lamina propria or submucosa.
  • T2: Invades muscularis propria.
  • T3: Invades adventitia (beyond muscularis propria).
  • T4a (Resectable): Invades adjacent structures (pleura, pericardium, diaphragm).
  • T4b (Unresectable): Invades adjacent structures (trachea, bone, aorta).
  • N1 / N2 / N3: 1-2 nodes / 3-6 nodes / ≥ 7 nodes.
• Stage-Directed Treatment Algorithm:
  • Stage 0, I, IIA: Primary surgery.
  • Stage IIB, III: Trimodality therapy (Neoadjuvant chemoradiation followed by surgery).
  • Stage IV: Primary chemoradiotherapy.
• Siewert Classification (GEJ Adenocarcinomas):

Operative / Procedural Notes

• Esophagectomy Principles: Outcomes are similar between transthoracic (with thoracotomy) and transhiatal (without thoracotomy) approaches.
• Conduit Options for Reconstruction:
  • Stomach (Most common): Relies on the right gastric and right gastroepiploic artery pedicles.
  • Left colon: Ascending branch of left colic artery pedicle.
  • Right colon: Middle colic artery pedicle.
  • Jejunal free graft: Requires microvascular anastomosis.
• Route of Reconstruction: The new conduit is translocated most commonly via the posterior mediastinum, but can also be routed substernally, subcutaneously (anterior to sternum), or via the pleural spaces.
• Endoscopic Mucosal Resection (EMR) Technique: "Cap and snare" or injection method. A saline cushion is injected into the submucosal space to elevate the lesion away from the muscularis propria, preventing perforation during electrocautery snare resection.

Complications / Prognosis

• Unresectability criteria: Metastatic disease (peritoneal, lung, bone, adrenal, brain, liver), extraregional lymph node spread (paraaortic/mesenteric), or T4b local invasion (aorta, trachea, spine).
• 50% "cure rate" limit for locally advanced tumors undergoing trimodality therapy due to inadequate pathologic response and occult distant metastases.

Past-Paper High Yield

• Locally Advanced Management (T3N0): The definitive next step in management for T3N0 esophageal cancer is neoadjuvant chemoradiation therapy followed by surgical resection. Primary esophagectomy alone has unacceptably high recurrence rates for T3 tumors. Gastrectomies are reserved for gastric or Siewert III tumors.
• Staging Accuracy (EUS): Endoscopic Ultrasound (EUS) is tested heavily as the single most accurate modality for determining the exact T-stage (mural depth) and N-stage in esophageal cancer. It uniquely delineates the mucosa, submucosa, muscularis, and adventitia. CT is for distant/gross invasion; PET is for metabolic/systemic spread; Barium evaluates stricture length/luminal diameter, not mural depth.

Memory Pearls

• Lymphatic mapping: "Esophagus breaks the GI rules" – lymphatics start in the lamina propria, leading to incredibly early metastasis compared to colon/stomach cancers.
• Stomach conduit blood supply: Remember Right is Right (Right gastric + Right gastroepiploic are preserved; PEG tubes ruin the right gastroepiploic).
• Chromoendoscopy: Normal mucosa drinks the iodine (dark); cancer voids it (pale).

Gastric cancer

Core Concepts

• Epidemiology: Peak incidence in the 7th decade; more common in men (M:F = 5:3) and the elderly (<8% below age 55). High incidence in Japan and parts of Asia.
• Risk Factors:
  • Helicobacter pylori: Most important risk factor. Doubles non-cardia cancer risk (higher with cagA-positive strains). Induces severe chronic atrophic gastritis (11-fold risk for cardia cancer, 3-fold for non-cardia).
  • Diet: High salt intake (≥16g/day triples risk), heavily salted foods/processed meat (N-nitroso compounds), low fat/protein diet, frying/grilling (heterolytic amines).
  • Protective: Fruits and vegetables (antioxidants inhibit N-nitroso compound formation).
  • Medical/Lifestyle: Smoking (doubles risk, lasts 10–20 years after quitting), heavy alcohol, obesity, pernicious anemia (2–3x risk), previous gastric surgery.
• Gastric Anatomy:
  • Relations: Anterior (left liver lobe), superior (diaphragm), medial (liver), lateral (spleen), inferior (transverse mesocolon, caudate lobe, retroperitoneal structures).
  • Arterial supply (Celiac Axis): Left/right gastric arteries (lesser curvature), left/right gastroepiploic arteries (greater curvature).
• Physiology Tie-in (Gastrin): Secreted by G cells (gastric antrum), stimulates parietal cells directly and via histamine from enterochromaffin-like (ECL) cells. Inhibited by low pH (via somatostatin). Promotes mucosal growth.

Diagnosis / Clinical Features

• Clinical Presentation:
  • Early: Vague epigastric discomfort/indigestion (often ignored or misdiagnosed as gastritis). Pain is constant, unrelieved by food/antacids.
  • Late: Weight loss, dysphagia (proximal tumors), early satiety, vomiting, jaundice, ascites, cachexia.
• Physical Signs (Advanced/Metastatic): Palpable abdominal mass, Virchow’s node (supraclavicular), Sister Mary Joseph’s nodule (periumbilical).
• Ulcer Management Rules:
  • Gastric Ulcers: Carry a significant risk of malignancy. Must undergo mandatory endoscopic biopsy at the margins to rule out adenocarcinoma.
  • Duodenal Ulcers: Almost universally benign; routine biopsy is not necessary.
• Gastric Outlet Obstruction: Frequently causes vomiting of old, undigested food and classically results in a hypochloremic, hypokalemic metabolic alkalosis.

Investigations

• Upper Endoscopy (EGD): Modality of choice/Gold standard. Requires multiple biopsies (≥7) from the ulcer edges (avoid the necrotic crater).
• Endoscopic Ultrasound (EUS): Most accurate/sensitive modality for T-stage (depth of mural invasion) and N-stage (local lymph node involvement).
  • Excellent for T1 and T3; poor for T2 (cannot assess invasion into muscularis propria). Can perform FNA.
• Diagnostic Laparoscopy: Indicated for locoregional disease to detect occult peritoneal spread missed by CT/EUS (detects mets in 30% of "resectable" scans). Allows for peritoneal washings/cytology.
• CT Scan (Chest/Abdo/Pelvis): Detects distant metastases. Poor at distinguishing T1 vs. T2 and misses small (<5mm) peritoneal/liver mets.
• PET Scan: Not universally preferred for primary staging due to low avidity/sensitivity for signet ring cell carcinomas. Used for follow-up or suspected progression.
• Exploratory Laparotomy: Not a routine part of preoperative staging (replaced by CT/EUS/diagnostic laparoscopy).
• Tumor Markers (CEA, CA 19-9): Low sensitivity and specificity for initial diagnosis; used for postoperative surveillance only.

Relevant Guidelines

• Borrmann’s Classification (Macroscopic Appearance):
  • Type 1: Polypoid or fungating lesion
  • Type 2: Ulcerated lesion surrounded by raised borders
  • Type 3: Ulcerated lesion with infiltration into the gastric wall
  • Type 4: Diffusely infiltrating lesion (Linitis plastica when involving the whole stomach)
  • Type 5: Unclassified
• Lauren Classification (Histological/Epidemiological):

• Japanese Lymph Node Classification:
  • Group 1 (N1): Perigastric lymph nodes (lesser/greater curvature).
  • Group 2 (N2): Major arteries (left gastric, common hepatic, celiac, splenic).
  • Group 3 (N3): Distant/Para-aortic nodes.
• Staging System (TNM):
  • T1: Mucosa/submucosa. T2: Muscularis propria. T3: Subserosal tissue. T4: Serosa or contiguous organs.
• Treatment Algorithms:
  • Stage IV (M1): Palliation therapy only.
  • Stage M0 (Medically unfit): Palliation or RT + 5-FU radiosensitization.
  • Stage M0 (Fit) ≤ T1: Primary Surgery.
  • Stage M0 (Fit) ≥ T2: Neoadjuvant chemotherapy (ECF - MAGIC trial protocol) followed by surgery.

Operative / Procedural Notes

• Surgical Resection Principles: Extent determined by achieving an R0 margin (requires 6cm clearance from the tumor edge).
  • Proximal tumors: Total gastrectomy (reconstructed with Roux-en-Y).
  • Distal tumors: Subtotal gastrectomy.
• Lymphadenectomy (D1 vs D2): D2 dissection has higher morbidity and mortality compared to D1, with no difference in overall survival.
• Endoscopic Mucosal Resection (EMR): Indicated for early tumors that are well/moderately differentiated, <30mm, non-ulcerated, and non-invasive.
• Surveillance: Intensive for first 3 years (visits every 4-6 months with annual CT). Annual EGD for subtotal gastrectomy patients.

Complications / Prognosis

• Dumping Syndrome:
  • Early Dumping (15-30 mins post-meal): Rapid emptying of hyperosmolar chyme into the small intestine causes massive fluid shifts. Presents with explosive diarrhea, crampy pain, nausea, and reflex autonomic symptoms (palpitations, tachycardia, diaphoresis).
  • Late Dumping (2-3 hrs post-meal): Sudden large carbohydrate load causes massive insulin oversecretion, leading to profound reactive hypoglycemia.
• Linitis Plastica (Diffuse Type): Grows deep in the submucosa and muscularis layers. Does NOT commonly present with massive GI bleeding. Because it spares the superficial mucosa early on, superficial endoscopic biopsies frequently miss the tumor.
• Sleeve Gastrectomy Complications: Causes de novo or worsening GERD (destroys the angle of His and sling fibers, increases intra-gastric pressure). Note: Because no small bowel is bypassed or mesentery divided, internal hernias do NOT occur after sleeve gastrectomy (unlike Roux-en-Y).

Past-Paper High Yield

• Endoscopic Ultrasound (EUS) is repeatedly tested as the single best/most sensitive test for T (depth) and N (local lymph node) staging.
• Lauren Classification Differentiators:
  • Diffuse type = Blood group A, CDH1 genetic mutation, poorly differentiated, young females, easily missed on biopsy.
  • Intestinal type = H. pylori, environmental, older men, hematogenous spread. (Do not associate Intestinal type with Blood type A or CDH1).
• Helicobacter pylori Characteristics: Gram-negative, microaerophilic (not an obligate anaerobe), highly motile (flagella), and produces urease (neutralizes acid; it is NOT acidophilic).
• Preoperative Staging Trap: Exploratory laparotomy is NOT routine. Modern staging relies on less invasive EUS, CT, and diagnostic laparoscopy.
• Gastrointestinal Stromal Tumors (GIST): Arise from interstitial cells of Cajal, express CD117 (c-kit), and are treated with surgical resection. Trap: Lymph node metastasis is extremely rare; therefore, routine lymphadenectomy is NOT indicated.
• Esophageal Adenocarcinoma: Overwhelmingly the most common malignancy in the lower third of the esophagus (arises from Barrett's/GERD).
• Histology Identification Trap: A mesenteric tumor with solid fat cells (lipoblasts or mature adipocytes) is a liposarcoma, not a fibrous tumor, GIST, or carcinoid.
• Clostridium difficile Risk Factors: Prolonged broad-spectrum IV antibiotics, PPIs, malnutrition, long-term steroids. Trap: Oral contraceptive (OCP) use does NOT predispose to C. diff.

Obesity & bariatric surgery

Core Concepts

• Definition: Abnormal or excessive fat accumulation that impairs health, defined by Body Mass Index (BMI = kg/m²).
• Bariatric Surgery Classification:
  • Restrictive: Reduces stomach capacity to produce early satiety and reduce oral intake (e.g., Intra-gastric balloon, Adjustable gastric banding, Sleeve gastrectomy).
  • Malabsorptive: Reconstructs the small intestine to bypass nutrient absorption segments before mixing with digestive juices (e.g., Bilio-pancreatic diversion, Duodenal switch).
  • Mixed: Combines gastric restriction and foregut bypass (e.g., Roux-en-Y gastric bypass).
• Physiological impact of Sleeve Gastrectomy: Removes the gastric fundus, which significantly reduces the production of the hunger hormone ghrelin.
• Rapid weight loss and Gallstones: Post-bariatric rapid weight loss causes high rates of gallstone formation primarily via increased cholesterol mobilization and altered bile salt metabolism (supersaturating the bile), rather than isolated gallbladder stasis.

Relevant Guidelines

BMI Classification:

Morbid Obesity Criteria:

• International: BMI ≥ 40, OR BMI ≥ 35 with severe obesity-related morbidities.
• Asia-Pacific: BMI ≥ 37, OR BMI ≥ 32 plus Type 2 Diabetes or two obesity-related comorbidities.

Indications for Bariatric Surgery:

• International:
  • BMI > 40
  • BMI > 35 with comorbidities (e.g., HTN, T2DM, hyperlipidemia, OSA, impaired glucose tolerance)
  • Failed less invasive methods and at high risk for obesity-associated morbidity/mortality.
• Asia-Pacific:
  • BMI > 35
  • BMI > 32 with comorbidities
  • BMI > 30 with central obesity and at least two criteria for metabolic syndrome.
• Obesity Treatment Pyramid:
  • BMI 25+: Lifestyle modifications (diet, exercise).
  • BMI 27+ with comorbidities (or BMI 30+): Pharmacotherapy.
  • BMI 35+ with comorbidities (or BMI 40+): Surgery.

Operative / Procedural Notes

Restrictive Procedures:

• Intra-gastric balloon (IGB): Endoscopically placed to decrease gastric space. Maximum duration of 6 months. Often used prior to definitive bariatric surgery.
• Laparoscopic Adjustable Gastric Banding (LAGB): Constricting ring placed around the fundus, adjustable via a subcutaneous port. Safest and fully reversible. However, yields significantly less long-term weight loss and has a high long-term failure rate (band slippage, erosion). It does not cause dumping syndrome, making it a poor choice for "sweet eaters".
• Sleeve Gastrectomy (SG): Vertical division of the stomach (reducing size to ~25%) while leaving the pyloric valve intact. Does not alter GI tract continuity or primary absorption, but is irreversible.

Malabsorptive Procedures:

• Bilio-pancreatic Diversion (BPD): Horizontal subtotal gastrectomy with a long Roux-en-Y limb and short common alimentary channel.
• Duodenal Switch (DS): Utilizes a sleeve gastrectomy (preserving the pylorus) rather than horizontal gastrectomy, dividing the duodenum just distal to the pylorus.
• Note: Provide the greatest weight loss and highest T2DM cure rates (98%), but carry higher mortality and complication rates; typically reserved for super-morbidly obese patients.

Mixed Procedure:

• Roux-en-Y Gastric Bypass (RYGB): The "gold standard." Creation of a small (15-30 cc) proximal gastric pouch anastomosed to a jejunal Roux limb, bypassing the distal stomach, duodenum, and proximal jejunum.
• Highly effective for severe T2DM and hypertension.
• Excellent anti-reflux operation; treatment of choice for obese patients with severe GERD.
• Best suited for "sweet eaters" as high-sugar intake triggers dumping syndrome, providing negative reinforcement.

Comparison of Surgical Outcomes:

Complications / Prognosis

• Intra-gastric balloon: Severe N/V (early), dehydration, un-noticed deflation leading to bowel obstruction.
• Sleeve Gastrectomy: Staple line leakage (<5%), bleeding, worsens or induces GERD. Can still cause iron/B12 deficiency due to loss of parietal cell mass (acid/intrinsic factor). Crucially: Does NOT cause internal hernias.
• Roux-en-Y Gastric Bypass (RYGB):
  • Internal hernia: Specific complication due to the creation of mesenteric defects during bowel rearrangement.
  • Nutritional deficiencies: Decreased absorption of iron, Vitamin B12 (anemia), and calcium (bone disease). Requires lifelong supplementation.
  • Dumping syndrome: Rapid emptying of hyperosmolar contents into the small bowel causing nausea, sweating, faintness, and diarrhea.
  • Bypassed stomach cannot be evaluated via standard upper endoscopy.
• Malabsorptive (BPD/DS): Highest rates of nutritional deficiency, anastomotic leak, and perioperative mortality.

Past-Paper High Yield

• Internal Hernias: Occur exclusively in Roux-en-Y Gastric Bypass (due to mesenteric defects). They do not occur in Sleeve Gastrectomy.
• Sleeve Gastrectomy Characteristics: Removes the fundus (decreases ghrelin/hunger); it is strictly restrictive (not malabsorptive); it is contraindicated in severe erosive esophagitis because it worsens GERD.
• Gallstone Formation Post-Bariatric Surgery: Driven by supersaturation (cholesterol mobilization and altered bile salts), distinguishing it from pure stasis-induced gallstones seen in TPN, prolonged fasting, or spinal cord injury.
• Procedure Selection for "Sweet Eaters": RYGB is the treatment of choice; the resulting dumping syndrome serves as a behavioral deterrent. Gastric banding and sleeve gastrectomy do not consistently cause dumping syndrome and have high failure rates in this demographic.
• RYGB and GERD: RYGB is the bariatric procedure of choice for patients with severe GERD (it cures GERD, whereas sleeve gastrectomy worsens it).
• GI/Metabolic derangements (General GI Principles tested alongside this topic):
  • Gastric Outlet Obstruction (e.g., ulcer stricture): Prolonged vomiting of HCl results in a classic hypokalemic hypochloremic metabolic alkalosis.
  • Severe Acute Pancreatitis Risk Factors: Predictors of severe disease include Obesity (BMI >30), Age >55 years, Hemoconcentration (Hct > 44%), and CRP > 150 mg/L at 48 hours. Young age (<30) is NOT a risk factor.
  • Pancreatic Adenocarcinoma: Cigarette smoking is the most significant and well-established modifiable risk factor.

Memory Pearls

• Sleeve = Restrictive + Removes Ghrelin + Worsens GERD.
• Bypass (RYGB) = Restrictive & Malabsorptive + Cures GERD + Causes Dumping (good for sweet eaters) + Internal Hernia Risk.
• Gallstones post-op = Supersaturation (not just stasis).
• Vomiting acid = Hypokalemic, hypochloremic metabolic alkalosis.

Primary liver tumors

Core Concepts

• Overall most common malignant liver tumor: Metastatic deposits (most often from colorectal primaries). The liver is a massive filter for venous blood from the GI tract.
• Most common primary malignant liver tumor: Hepatocellular Carcinoma (HCC).
• Most common benign solid liver tumor: Cavernous hemangioma.
• Liver Transplant Indication: Liver cirrhosis (representing end-stage liver disease from varying etiologies) is the overall most common cause for liver transplant globally.
• Malignancy Risk Factors: Non-alcoholic fatty liver disease (NAFLD) can progress to NASH and cirrhosis, which significantly increases the risk of HCC.

Diagnosis / Clinical Features

Benign Liver Lesions:

• Cavernous Hemangioma (0.5–5%):
  • Most common benign tumor.
  • Overwhelmingly incidental and asymptomatic. Can cause pain or early satiety if very large.
  • Classified as "Giant" if > 6 cm.
• Hepatic Adenoma (HCA):
  • Rare, highly associated with young females taking oral contraceptive pills (OCPs) or hormone replacement therapy.
  • Usually incidental and asymptomatic, but can present with RUQ pain or hemorrhagic shock if it ruptures.
• Focal Nodular Hyperplasia (FNH):
  • More common in young women. Believed to arise from a congenital localized vascular anomaly (arteriovenous malformation).
  • Completely benign and typically asymptomatic.

Malignant Liver Lesions:

• Hepatocellular Carcinoma (HCC):
  • Strong male predominance. High geographic variation (Southeast Asia/Africa due to HBV; increasing in the West due to steatohepatitis).
  • Risk factors: HBV, HCV, cirrhosis (any etiology), alcoholism, hemochromatosis, Wilson's disease, aflatoxin, diabetes.
  • Often asymptomatic. Late presentation includes RUQ pain, weight loss, palpable mass, and hepatic decompensation in a known cirrhotic.
  • Rupture can cause hemoperitoneum and hypovolemic shock.
  • Fibrolamellar variant: Occurs in young patients without underlying cirrhosis; usually encapsulated with internal fibrous septations.
• Cholangiocarcinoma:
  • Second most common primary liver cancer; arises from biliary epithelium (typically extrahepatic).
  • Late presentation with obstructive jaundice.
  • Risk factors: Primary Sclerosing Cholangitis (PSC), Oriental cholangiohepatitis.
• Hepatoblastoma:
  • Primary liver cancer in infants/children. Arises from immature liver cells.
  • Presents as a palpable abdominal mass.
  • Co-exists with syndromes: FAP (Familial Adenomatous Polyposis), Trisomy 18, Trisomy 21.

Infectious Differential:

• Pyogenic Liver Abscess: Fever, RUQ pain, marked tenderness, and a hypoechoic liver mass. Strongly associated with previous biliary disease/surgery (e.g., post-cholecystectomy).

Investigations

Tumor Markers:

• Alpha-fetoprotein (AFP):
  • Elevated in: HCC (>400 ng/dL is highly specific), hepatoblastoma (>500 ng/dL), fulminant hepatitis infection, liver cirrhosis with active regeneration, and teratocarcinomas.
  • Normal in: Cholangiocarcinoma, fibrolamellar HCC variant, and ~30% of classic HCC cases.
• CA 19-9:
  • Elevated in cholangiocarcinoma.

Imaging Characteristics:

• Hemangioma: CT shows peripheral nodular enhancement with gradual centripetal (inward) fill-in.
• FNH: CT/MRI classically demonstrates a central stellate scar.
• Hepatic Adenoma: Hypervascular lesion on imaging.
• HCC: Triphasic CT scan uniquely shows early arterial filling and delayed venous washout.
• Pyogenic Abscess: Appears as a hypoechoic focal mass on ultrasound.

Biopsy Considerations:

• Hemangioma: Needle biopsy is contraindicated due to severe bleeding risk.
• Hepatic Adenoma: Percutaneous fine needle biopsy carries a high bleeding risk and is generally avoided.
• HCC: Biopsy is completely avoided if diagnostic imaging criteria and tumor markers are met in a high-risk patient (see guidelines below).

Management

• Hemangioma: Observation; surgical resection or embolization if symptomatic/complicated.
• Hepatic Adenoma:
  • First step: Stop OCPs/hormonal therapy immediately.
  • Surgery: Definitive surgical resection is indicated for large tumors (> 5 cm) due to significant risks of spontaneous hemorrhage and malignant transformation.
• Focal Nodular Hyperplasia: Observation. Surgery is only indicated if the diagnosis remains unclear.
• Hepatocellular Carcinoma:
  • Curative:
    • Resection is feasible if there is no cirrhosis, Child-Pugh A status, or for the fibrolamellar variant.
    • Liver transplantation (preferably cadaveric) if specific size criteria are met.
  • Palliative: Radiofrequency ablation (RFA), Transarterial chemoembolization (TACE), Ethanol injection, Sorafenib, Systemic chemotherapy, Transarterial radioembolization (TARE), or High-Intensity Focused Ultrasound (HIFU).
• Cholangiocarcinoma: Resection is the ideal treatment if achievable.
• Hepatoblastoma: Neoadjuvant chemotherapy followed by surgical resection or liver transplantation.

Relevant Guidelines

HCC Diagnostic Pathway

• Diagnosis WITHOUT Biopsy: Presence of cirrhosis or HBV/HCV + elevated AFP (>400 ng/dL) + typical imaging.
• Proceed to Biopsy: Absence of cirrhosis, negative HBV/HCV, and normal AFP levels.
• Diagnostic finding: Portal vein thrombosis in the presence of a liver lesion is considered diagnostic of HCC.

Liver Transplantation Criteria for HCC

• Single lesion < 5 cm.
• OR up to 3 lesions, each < 3 cm.

Child-Pugh Score for Liver Cirrhosis Severity

• Assesses severity using 5 parameters:
  1. Ascites
  2. Serum Albumin
  3. Prothrombin time (PT/INR)
  4. Serum Bilirubin
  5. Hepatic Encephalopathy (degree)
• Note: Serum AST/ALT are NOT components of the Child-Pugh prognostic score.

Complications / Prognosis

• Hepatic Adenoma: Significant risk of rupture/bleeding and harbors a small risk of malignant transformation to HCC.
• HCC:
  • With cirrhosis + untreated: Very poor survival (3–6 months).
  • With transplantation (meeting criteria): > 80% survival at 5 years.
  • Without cirrhosis + resected: Considered cured.
  • Tumor differentiation grade has no relation to prognosis.
• Hepatoblastoma: Survival is close to 100% if the tumor responds to neoadjuvant chemotherapy followed by resection/transplant. Poor prognosis if metastases are present.

Past-Paper High Yield

• Metastatic vs. Primary: The most common malignant tumor in the liver is metastatic deposits (often GI/colorectal). HCC is the most common primary malignancy.
• Adenoma vs. FNH Trap:
  • Adenoma: Associated with OCPs, has a risk of bleeding/malignancy, large tumors require resection. Most are asymptomatic (do not fall for the distractor that 50-70% are symptomatic). Stop OCPs immediately.
  • FNH: Benign hyperplastic vascular response, central stellate scar, completely benign, NO malignant transformation, observe.
• Biopsy Contraindications: Never needle-biopsy a hemangioma. Avoid percutaneous biopsy of hepatic adenomas due to hemorrhage risk.
• AFP Fallacies: Cholangiocarcinoma does not elevate AFP (elevates CA 19-9). AFP can be elevated by completely benign conditions like active liver regeneration in cirrhosis and fulminant hepatitis.
• Child-Pugh Trap: Serum AST is a marker of hepatocellular injury but is never part of the prognostic Child-Pugh scoring system.
• Biliary Anatomy Concept: Alagille syndrome involves a paucity of intrahepatic bile ducts. Conditions like Primary sclerosing cholangitis, Cholangiocarcinoma, Choledochal cysts, and Biliary atresia involve extrahepatic bile ducts.
• Choledochal Cysts: Strongly associated with an increased risk of cholangiocarcinoma.
  • Type 1: Fusiform dilation.
  • Type 2: Simple extrahepatic diverticulum.
  • Type 3: Choledochocele.
  • Type 4: Multiple dilations.
  • Type 5: Caroli disease (intrahepatic). Do not mistake Type 4 for Caroli disease.

Memory Pearls

• Adenoma Management (The 3 A's): Associated with OCPs, Avoid biopsy (bleeds), Amputate (resect) if > 5cm.
• FNH (Focal Nodular Hyperplasia): Female, No malignancy, Has a central scar.
• Hemangioma Diagnosis: Centripetal (outside-in) fill-in on CT.
• Child-Pugh Score (A-B-C-D-E): Albumin, Bilirubin, Coagulation (PT/INR), Distension (Ascites), Encephalopathy.

Liver metastasis

Core Concepts

• Hepatic Segmental Anatomy (Couinaud Classification):
  • The liver is divided into 8 functionally independent segments (not 10).
  • Divisions are based on the distribution of the portal triads (portal vein, hepatic artery, bile duct).
  • This French classification system is the universal standard for planning surgical resections.
• Segment I (Caudate Lobe) Anatomy:
  • Anatomically unique: Venous drainage bypasses the main hepatic veins.
  • Drains directly into the inferior vena cava (IVC) via short hepatic veins.
• Hepatic Circulation:
  • The liver has a dual blood supply.
  • Portal Vein: Supplies 75% of the hepatic blood flow.
  • Hepatic Artery: Supplies 25% of the hepatic blood flow (originates from the celiac trunk).
  • Main hepatic veins drain the liver into the IVC.
• Hepatic Physiology & Reserve:
  • Albumin Synthesis: Exclusively synthesized by hepatocytes in the liver.
  • Bilirubin Conjugation: Occurs entirely within the liver (not in the spleen).
  • Functional Reserve: The liver possesses massive reserve capacity; clinical signs of hepatic failure typically do not manifest until 80–90% of the liver parenchyma is destroyed (not 60%).
  • Regenerative Capacity: The liver can successfully regenerate even after resection of up to 70–80% of healthy tissue.

Management

• Colorectal Cancer (CRC) Liver Metastasis & Adjuvant Therapy:
  • Stage IV Disease: Bi-lobar liver metastasis is classified as Stage IV disease and necessitates systemic therapy.
  • Postoperative Adjuvant Chemotherapy Indications (e.g., post-anterior resection):
    • Node-positive disease (Stage III).
    • High-risk Stage II disease (e.g., T4 stage tumor, presence of lymphovascular invasion).
  • Exception: Gross tumor size alone (e.g., > 3 cm) does not upstage the tumor and is not an independent indication for postoperative adjuvant chemotherapy if regional nodes are negative.
• Differential Diagnosis Note - Pyogenic Liver Abscess:
  • When differentiating cystic/necrotic lesions from metastatic disease, note that E. coli is classically identified as the most common bacterial isolate in pyogenic liver abscesses (frequently originating from biliary or gastrointestinal tract infections).
  • Klebsiella is a common isolate specifically in Asian populations.
  • Streptococcus, Staphylococcus aureus, and Pseudomonas aeruginosa can cause abscesses but are much less prevalent.

Complications / Prognosis

• Hepatic Failure:
  • Leads to absent/decreased albumin synthesis and failure of bilirubin conjugation.
  • Hepatic Encephalopathy: Generally reversible with appropriate treatment (e.g., lactulose) once it develops; it is a misconception that it is universally irreversible.

Past-Paper High Yield

• Anatomy trap: Do not confuse the proportions of hepatic blood supply. The portal vein provides 75%, while the hepatic artery provides only 25%.
• Couinaud classification trap: There are exactly 8 functionally independent segments, not 10.
• Caudate lobe (Segment I): Routinely tested for its unique venous drainage—it drains directly into the IVC, bypassing the main hepatic veins.
• Oncology staging trap: In CRC, tumor size alone does not mandate adjuvant chemotherapy. Look for node-positive disease, T4 stage, or lymphovascular invasion.
• Microbiology of Liver Abscess: E. coli is the classic and most common overall isolate.
• Physiology fundamentals: Albumin is synthesized only in the liver. Liver failure requires 80–90% destruction, and the liver can regenerate after massive (70–80%) resection.

Memory Pearls

• Blood Supply 75/25 Rule: Portal is Primary (75%).
• Segment I = IVC: The caudate lobe gets a VIP direct pass to the Inferior Vena Cava.

Liver hydatid cyst

Core Concepts

• Pathogen: Echinococcus granulosus (a tapeworm).
• Life Cycle & Transmission:
  • Definitive host: Canines (dogs, wolves) house the adult tapeworm in the small intestine.
  • Infective stage: Embryonated eggs are shed in canine feces.
  • Intermediate host: Sheep, goats, swine, or humans (accidental ingestion).
  • Diagnostic stage: Hydatid cysts develop in target organs (Liver > Lungs > Brain > Bone).
• Cyst Wall Anatomy (Outer to Inner):
  • Pericyst: Outermost layer formed by the host's inflammatory response and fibrous tissue.
  • Ectocyst: Middle acellular, laminated, gelatinous chitinous membrane.
  • Endocyst: Inner germinal layer (nucleated); produces brood capsules and protoscoleces (hydatid sand).

Diagnosis / Clinical Features

• Latency Phase: Often asymptomatic; may present with dull abdominal pain.
• Pressure Effects: Compression of surrounding liver parenchyma, hilum, or hepatic veins.
• Suppuration: Occurs in 11–27% of cases, most commonly secondary to Escherichia coli infection.
• Cyst Rupture:
  • Obscure: Silent or occult rupture of the endocyst.
  • Communicant: Rupture into the biliary or bronchial tree (occurs in 5–25% of cases).
  • Free Rupture: Rupture into free body cavities (peritoneum, pleura) or adjacent organs (1–4%). Risk of severe anaphylaxis and peritoneal seeding.

Investigations

• Imaging:
  • Ultrasound: First-line diagnostic modality (classifies cysts via Gharby system).
  • CT Scan: Gold standard for detailing anatomy, size, location, and calcifications. Excellent for identifying complex or multi-organ disease (giant cysts).
  • MRI: Modality of choice for suspected biliary communication and delineating soft tissue relationships.
  • ERCP: Indicated if there is suspected biliary rupture or if daughter cysts are present in the common bile duct (CBD).
  • Plain X-ray: May reveal curvilinear calcification of the cyst wall.
• Immunology / Serology: Enzyme-Linked Immunosorbent Assay (ELISA), Indirect Hemagglutination Assay (IHA), Complement Fixation Test (CFT).

Relevant Guidelines

Gharby Ultrasound Classification (1981) Used to stage hydatid cysts and guide intervention:

• Type 1: Simple cyst. Unilocular, well-circumscribed, anechoic (active budding + hydatid sand).
• Type 2: Fluid collection with a split wall. Classic "Water-lily" sign (detached/collapsed germinal membranes).
• Type 3: Fluid collection with septa. Classic "Honeycomb" pattern or wheel-spoke appearance (multiseptated with daughter cysts).
• Type 4: Heterogeneous, complex, solid-appearing mass (simulates a liver abscess or tumor).
• Type 5: Highly reflecting thick wall with dense posterior acoustic shadow (calcified, inactive/dead cyst).

Overall Treatment Pathway

• Medical: Albendazole (ideal but rarely completely efficient alone).
• Radiological: Selective PAIR (Puncture, Aspiration, Injection, Re-aspiration).
• Surgical: Laparoscopic (attractive, minimally invasive) vs. Radical conventional (open surgery). Laparoscopy is emerging as the gold standard for suitable cysts, offering superior recurrence rates over PAIR.

Management

• Medical Therapy:
  • Albendazole: The anti-helminthic drug of choice.
    • Dosing: 10–14 mg/kg/day in three 28-day courses, separated by a 2-week drug-free interval.
    • Adjuvant/Neoadjuvant use: Kills the parasite preoperatively (8 weeks pre-op kills 90%) and acts directly on the germinal layer/protoscoleces. Reduces post-op recurrence rates dramatically (from 18% down to 5%).
    • Synergy: Praziquantel can be added to Albendazole for enhanced efficacy.
• Radiological (PAIR): Highly successful for Gharby Types 1–3 if strictly solitary/uncomplicated. Not for calcified (Type 5) cysts.
• Surgical Options:
  • Cystectomy Plus: Partial, subtotal, or total pericystectomy.
  • Hepatic Resection: Segmental resection, lobectomy, or total hepatectomy + liver transplant (reserved for extensive destruction).
  • Cavity Management: Must be addressed post-resection to prevent collections. Options include capitonnage (suturing walls from inside to obliterate space), omentoplasty (filling with vascularized greater omentum), or simple primary closure/drainage.

Operative / Procedural Notes

PAIR Technique (Percutaneous Puncture, Aspiration, Injection, Re-aspiration):

1. Percutaneously insert an 18G Seldinger needle.
2. Aspirate 25–35% of cyst volume.
3. Inject hypertonic saline (15-25% NaCl) at ~10% of aspirated volume. Wait 10 mins (allows protoscoleces death and pericyst separation).
4. Reaspirate completely.
5. If catheterized (6F catheter): wash out, place on external drain for 24h. If output <10 cc/24h (no bile leak), perform cystogram, inject 95% alcohol, reaspirate, and remove.

Open Surgical Principles:

• Isolation: Pack the operative field strictly with scolicidal-soaked abdominal packs to prevent anaphylaxis/seeding in case of spillage.
• Aspiration-Suction Technique: Halt patient breathing temporarily during initial puncture/aspiration to prevent diaphragmatic movement and spillage.
• Scolicidal agents: Sterimide 0.5% - 1%, hypertonic saline, or alcohol.
• Cysto-Biliary Communication Management:
  • Always actively look for biliary fistulae (present in up to 39% of surgical series).
  • Micro/simple fistulas: Primary suture.
  • Frank rupture (spillage into CBD): Requires preoperative EPST (endoscopic papillosphincterotomy), intraoperative transduodenal sphincteroplasty, and T-tube drainage of the CBD.
  • Clinical note: Simple tube drainage of the residual cavity with an open fistula has high infection rates; capitonnage, omentoplasty, or cyst excision are superior.

Complications / Prognosis

• PAIR Complications:
  • Fever/urticaria (10-20%) due to allergic reaction from spilled antigens.
  • Biliary fistula (5-10%).
  • Cyst cavity infection (~3%).
  • Overall recurrence is very low (0-4%) in appropriately selected patients.
• Surgical Complications: Wound infection (13.5%), subphrenic/liver abscesses, biliary leakage, chest problems. Post-op mortality is generally <3%.

Past-Paper High Yield

• Albendazole is the definitively tested drug of choice for cystic echinococcosis (hydatid disease).
  • Why? It has excellent tissue penetration into the cyst, unlike other agents.
  • Distractors: Mebendazole is less effective (poor penetration). Ketoconazole treats fungi. Metronidazole treats amoebas/anaerobes. Steroids treat anaphylaxis/inflammation but have no scolicidal effect.
• "Water-lily sign" on ultrasound strongly points to a Gharby Type 2 hydatid cyst (indicating detached endocyst membranes).
• Never drain a hydatid cyst percutaneously without scolicidal injection (like a simple abscess), due to the risk of anaphylactic shock and widespread intra-abdominal seeding.

Memory Pearls

• Hydatid Layers (Outside to Inside): Pericyst (Patient's tissue), Ectocyst (Egg-shell/chitinous), Endocyst (Embryo/germinal layer).
• Gharby's "Garden" on Ultrasound:
  • Type 2 = Water-lily (floating membranes).
  • Type 3 = Honeycomb (daughter cysts).
  • Type 5 = Rock (calcified, dead).

Gallstones

Core Concepts

Epidemiology & General Principles

• Gallstones are present in ~10% of the US population (30 million people).
• Incidence is 2–3 times higher in females and increases with age (found in 50% of females in their 70s, and 80% of individuals in their 90s).
• Two-thirds of all gallstones are completely asymptomatic and found incidentally.
• Biliary Sludge: A viscous mixture of mucin glycoproteins, calcium bilirubinate, and cholesterol crystals.
• Unconjugated Bilirubin: It is lipid-soluble (not water-soluble), tightly bound to albumin in the blood, conjugated by the liver, and cannot be excreted in the urine.

Pathogenesis of Gallstones Stone formation requires specific metabolic and physiologic derangements:

1. Solubilization Failure & Supersaturation: High cholesterol, decreased bile salts, or decreased lecithin.
2. Nucleation: Precipitation of cholesterol monohydrate crystals from a saturated solution. The gallbladder's impaired absorptive capacity or increased mucin secretion promotes this.
3. Stone Growth: Aggregation of crystals, calcium, and mucous glycoproteins (grows ~1–2 mm/year).
4. Gallbladder Stasis: Impaired contraction (increased fasting/residual volume) prevents clearance of crystals.

Types of Gallstones

• Cholesterol Stones (70–80%): Contain >50% cholesterol (Pure stones are 90–100% cholesterol, Mixed are 50–90%).
  • Mechanism: Formed when micelles and vesicles fuse to form multilamellar vesicles. Cholesterol crystals grow on the vesicle membrane and interact with mucin gel to precipitate.
  • Risk Factors: Elevated estrogens (puberty, pregnancy, OCPs, HRT), obesity (increased HMG-CoA reductase activity), rapid weight loss (stasis and increased excretion), spinal cord injury, increasing age (declined cholesterol 7-alpha hydroxylase), prolonged TPN, and medications.
  • Medications: Ceftriaxone (>2g/day precipitates with calcium; known as "pseudolithiasis") and Octreotide (alters bile flow and inhibits postprandial secretion).
• Black Pigment Stones (~10-15%): Contain <20% cholesterol.
  • Composition: Calcium bilirubinate monohydrate, calcium carbonate, calcium palmitate, and calcium phosphate.
  • Mechanism: Driven by high levels of conjugated bilirubin in bile. Endogenous mucosal β-glucuronidase converts conjugated bilirubin to unconjugated bilirubin. This binds to calcium, precipitates, and polymerizes in the mucin gel.
  • Risk Factors: Cirrhosis, chronic hemolysis (sickle cell anemia, thalassemia), ileal resection.
• Brown Pigment Stones (~5-10%): Contain <20% cholesterol.
  • Composition: High in calcium palmitate and calcium stearate.
  • Mechanism: Driven by biliary stasis and bacterial infection (e.g., E. coli). Bacterial β-glucuronidase produces unconjugated bilirubin, and bacterial phospholipase degrades lecithin into free fatty acids. These interact with calcium to form precipitates.
  • Location: Fundamentally formed within the bile ducts (primary duct stones).
  • Risk Factors: Oriental cholangiohepatitis, choledochal cysts, biliary strictures, periampullary diverticula, sphincterotomy.

Diagnosis / Clinical Features

• Acute Cholangitis: Ascending infection (not hematogenous) strictly driven by biliary stasis/obstruction (e.g., choledocholithiasis). Presents with direct (conjugated) hyperbilirubinemia.
  • Charcot’s Triad: RUQ pain, fever, jaundice.
  • Reynold’s Pentad: Charcot’s triad + hypotension + altered mental status (indicates severe disease).
• Mirizzi Syndrome: A large gallstone impacted in the cystic duct or gallbladder neck causes severe extrinsic mechanical compression of the common hepatic duct.
  • Presents with obstructive jaundice (elevated direct bilirubin, alkaline phosphatase, and GGT). LFTs are never normal.
• Emphysematous Cholecystitis: A rapidly progressive surgical emergency.
  • Etiology: Gas-forming organisms (Clostridium perfringens, E. coli; NOT Pseudomonas).
  • Unique feature: Frequently acalculous (up to 50% of cases occur without stones).
  • Demographics: Classically affects elderly diabetic males.
• Acalculous Cholecystitis: Typically seen in critically ill patients.
  • Risk Factors: Multiorgan failure, severe trauma, prolonged TPN, systemic infection.
  • Note: Gallbladder polyps are mucosal outgrowths and do not precipitate acalculous cholecystitis.
• Gallstone Ileus: A mechanical small bowel obstruction caused by a large gallstone eroding through the gallbladder wall.
  • Anatomy: The fistula typically forms between the gallbladder and the adjacent duodenum (cholecystoduodenal fistula), strictly not the ileum.
  • Presentation: Mostly affects females >70 years old. Stone classically lodges at the narrowest point: the ileocecal valve.

Investigations

• Transabdominal Ultrasound: Primary modality for gallbladder stones. However, it has a poor diagnostic yield for distal (lower) common bile duct (CBD) stones because the area is frequently obscured by overlying bowel gas from the duodenum.
• MRCP (Magnetic Resonance Cholangiopancreatography): Highly sensitive, specific, and completely non-invasive. It is the best non-invasive modality to map the biliary tree and exact location/cause of obstruction when choledocholithiasis is equivocal. Not contraindicated in acute cholangitis.
• CT Scan (Abdomen/Pelvis with contrast): Best next diagnostic step in a stabilized patient with suspected gallstone ileus to map the anatomy, define the fistulous tract, and locate the ectopic stone.
• Scoring Systems context: The Child-Pugh score is strictly used to assess the prognosis of liver cirrhosis. It is not used for acute cholecystitis or acute pancreatitis (which use Ranson's, APACHE II, etc.).

Management

• Asymptomatic Gallstones: Observation only (no prophylactic surgery required).
• Acute Cholangitis: Initial management is aggressive IV fluid resuscitation and broad-spectrum antibiotics, followed by urgent/early biliary decompression (usually via ERCP).
• Acute Pancreatitis (Gallstone-induced): The cornerstone of initial conservative management is aggressive IV fluid resuscitation to combat third-spacing and prevent pancreatic necrosis. (Prophylactic antibiotics or steroids are not routinely indicated).
• Emphysematous Cholecystitis: Medical management/observation alone is completely insufficient and highly lethal.
  • Requires emergent broad-spectrum antibiotics and surgical intervention (cholecystectomy).
  • If the patient is a poor/high-risk surgical candidate (e.g., severe COPD/multimorbidity), place a percutaneous cholecystostomy tube for immediate source control.
• Pyogenic Liver Abscess: Biliary tract disease (ascending cholangitis, choledocholithiasis) is the single most common underlying cause of pyogenic liver abscesses in developed countries.

Relevant Guidelines

Classification of Gallstones

• Cholesterol Stones (~80%): >50% Cholesterol
  • Pure: 90–100% Cholesterol (Make up ~5% of cholesterol stones)
  • Mixed: 50–90% Cholesterol (Make up 90–95% of cholesterol stones)
• Pigment Stones (~20%): <20% Cholesterol
  • Black Stones: Formed via endogenous pathways (high bilirubin).
  • Brown Stones: Formed via bacterial enzymatic degradation.

Operative / Procedural Notes

• Surgical Prophylaxis: For a standard elective laparoscopic cholecystectomy in a low-risk patient, a first-generation cephalosporin (Cefazolin) is the standard antibiotic of choice.
• Prophylactic Cholecystectomy Indications:
  • Indicated for Porcelain gallbladder (extensive intramural calcification) due to the increased risk of gallbladder carcinoma.
  • Not indicated for: Asymptomatic gallstones, asymptomatic 3 mm polyps (only resect if >10 mm), asymptomatic adenomyomatosis, or mild incidental chronic cholecystitis.
• Incidental Gallbladder Carcinoma:
  • If pathology reveals T1a disease (tumor invades lamina propria only) with negative margins following a simple cholecystectomy: Observation and routine follow-up only. The simple cholecystectomy is considered curative.
  • If disease is T1b (invades muscularis) or deeper: Requires re-operation for extended cholecystectomy (liver wedge resection + regional hepatoduodenal lymph node dissection).
• Incidental Liver Hemangioma: If a small, asymptomatic hemangioma (e.g., 1 cm) is found incidentally during cholecystectomy, the correct management is to observe and leave it alone. Biopsy is strictly contraindicated (hemorrhage risk).

Complications / Prognosis

• Emphysematous Cholecystitis: Carries a significantly higher risk of rapid gallbladder gangrene and perforation compared to standard acute cholecystitis due to rapid ischemia.
• Mirizzi Syndrome: Prolonged, untreated extrinsic compression can eventually lead to tissue necrosis and the formation of a cholecystocholedochal fistula.
• Post-Operative Distractors: Acute cholecystitis is generally unrelated to recent colonic/pelvic surgeries (e.g., sigmoid colectomy) and is the least likely direct post-operative complication compared to SBO, anastomotic leak, or C. difficile colitis.

Past-Paper High Yield

• Mirizzi Syndrome Trap: Do not be fooled by normal LFTs. Because it mechanically obstructs the common hepatic duct, patients will always present with an obstructive pattern on liver function tests (elevated direct bilirubin).
• Gallstone Ileus Trap: The fistula is a cholecystoduodenal fistula. Examiners frequently state it is a "cholecystoileal" fistula—this is anatomically FALSE.
• Emphysematous Cholecystitis Traps:
  1. It is frequently caused by Clostridium, NOT Pseudomonas.
  2. Over 50% are acalculous (occurring without stones).
  3. Medical management alone is the wrong answer. Emergent drainage/surgery is required.
• Ultrasound Limitations: Excellent for stones in the gallbladder, but explicitly poor for detecting stones in the distal CBD due to duodenal bowel gas shadowing.
• Acalculous Cholecystitis Risk Factors: Multiorgan failure, trauma, prolonged TPN. Gallbladder polyps do NOT cause acalculous cholecystitis.

Memory Pearls

• Rigler’s Triad (Gallstone Ileus): 1) Small Bowel Obstruction, 2) Pneumobilia (air in biliary tree), 3) Ectopic calcified gallstone at the ileocecal valve.
• Black vs. Brown Stones:
  • Black = Bilirubin (Hemolysis/Cirrhosis), endogenous mucosal glucuronidase.
  • Brown = Bacteria (Infection/Stasis), exogenous bacterial glucuronidase.

Acute pancreatitis

Core Concepts

• Definition: A reversible inflammation of the pancreas resulting from autodigestion by its own enzymes. It is an acute emergency presenting with sudden abdominal pain and lasting for days.
• Pathophysiology:
  • Normal state: Acinar cells produce inactive zymogens (e.g., trypsinogen). These are normally activated in the small intestine (trypsinogen is activated to trypsin by duodenal enteropeptidase/enterokinase) to prevent self-digestion.
  • Pathological state: Any early, intracellular activation of pro-enzymes leads to autodigestion. Trypsinogen is prematurely converted to active trypsin via Cathepsin B.
  • Amplification loop: Active trypsin triggers a massive feedback loop, activating more trypsinogen and other zymogens (chymotrypsin, elastase, phospholipase).
  • Enzymatic lesions:
    • Proteases → Proteolysis
    • Lipase/phospholipase → Fat necrosis
    • Elastase → Hemorrhage
• Etiologies:
  • Most common: Gallstones and Alcohol abuse (account for 90% of cases; biliary is most prevalent even in the West).
  • Other causes: Idiopathic, Trauma (penetrating), ERCP (iatrogenic), Hyperlipidemia (hypertriglyceridemia), Hypercalcemia (e.g., hyperparathyroidism), Autoimmune (Polyarteritis nodosa), Viral (Mumps), Steroids, Scorpion bite, Cardiopulmonary bypass (ischemia/hypoperfusion).
  • Drugs: Diuretics, Isoniazid (INH), Reverse transcriptase inhibitors, Metronidazole.

Diagnosis / Clinical Features

• Diagnostic Criteria: Diagnosis is established by the presence of 2 of the following 3 criteria:
  1. Characteristic abdominal pain.
  2. Serum amylase and/or lipase >3 times the upper limit of normal.
  3. Characteristic findings of pancreatic inflammation on contrast-enhanced CT (CE-CT).
• Classic Presentation:
  • Pain: Sudden onset; dull, boring, and steady. Usually in the epigastric region and classically radiates directly through to the back (in ~50% of cases). Gradually intensifies to a constant ache.
  • Associated symptoms: Nausea, vomiting (~85%), tachycardia (~80%), low-grade fever (~50%).
  • History clues: Recent ERCP, binge alcohol consumption, previous biliary colic, or a family history of hypertriglyceridemia.
  • Severe cases: Patients appear gravely ill with profound shock, toxicity, hypotension, and confusion.

Investigations

• Serum Markers:
  • Amylase: Easiest/most widely used. Rises immediately, peaks in a few hours, remains elevated for 3-5 days. Caveats: Can be normal in severe attacks, falsely negative in hyperlipidemic patients, and has an inverse correlation with severity. A 3-fold rise is diagnostic.
  • Lipase: Rises more dramatically than amylase (peaks 6-12 hours) and stays elevated longer (highly diagnostic at 72-96 hours).
• Imaging:
  • Plain X-ray: Non-specific signs include "Sentinel loop" (localized jejunal dilation) and "Colon cutoff sign" (abrupt termination of gas column at the splenic flexure).
  • Ultrasound: Used primarily for diagnosing gallstones and follow-up of pseudocysts.
  • Contrast-Enhanced CT (CE-CT): The gold standard for detecting and assessing severity. Routinely performed if severe pancreatitis is suspected. Findings include focal/diffuse enlargement, irregular enhancement, shaggy contour, fascial thickening, and fluid collections.

Relevant Guidelines

• Atlanta Revision (2013) - Classification of Severity:
  • Mild: Absence of organ failure and absence of local complications.
  • Moderately Severe: Local complications AND/OR transient organ failure (<48 hours).
  • Severe: Persistent organ failure (>48 hours).
    • Organ Failure Definitions: SBP ≤ 90 mmHg (Shock), PaO2 ≤ 60%, Creatinine ≥ 2.0 mg/dL, GI bleeding >500cc/24 hr.
• Ranson's Criteria (Prognostic Signs): Assessed at admission and during the initial 48 hours to predict mortality.
  • At Admission (Non-gallstone): Age >55, WBC >16,000, Blood glucose >200 mg/dL, LDH >350 IU/L, AST >250 U/dL. (Note: Amylase is NOT a criterion).
  • At 48 Hours (Non-gallstone): HCT fall >10%, BUN rise >5 mg/dL, Serum Calcium <8 mg/dL, Arterial PO2 <60 mmHg, Base deficit >4 mEq/L, Fluid sequestration >6 L.
• Balthazar CT Severity Index (CTSI): Combines CT Grade (0-4 points) with Necrosis Grade (0-6 points) to predict mortality and complications.
  • CT Grades: A (Normal = 0), B (Enlargement = 1), C (Peripancreatic fat infiltration = 2), D (Single fluid collection = 3), E (≥2 fluid collections = 4).
  • Necrosis Grades: None (0), <33% (2), 33-50% (4), >50% (6).
  • Scoring: 0-3 (Mortality 3%), 4-6 (Mortality 6%), 7-10 (Mortality 17%, Complications 92%).

Management

• Mild Pancreatitis:
  • Supportive care is the mainstay: NPO and IV fluids.
  • Disproven therapies: NG tubes, H2 blockers, anti-secretory agents (Somatostatin), and prophylactic antibiotics have no benefit in mild disease.
  • Diet resumption: Average 3-7 days. Criteria: absence of pain/tenderness and patient feeling hungry. Start with sips of water, build up to a low-fat/low-protein diet.
• Severe Pancreatitis:
  • Sterile Necrosis (Uncomplicated): Supportive + prophylactic antibiotics.
  • Mild Complication / Suspected Infection: CT-guided aspiration → Gram stain/culture → targeted antibiotics.
  • Frank Complication / Toxicity / Shock: Requires surgical debridement.
• Nutritional Support in Severe Disease:
  • TPN causes gastric mucosal atrophy, leading to bacterial translocation.
  • Jejunal tube feeding is superior to TPN and is preferred if NPO status extends >7 days.
• Biliary Pancreatitis specific pathway:
  • Bilirubin dropping: Laparoscopic cholecystectomy + intra-operative cholangiogram during the same admission.
  • Bilirubin persists: MRCP to confirm stone → ERCP → Laparoscopic cholecystectomy.

Complications / Prognosis

• Mortality Timeline:
  • Early phase (Week 1): 45-50% of deaths occur here. The most common cause of early death is Respiratory Failure / ARDS secondary to massive SIRS and capillary permeability.
  • Late phase (Weeks 2-3): Deaths are predominantly driven by sepsis due to infected pancreatic necrosis.
• Pancreatic Pseudocyst:
  • Encapsulated collection of enzymes, fluid, and necrotic debris in the lesser sac. Lacks an epithelial lining.
  • Management: Many resolve spontaneously. Asymptomatic cysts <5cm require only observation via periodic CT.
  • Intervention rules: Size/time are not the sole indications for drainage; symptoms drive intervention.
    • Infected pseudocyst (abscess): Requires external percutaneous drainage or surgical/endoscopic debridement.
    • Mature, symptomatic, uninfected pseudocyst: Requires internal drainage (surgical or endoscopic cystogastrostomy/cystojejunostomy).

Past-Paper High Yield

• Amylase and Severity: Amylase levels are used for diagnosis but do not correlate with disease severity or mortality. It is explicitly NOT part of the Ranson criteria.
• Hypocalcemia Mechanism: While lipase is secreted in its active form, it does not directly cause decreased serum calcium under normal conditions. Hypocalcemia in severe pancreatitis is due to fat saponification (calcium binding to free fatty acids released by autodigestion).
• Enzyme Secretion Physiology: Amylase and lipase are secreted in their active forms. Trypsinogen is secreted inactive and activated by enterokinase in the duodenum.
• Differential Diagnosis Traps:
  • Acute pancreatitis classically presents with epigastric pain radiating to the back. It is rarely confused with localized right lower quadrant (RLQ) pain (unlike Meckel's, gastroenteritis, testicular torsion, or right ureteric colic).
  • Hyperthyroidism is NOT a recognized cause of acute pancreatitis (though hyperparathyroidism is, via hypercalcemia).
  • Hyperthyroidism is also very rarely a cause of a severe "acute abdomen" (unlike DKA, acute intermittent porphyria, lead colic, or sickle cell crisis).
• Pseudocyst Drainage: Do not internally drain a frankly infected pseudocyst. Infected cysts require external drainage/debridement. Internal drainage is reserved for mature, uninfected, symptomatic cysts.
• General Surgery Pearl (BUN post-op): A rising BUN without a proportional rise in creatinine, particularly after vascular injury/surgery (e.g., hepatic artery injury), strongly indicates progressive internal bleeding, as blood proteins are absorbed by the gut.

Memory Pearls

• Diagnosis: Needs 2 of 3 (Pain, Enzymes >3x normal, CT findings).
• Ranson's Admission Criteria: Age, WBC, Glucose, LDH, AST (Amylase is absent!).
• Most common cause of early death: Respiratory failure (ARDS).
• Most common cause of late death: Sepsis (infected necrosis).
• Nutrition: Gut is best (Jejunal > TPN) to prevent bacterial translocation.

Pancreatic cancer

Core Concepts

• Epidemiology: 7th leading cause of cancer deaths worldwide. Predominantly affects patients >45 years old (peak incidence 65–79 years). Higher incidence in Western/industrialized nations and males (1.3:1).
• Tumor Origins:
  • >95% arise from exocrine elements.
  • Ductal adenocarcinoma: Accounts for 85–90% of all pancreatic neoplasms. It is an extremely aggressive malignancy.
  • Neuroendocrine tumors: Comprise <5% of cases.
• Tumor Location: Approximately 62% occur in the head of the pancreas, 10% in the body, and 6% in the tail.
• Risk Factors:
  • Environmental: Tobacco use (most significant), alcohol consumption, high dietary fat/caloric intake.
  • Metabolic/Medical: High fasting plasma glucose, high BMI, pancreatic cysts, chronic pancreatitis.
  • Genetics (5–10% of cases): Hereditary cancer syndromes (e.g., BRCA1/2 mutations, Peutz-Jeghers, Lynch syndrome, Li-Fraumeni).

Diagnosis / Clinical Features

• Classic Presentation: The most common initial symptoms are abdominal pain, jaundice, and weight loss.
• Tumors in the Pancreatic Head: Primarily present with painless, progressive obstructive jaundice (extrahepatic cholestasis).
• Key Physical Signs:
  • Courvoisier's Sign: Nontender but palpable, distended gallbladder at the right costal margin in a jaundiced patient.
  • Trousseau's Syndrome: Unexplained, migratory superficial thrombophlebitis reflecting a cancer-associated hypercoagulable state.
  • Pancreatic Panniculitis (Rare): Erythematous subcutaneous areas of nodular fat necrosis, typically located on the legs.
• Signs of Advanced, Incurable Disease:
  • Palpable abdominal mass or ascites.
  • Hepatomegaly (liver metastases).
  • Virchow's Node: Left supraclavicular lymphadenopathy.
  • Sister Mary Joseph's Node: Palpable periumbilical metastatic mass.

Investigations

• Laboratories: Elevated direct bilirubin and alkaline phosphatase (obstructive pattern), mild anemia. Tumor marker: CA 19-9 (used for staging and post-op monitoring, not primary screening).
• Initial Imaging of Choice: A multiphasic thin-slice CT scan of the abdomen (pancreatic protocol) is the best initial modality for both diagnosing and non-invasively staging suspected pancreatic cancer.
• ERCP / MRCP: Classically reveals the "double duct sign"—concurrent, severe dilation of both the main pancreatic duct and the common bile duct ending abruptly at the pancreatic head mass. ERCP allows for forceps biopsy, brush cytology, and therapeutic biliary stenting.
• Endoscopic Ultrasound (EUS): Provides high-resolution imaging and is excellent for EUS-guided fine-needle biopsy of small lesions or evaluating chronic/autoimmune pancreatitis. (Not universally required if CT confirms clearly resectable disease).

Management

• Surgical Resection: The only potentially curative treatment. Only 15–20% of patients present with resectable disease.
• Preoperative Considerations: May include staging laparoscopy, preoperative biliary drainage (for severe jaundice/cholangitis), and neoadjuvant chemotherapy.
• Surgical Procedures by Location:
  • Head of pancreas: Pancreaticoduodenectomy (Whipple procedure).
  • Body or Tail: Distal subtotal pancreatectomy, usually combined with splenectomy.
  • Entire gland: Total pancreatectomy.

Relevant Guidelines

• Continuum of Resectability for Pancreatic Adenocarcinoma:
  • High Resectability (Candidates for Surgery):
    • No distant metastases.
    • No arterial or venous involvement.
    • Venous involvement (SMV or portal vein) is <180 degrees with suitable proximal and distal vessels for reconstruction.
    • Gastroduodenal artery encasement up to the common hepatic artery without extending to the celiac trunk.
  • Low Resectability / Unresectable (Contraindications for Surgery):
    • Distant metastases (e.g., peritoneum, liver).
    • Metastases to lymph nodes beyond the peripancreatic tissues.
    • >180-degree encasement or occlusion of the superior mesenteric artery (SMA).
    • Unreconstructable SMV or SMV-portal vein confluence occlusion.
    • Direct involvement of the IVC, aorta, celiac trunk, or hepatic artery (absence of fat plane on CT/EUS).
• Inherited Cancer Syndromes Associated with Pancreatic Cancer:
  • Hereditary breast/ovarian cancer (BRCA1, BRCA2, PALB2)
  • Familial atypical multiple mole melanoma (FAMMM) (CDKN2A)
  • Peutz-Jeghers syndrome (STK11)
  • Hereditary nonpolyposis colon cancer/Lynch syndrome (DNA mismatch repair genes)
  • Hereditary pancreatitis (PRSS1, SPINK1)

Operative / Procedural Notes

• Pancreaticoduodenectomy (Whipple Procedure) Execution:
  • Resection margins: The head of the pancreas, distal stomach, duodenum, gallbladder, and distal common bile duct are resected en bloc.
  • Reconstruction (3 key anastomoses):
    1. Pancreaticojejunostomy (anastomosing the remnant pancreatic stump to the jejunum; can be end-to-side or end-to-end).
    2. Choledochojejunostomy (biliary tree to the jejunum).
    3. Gastrojejunostomy / Duodenojejunostomy (restoring GI continuity).
• Total Pancreatectomy Consequences: Results in permanent exocrine insufficiency (requiring enzyme replacement) and "brittle" diabetes (absolute lack of endogenous insulin and glucagon).

Complications / Prognosis

• Survival Rates: Extremely lethal malignancy. Even following successful curative resection, the 5-year survival rate for ductal adenocarcinoma is only ~20%.
• Prognostic Factors:
  • Nodal status (the most important prognostic factor in completely resected patients).
  • Tumor stage (TNM), surgical margin status, and tumor differentiation.
  • Lymphatic invasion and peri-operative CA 19-9 levels.
  • Pathological subtype: Papillary and mucinous cystadenocarcinomas carry a better prognosis than standard invasive ductal adenocarcinoma. Adenosquamous cancers carry a worse prognosis.

Past-Paper High Yield

• Contraindications to Resection: The presence of peritoneal metastasis indicates advanced, disseminated disease and is an absolute contraindication for curative pancreatic resection. Advanced age (>80 years), limited portal vein involvement (amenable to reconstruction), mild diabetes mellitus, or regional/peripancreatic lymph node invasion do not categorically preclude resection.
• Primary Environmental Risk Factor: Tobacco use (smoking) is the single most clearly established and significant environmental risk factor for the pathogenesis of pancreatic cancer.
• Tumor Genetics & Prognosis: The p16 tumor suppressor gene mutation, alongside K-RAS and SMAD4, is found in >90% of ductal adenocarcinoma cases. Remember that ductal adenocarcinoma has a much worse prognosis compared to papillary and mucinous cystadenocarcinomas.
• Optimal Imaging: A multiphasic thin-slice CT scan of the abdomen (pancreatic protocol) is always the best initial imaging modality for diagnosing and staging suspected pancreatic cancer.
• Chronic Pancreatitis Surgery: Intractable, debilitating abdominal pain that fails medical and endoscopic therapy is the most common indication for surgical intervention in chronic pancreatitis (not diabetes or steatorrhea, which are managed medically).
• Insulinoma Diagnostics (Endocrine Tumor): In functional endogenous insulinomas, insulin is secreted alongside equimolar amounts of C-peptide. During a hypoglycemic episode, laboratory testing will reliably show high insulin and high C-peptide levels. Low C-peptide with high insulin firmly suggests surreptitious exogenous insulin administration.

Memory Pearls

• Double Duct Sign: Seen on MRCP/ERCP/CT; simultaneous dilation of the common bile duct and pancreatic duct strongly points to a pancreatic head mass.
• Courvoisier's Law: Painless jaundice + palpable non-tender gallbladder = unlikely to be gallstones; suspect pancreatic/biliary malignancy.
• Sister Mary Joseph vs. Virchow: Sister Mary Joseph = periumbilical node; Virchow = left supraclavicular node. Both mean Stage IV/unresectable disease.

Cystic tumors of the pancreas

Core Concepts

• Epidemiology: Increasing diagnostic rate (~2.6 per 100 individuals/year) due to better imaging, an aging population, and a lower threshold for abdominal CT scans.
• WHO Classification:
  • Neoplastic: Intraductal papillary mucinous neoplasms (IPMNs), Mucinous cystic neoplasms (MCNs), Serous cystadenomas (SCAs), Solid pseudopapillary tumors (SPTs).
  • Non-neoplastic: Inflammatory Pseudocysts (account for the majority of cystic lesions; surrounded by granulation tissue, lack true epithelium; occur in ~50% of acute pancreatitis cases).
• Neoplastic Histological Grouping:
  • Mucin-producing (Malignant Precursors): IPMN, MCN. Covered with endoderm-derived columnar epithelium.
  • Nonmucin-producing (Usually Benign/Low-grade): SCA, SPT. Lined by simple cuboidal epithelium.

Diagnosis / Clinical Features

• General Presentation: 20% of unexplained pancreatitis occurs due to underlying cystic neoplasms. Symptoms, when present, typically include abdominal pain, palpable mass, weight loss, or infrequently, jaundice.
• Key Differentiators of Neoplastic Cysts:

Investigations

• Imaging Modalities:
  • CT Scan: First line for anatomical delineation.
  • MRCP: Modality of choice to detect communication with the main pancreatic duct (essential for differentiating BD-IPMN from MCN or oligocystic SCA).
  • EUS (Endoscopic Ultrasound): Crucial for evaluating mural nodules and differentiating mucinous from non-mucinous cysts via fluid aspiration.
• Cyst Fluid Analysis:
  • CEA Level: Best predictor for mucinous lesions; CEA > 192 ng/mL strongly indicates a mucinous cyst (IPMN/MCN).
  • Glucose: Low glucose has diagnostic accuracy comparable to high CEA for mucinous lesions.
  • Amylase: Low amylase confidently excludes a pseudocyst. High amylase is nonspecific (can be elevated in pseudocysts, IPMN, SCA, or MCN).
  • Fluid content:
    • SCA = Serous fluid, low CEA.
    • MCN/IPMN = Mucin, high CEA.
    • SPT = Necrotic debris and blood.

Management

• Pseudocysts: Zero malignant potential; manage conservatively or with drainage if symptomatic/complicated.
• Serous Cystadenomas (SCAs):
  • Observation is standard since the risk of pancreatectomy outweighs the <1% malignancy risk.
  • Resection indicated if: Symptomatic, significant growth (>4cm size limits), unclear diagnosis, or concern for invasion.
• Solid Pseudopapillary Tumors (SPTs):
  • Typically cured with surgical resection.
  • Metastases (present in 15%) or locally advanced disease with vascular invasion are criteria for malignancy but do not always preclude resection, as long-term survival is often possible.
• IPMN-MD & MCN Resection Principles:
  • High risk of High-Grade Dysplasia (HGD) or invasive carcinoma.
  • Resection is generally recommended (see Guidelines below).

Relevant Guidelines

Mucinous Cystic Neoplasms (MCNs):

• IAP (2012): Recommends surgical resection for all MCNs regardless of size.
• European Guidelines (2018): Recommends resection only if: Cyst > 4 cm, enhancing mural nodules, or symptomatic (jaundice, pancreatitis, new-onset DM). Asymptomatic cysts < 4 cm can be observed (EUS every 6 months for 1 year, then yearly).

Main-Duct IPMN (IPMN-MD):

• IAP (2017): Surgical resection for all with duct > 10 mm. Dilation of 5–10 mm is a "worrisome feature" requiring EUS (no immediate resection recommendation).
• European Guidelines (2018): Dilation ≥ 10 mm is an absolute indication for resection. Dilation of 5–10 mm is a relative indication.

Branch-Duct IPMN (IPMN-BD) Resection Guidelines:

• IAP (2017) Classification:
  • "High-Risk Stigmata" → Resect without further testing: Symptomatic obstructive jaundice, enhancing mural nodule > 5 mm, Main Duct > 10 mm. (Associated with 40% risk of IPMN-related death).
  • "Worrisome Features" → Evaluate with EUS: Pancreatitis, cysts > 3 cm, enhancing/thickened nodule < 5 mm, MD 5–9 mm, abrupt change in PD caliber with distal atrophy, lymphadenopathy, increased CA19-9, cyst growth rate > 5 mm/2 years. (96% 5-year disease-specific survival with non-operative management).
• European Guidelines (2018):
  • Absolute indications: Jaundice, cytology positive for HGD/cancer, enhancing mural nodule > 5 mm, or a solid mass.
  • Relative indications: Growth > 5 mm/year, CA19-9 > 37 U/mL (without jaundice), MD 5–9.9 mm, cyst > 4 cm, new-onset DM/acute pancreatitis, enhancing mural nodule < 5 mm.

Operative / Procedural Notes

• IPMN-MD Resection:
  • Extent of resection is controversial but aims to remove all invasive carcinoma and High-Grade Dysplasia (HGD).
  • Frozen section is mandatory intraoperatively to ensure a free resection margin.
  • Positive margins for HGD imply a high risk of progression; Low-Grade Dysplasia (LGD) at the margin has a low recurrence risk.
  • Total pancreatectomy is indicated in select cases.

Complications / Prognosis

• IPMN vs Ductal Adenocarcinoma: IPMN-derived adenocarcinoma has a significantly better prognosis than primary pancreatic ductal adenocarcinoma (5-year survival 43–60% vs 15%). Primary ductal adenocarcinoma is far more associated with lymph node metastasis, advanced T-stage, perineural, and vascular invasion.
• SPT Risk of Progression: Associated with male gender, positive margins, positive lymph nodes, and lymphovascular invasion.

Past-Paper High Yield

• IPMN Malignant Potential: Main-duct IPMN carries the highest risk of malignant transformation to invasive pancreatic adenocarcinoma (30% to >70%) among cystic lesions. Standard guidelines strongly recommend surgical resection for all main-duct IPMNs in operative candidates. By contrast, pseudocysts have zero malignant potential, serous cystadenomas have near-zero risk, and branch-duct IPMNs/MCNs have a substantially lower risk than main-duct IPMN.
• Mirizzi Syndrome Type II: Although primarily a biliary issue, note that Mirizzi syndrome type II involves a cholecystobiliary fistula specifically affecting the common bile duct (Type I is purely extrinsic compression of the common hepatic duct).

Memory Pearls

• CEA > 192: Mucinous (MCN or IPMN).
• Honeycomb / Central Stellate Scar: Serous cystadenoma (Head, female 60+, Benign).
• Eggshell calcification + Ovarian stroma: MCN (Body/tail, female 40s).
• Grape-like clusters + Duct communication: BD-IPMN (MRCP is key).
• Solid/cystic + Hemorrhage + Young Female: SPT / Frantz tumor.

Inflammatory bowel disease

Core Concepts

• Inflammatory Bowel Disease (IBD) management requires a multidisciplinary team (MDT) including colorectal surgeons, gastroenterologists, specialized nurses, dieticians, and pathologists.
• Ulcerative Colitis (UC) is classically a continuous mucosal inflammatory disease universally involving the rectum and progressing proximally.
  • Backwash Ileitis: In severe pancolitis (10–20% of cases), inflammation can continuously "spill over" from the colon into the terminal ileum. This finding favors UC over Crohn's disease.
• Crohn’s Disease (CD) is characterized by discontinuous ("skip") lesions and transmural inflammation that can affect any part of the gastrointestinal tract (mouth to anus).
  • Rectal Sparing: Unlike UC, CD characteristically spares the rectum.

Diagnosis / Clinical Features

• Ulcerative Colitis (UC)
  • Presents with painful, bloody diarrhea and tenesmus (a feeling of incomplete evacuation due to direct rectal mucosal inflammation).
  • Extra-intestinal manifestations (EIMs):
    • Respond to colectomy: Peripheral arthritis, uveitis, iritis.
    • Do NOT respond to colectomy: Ankylosing spondylitis, sacroiliitis, Primary Sclerosing Cholangitis (PSC).
• Crohn's Disease (CD)
  • Classically presents with abdominal pain, stricturing/obstructive symptoms, and fistula formation (due to transmural inflammation).
  • Gross bleeding per rectum occurs but is less frequent than in UC.
  • Enterocutaneous and complex perianal fistulas are characteristic. Note: A complex perianal fistula typically presents with pain and purulent discharge, but does not classically cause tenesmus.

Investigations

• Endoscopy / Histology
  • UC: Mucosal inflammation, continuous involvement, crypt abscesses.
  • CD: Cobblestone appearance of the mucosa, strictly non-caseating granulomas, and discontinuous skip lesions.
• Radiology
  • Barium Enema (UC): Demonstrates a "lead pipe" appearance (a rigid, foreshortened colon lacking normal haustra) indicating chronic UC.
  • Abdominal X-Ray (AXR): Essential in acute presentations to evaluate for toxic megacolon (diameter > 5.5 cm or cecum > 9 cm).
• Cancer Surveillance in UC
  • High risk of malignancy (1-2% per year after 10 years). Risk factors: pancolitis, concomitant PSC (50% risk at 25 years), and dysplasia.
  • Dysplasia Progression:
    • Low-grade dysplasia (LGD) progression to High-grade dysplasia (HGD) or cancer: 0.5%–54%.
    • Risk of concomitant cancer is up to 19% in LGD, and up to 58% in HGD / Dysplasia-Associated Lesion or Mass (DALM).
    • ≥ 3 biopsies with LGD increases progression risk six-fold.

Management

• Acute Severe Ulcerative Colitis
  • Initial management involves IV steroids, DVT prophylaxis, rule out infections (C. diff, CMV), and daily surgical/MDT review.
  • A stool frequency > 8/day or CRP > 45 mg/L at Day 3 predicts the need for surgery in 85% of cases.
  • IV steroids have no benefit beyond 7–10 days. By Day 5, if the patient is refractory to IV steroids, immediate escalation is required (rescue therapy with Cyclosporine/Biologics OR emergency colectomy).
• Indications for Emergency Surgery in UC
  • Refractory to medical management by Day 5.
  • Perforation (up to 40% mortality if performed after perforation vs. 2-8% before).
  • Hemorrhage.
  • Toxic megacolon with systemic toxicity.
• Indications for Elective Surgery in UC
  • Medical intractability (failed treatment, steroid dependence).
  • Poor quality of life (chronic hospitalizations, anemia, malnutrition).
  • Malignancy or significant dysplasia.
  • Note: The concurrent diagnosis of Primary Sclerosing Cholangitis (PSC) alone is NOT an indication for colectomy, as colectomy does not alter the clinical course of PSC.
• Indications for Surgery in Crohn's Disease
  • Surgery is strictly for complications: stenosis/stricture causing obstruction, fistulas (enterocutaneous, intra-abdominal), abscess, free perforation, or acute/chronic bleeding.
  • Preoperative malnutrition heavily increases the risk of poor tissue healing; optimizing preoperative nutrition is the most significant factor in decreasing anastomotic leak rates in CD surgery.

Relevant Guidelines

• Severity Classification of Acute Ulcerative Colitis (Truelove & Witts Criteria)
  • Severe Episode: ≥ 6 bloody stools/day, PLUS signs of systemic toxicity:
    • Heart Rate > 90 bpm
    • Temperature > 37.8^°C
    • Hemoglobin ≤ 10.5 g/dL
    • ESR (Hemosedimentation speed) > 30 mm/hr
• Acute Severe Colitis Management Timeline
  • Day 1: Initiate IV Steroids.
  • Day 3: Assess response. If poor (e.g., CRP > 45), discuss surgery and involve stoma therapist.
  • Day 5: Consideration of definitive colectomy vs. rescue therapy (Cyclosporine/Biologics).

Operative / Procedural Notes

• UC Acute Surgery: Subtotal Colectomy and Ileostomy
  • The procedure of choice in the acute emergency setting.
  • Leaves a rectal stump (closed, mucus fistula, or subcutaneous stump).
  • Mortality ~3%; stump blowout risk 2–12%. Allows confirmation of diagnosis, halts medical immunosuppression, and improves nutritional status before a delayed secondary reconstructive stage (e.g., at 6 months).
• UC Elective Surgery: Restorative Proctocolectomy with Ileal Pouch-Anal Anastomosis (IPAA)
  • Curative "lifestyle operation" performed in one or two stages.
  • Pouch configuration (J-pouch vs. W-pouch) demonstrates no statistically significant difference in functional outcomes or stool frequency.
  • Rectal cuff surveillance post-IPAA is not necessary unless there was dysplasia/cancer in the original specimen.
• Crohn's Disease Surgery
  • Goal: Bowel conservation to prevent short bowel syndrome. Avoid wide resections.
  • Segmental Resection: Resecting only the overtly symptomatic diseased segment.
  • Strictureplasty (Heineke-Mikulicz): Longitudinal incision across a benign stricture, closed transversely to widen the lumen without sacrificing bowel length.
  • Intraoperative finding: Serosal involvement with fat wrapping ("creeping fat") is highly pathognomonic for CD.

Complications / Prognosis

• Fibrotic Colonic Strictures
  • Crohn's Disease, Ischemic Colitis, and Diverticular Disease frequently heal with intense fibrosis, leading to benign strictures.
  • Ulcerative Colitis: Benign fibrotic strictures are extremely rare in uncomplicated UC. If a stricture is found in a UC patient, it is highly suspicious for malignancy until proven otherwise.
• Gastrointestinal Fistulas
  • Crohn's disease is a classic cause due to transmural inflammation. Diverticulitis causes >50-60% of colovesical fistulas. Radiation, malignancy, and surgical trauma (most common iatrogenic cause) are also known culprits.
  • Amoebic infections cause colitis or liver abscesses but are not known to form fistulas.
• Post-IPAA Complications (UC)
  • Pouchitis: Occurs in up to 50% of patients.
  • Pouch Failure: 5.9% at 10 years (driven by pelvic sepsis, leaks, or delayed diagnosis of CD).
  • Fertility: Fecundity is reduced by 40–50% following restorative proctocolectomy.
  • Function: Nocturnal seepage (15% at 20 yrs) and urgency persist, though overall continence is acceptable.
• Crohn's Disease Recurrence
  • Smoking is the single most important, modifiable risk factor. It significantly increases disease onset, severity (linear dose-response), incidence of relapse, and recurrence after surgical resection.

Past-Paper High Yield

• Clostridioides difficile Colitis: The primary mechanism of antibiotic-induced pseudomembranous colitis is the loss of normal protective gut flora. Risk factors include broad-spectrum antibiotics, systemic steroids, and PPIs. Cigar smoking is NOT a recognized risk factor.
• Tenesmus & Bleeding Differentials: Tenesmus is caused by direct rectal vault mucosal irritation. UC, rectal adenomas, internal rectal prolapse, and radiation proctitis cause tenesmus. Complex perianal fistulas do not.
• Lower GI Bleed: Diverticulosis is the most common cause of massive, painless lower GI bleeding in older adults, often requiring transfusion.
• Hemorrhoidal Bleeding: Classically presents as bright red blood per rectum (hematochezia) coating the outside of the stool, dripping into the bowl, or seen on toilet paper. Dark blood intimately mixed within the stool indicates a proximal source (e.g., CRC, IBD).
• Colovesical Fistula: Diverticulitis is by far the most common underlying cause (>50-60%), followed by malignancy and Crohn's disease.
• Pediatric Inguinal Hernias: A strong, reliable history of an intermittent groin bulge from a parent is sufficient to justify elective surgical repair (herniotomy) in infants, even if the hernia is absent on clinical exam. Ultrasound is rarely needed.
• Bilirubin Production: The normal daily production of bilirubin in a healthy adult is approximately 250 to 300 mg/day (0.25 - 0.3 g/day).

Memory Pearls

• UC hallmark triad: Continuous, Mucosal, Rectum involved.
• CD hallmark triad: Skip lesions, Transmural, Rectum spared.
• Stricture rule in UC: "A stricture in UC is cancer until proven otherwise."
• Day 5 UC Rule: Severe UC failing IV steroids by day 5 → Cut (Subtotal Colectomy) or Cyclosporine/Biologic. Do not increase/switch steroids.

Intestinal obstruction

Core Concepts

• Definition: Interruption in the normal flow of intestinal contents.
• Classification:
  • Mechanical: Physical blockage (Simple or Strangulated).
  • Functional (Ileus/Adynamic): Interruption due to decreased motor activity (e.g., post-operative, metabolic, sepsis).
• Small Bowel Obstruction (SBO) Etiologies: Post-operative adhesions (most common), hernias, malignancy, Crohn's disease, volvulus, foreign bodies (bezoars, gallstones), and pediatric causes (atresia, pyloric stenosis, intussusception).
• Large Bowel Obstruction (LBO) Etiologies: Neoplasm (most common adult cause), diverticular or ischemic strictures, volvulus, intussusception (mostly tumor lead points in adults), and fecal impaction.
• Closed-Loop Obstruction: Obstruction at two points forming a sequestered segment (e.g., incarcerated hernia, volvulus, or colonic obstruction with a competent ileocecal valve). Highly susceptible to rapid ischemia and gangrene.
• Pathophysiology: Increased peristalsis initially → proximal distension → third space fluid loss/electrolyte imbalance → bacterial overgrowth/translocation → increased wall tension → circulatory compromise and ischemia.

Diagnosis / Clinical Features

• Symptoms:
  • Pain: Crampy, central, and intermittent in simple mechanical obstruction. A change to constant pain suggests strangulation/ischemia.
  • Vomiting: Greenish (bilious) indicates obstruction distal to the ampulla of Vater. Feculent vomiting is a late sign of prolonged obstruction. Projectile non-bilious suggests pre-ampullary (e.g., pyloric stenosis).
  • Bowel function: Obstipation (>24 hours) and failure to pass flatus. Diarrhea may occur in partial/intermittent obstruction.
• Physical Examination:
  • Distention: Less prominent in proximal SBO; massive in LBO.
  • Auscultation: Hyperactive, high-pitched ("tinkling") bowel sounds and borborygmi early. Diminished/silent in late obstruction or adynamic ileus.
  • Palpation: Check for surgical scars and carefully examine all hernia orifices (inguinal, femoral, umbilical).
  • Digital Rectal Exam (DRE): Empty vault suggests proximal obstruction; occult/gross blood suggests malignancy, late strangulation, or intussusception.
• Strangulation Warning Signs: Fever, tachycardia, severe continuous pain, leukocytosis, and peritoneal signs (rigidity, rebound tenderness). Note: No reliable clinical exam definitively differentiates simple from early strangulated obstruction.
• Ileus vs. Mechanical: Ileus presents with minimal pain, massive diffuse distention, and diminished bowel sounds without a discrete transition point.

Investigations

• Computed Tomography (CT) Abdomen/Pelvis: The imaging modality of choice for suspected mechanical obstruction.
  • Does not require oral contrast (retained fluid acts as contrast). Water-soluble IV/oral contrast is preferred if LBO is suspected.
  • Identifies transition point, distinguishes intrinsic vs. extrinsic vs. intraluminal causes, and differentiates ileus from mechanical post-op obstruction.
  • Best for identifying strangulation (bowel wall thickening, mucosal hypo-enhancement, fat stranding).
  • Best step to characterize any calcified abdominal mass causing symptoms.
• Plain Radiographs: Requires supine/flat and upright views.
  • SBO: Distended loops, central location, valvulae conniventes crossing the entire width, and "stepladder" air-fluid levels on upright film.
  • LBO: Peripheral distention with haustral markings that do not cross the full width.
  • Ileus: Generalized gas in both small and large bowel without a cut-off point; sluggish, long air-fluid levels.
  • Pneumoperitoneum: Upright chest/abdomen film screens for free air (perforation).
• Contrast Enema: Useful in distinguishing intussusception and volvulus ("bird's beak" or "ace of spades" sign for sigmoid volvulus).
• Enteroclysis: Fluoroscopy with contrast via nasojejunal tube. Distinguishes adhesions from metastases or radiation enteritis.
• Ultrasonography: Reliable for bedside exclusion of SBO (up to 89% accuracy).

Management

• Initial Resuscitation (All Types): NPO, nasogastric (NG) tube decompression (especially for vomiting/distension), aggressive IV fluid resuscitation (Isotonic saline or Ringer's), and electrolyte correction.
• Non-Operative Management Indications (SBO):
  • Adhesions (without strangulation signs).
  • Malignant tumor/carcinomatosis.
  • Crohn's disease (high-dose steroids + bowel rest).
  • Radiation enteritis.
  • Intra-abdominal abscess (treat with CT-guided drainage).
• Emergency Surgical Indications: Strangulated obstruction, closed-loop obstruction, bowel ischemia, or perforation.

Relevant Guidelines

• Adhesive Small Bowel Obstruction (ASBO) Pathway:
  1. Attempt NG tube decompression first.
  2. Administer Water-Soluble Contrast Medium (WSCM) for diagnostic and therapeutic purposes.
  3. Manage non-operatively for up to 72 hours in the absence of strangulation/peritonitis.
  4. If unresolved after 72 hours, surgical intervention (open or laparoscopic adhesiolysis) is recommended.
• Acute Colonic Pseudo-Obstruction (Ogilvie Syndrome) Pathway:
  1. Initiate conservative management (bowel rest, hydration, address underlying disorder) for the first 24 hours (if no perforation).
  2. Pharmacologic intervention: IV Neostigmine.
  3. Endoscopic intervention: Colonoscopic decompression (effective in ~80% of cases).
  4. Surgery: Reserved for refractory cases, ischemia, or perforation (associated with high morbidity/mortality).

Operative / Procedural Notes

• Volvulus Interventions:
  • Sigmoid Volvulus: First-line is endoscopic detorsion/decompression (rigid or flexible sigmoidoscopy). Surgical resection is always indicated post-decompression due to a ~50% recurrence rate. If necrotic/perforated, proceed to emergency laparotomy.
  • Cecal Volvulus: Endoscopic detorsion is highly unsuccessful and carries a high risk of perforation. Primary surgical treatment is Right Hemicolectomy.
• LBO Malignancy Resection:
  • Left colon carcinoma: Resection without primary anastomosis OR resection with primary anastomosis and intraoperative lavage. Endoscopic stenting (SEMS) may be used as a bridge to elective surgery.
  • Right colon carcinoma: Right colectomy with primary anastomosis (ileum to transverse colon).
• Intussusception: Contrast enema reduces 60-80% in children. Adults usually require surgery due to a high likelihood of an underlying malignant lead point.

Complications / Prognosis

• Strangulated SBO: 100% mortality if untreated. Drops to 8% if operated within 36 hours. Delaying >36 hours increases mortality to 25%.
• Large Bowel Obstruction: Overall mortality is ~20%. Increases to 40% if colonic perforation occurs. The cecum is the most likely area to perforate due to Laplace's Law.
• Ogilvie Syndrome: 15% mortality with early care; jumps to 36% if ischemia or perforation develops.
• Short-bowel syndrome: Potential late complication resulting from repeated resections for recurrent SBO.

Past-Paper High Yield

• Volvulus Distinctions:
  • Sigmoid Volvulus: Shows a "coffee bean" sign on X-ray. Pre-requisite is a narrow mesentery with a redundant sigmoid (a wide mesentery prevents twisting). Risk factors include old age, chronic constipation, African/high-fiber diet, and pregnancy. 180° twist causes luminal obstruction; ≥360° twist is typically required for irreversible ischemia.
  • Cecal Volvulus: Displaced to mid/LUQ. Treatment is always a Right Hemicolectomy. Do not attempt endoscopic reduction.
• Abdominal Wall Hernias (Common Traps):
  • Pregnancy: Elective repair of asymptomatic hernias is contraindicated and delayed until postpartum.
  • Pediatric: Unrepaired indirect inguinal hernias have a ~40% incarceration risk in the first year of life (mandates early repair).
  • Spigelian Hernia: Occurs at the semilunar line, lateral to rectus abdominis. Often has a narrow neck, giving it a very high risk of incarceration/strangulation. Requires mesh repair.
  • Deep Inguinal Ring Anatomy: Located 1.5 cm ABOVE the mid-inguinal point (not below). Indirect hernias traverse this ring.
  • Direct Hernias: Located medial to the inferior epigastric vessels. Femoral hernias have narrow necks (high strangulation risk).
• Simple vs. Complicated Obstruction: Simple mechanical obstruction classically has hyperactive "tinkling" bowel sounds early, mild leukocytosis, and oliguria. Board-like rigidity indicates a perforated viscus/peritonitis, not simple obstruction.
• CT utility: A CT abdomen is always the best next step to fully characterize a calcified abdominal mass (gallstone ileus, malignancy) and evaluate for bowel obstruction.
• Vomiting types: Bilious (green) = distal to ampulla of Vater. Projectile non-bilious = proximal to ampulla. Feculent = very distal.
• Pediatric lower GI bleeding: Meckel's diverticulum (contains ectopic gastric mucosa) is the classic cause of massive, painless lower GI bleeding in an infant. Intussusception causes painful currant-jelly stools.
• Rectus Sheath Hematoma: Fothergill's sign is positive (mass does not cross midline and remains palpable when the patient tenses their abdominal muscles). Usually older patients on anticoagulation with coughing fits.

Memory Pearls

• Laplace Law (T = P × R): The cecum has the largest radius (R) in the colon, subjecting it to the highest wall tension (T). Therefore, it is the most common site of colonic perforation in LBO/closed-loop obstructions.
• Rigler's Triad: Pathognomonic for Gallstone Ileus → 1. Pneumobilia, 2. Small bowel obstruction, 3. Ectopic radiopaque gallstone (usually in right lower quadrant/terminal ileum).
• Bird's Beak vs. Coffee Bean:
  • Coffee bean / bent inner tube = Plain X-ray sign of Sigmoid Volvulus.
  • Bird's beak / ace of spades = Contrast enema fluoroscopy sign of Sigmoid Volvulus.

Mesenteric ischemia

Core Concepts

• Definitions:
  • Mesenteric ischemia: Ischemia affecting the small intestine.
  • Colonic ischemia: Ischemia affecting the large intestine.
  • Splanchnic ischemia: Broad term encompassing ischemia of the intestines, liver, spleen, or kidneys.
• Physiology: Splanchnic circulation receives 10–35% of cardiac output. Due to high capillary density and baseline low oxygen extraction, intestinal blood flow must drop by >50% from fasting levels before oxygen delivery is compromised.
• Arterial Anatomy & Relations:
  • Celiac Trunk: Trifurcates directly into the common hepatic artery, splenic artery, and left gastric artery.
  • Aortic Branches: Superior mesenteric (SMA), inferior mesenteric (IMA), renal, and gonadal arteries branch directly off the abdominal aorta independently.
  • Duodenal Relations: The head of the pancreas sits snugly within the C-loop of the duodenum. The 3rd part of the duodenum and the uncinate process pass posterior to the superior mesenteric vessels. The 2nd part of the duodenum is retroperitoneal.
• Collateral Circulation: Protects against gradual/chronic occlusions.
  • Between Celiac and SMA: Superior and inferior pancreaticoduodenal arteries.
  • Between SMA and IMA: Marginal artery of Drummond and the meandering mesenteric artery (Arc of Riolan).
• Watershed Zones: Vulnerable to systemic hypoperfusion due to narrow terminal branches.
  • Griffiths' point: Splenic flexure (junction of SMA and IMA territories).
  • Sudeck's point: Rectosigmoid junction (junction of IMA and internal iliac systemic circulation).

Diagnosis / Clinical Features

• Acute Mesenteric Arterial Occlusion (Arterial Embolism & Thrombosis):
  • Classic hallmark: Abdominal pain out of proportion to physical examination.
  • Arterial Embolism: Sudden, severe, periumbilical pain; often with nausea/vomiting. Causes greater blood flow reduction due to a lack of pre-existing collaterals.
  • Arterial Thrombosis: Acute-on-chronic presentation; patients often report preceding, worsened postprandial pain.
• Mesenteric Venous Thrombosis (MVT): Insidious onset of abdominal pain. Rarely involves the colon. Chronic MVT is associated with cavernous transformation of the portal vein.
• Nonocclusive Mesenteric Ischemia (NOMI): Variable presentation. Caused by severe primary mesenteric vasoconstriction/hypoperfusion rather than mechanical blockage.
• Chronic Mesenteric Ischemia:
  • Fundamentally an atherosclerotic arterial disease.
  • Classic triad: Postprandial pain ("intestinal angina"), "food fear," and resulting significant weight loss.
• Colonic Ischemia (Ischemic Colitis):
  • Predominantly in patients >60 years old.
  • Caused by transient global low-flow states (heart failure, MI, sepsis, hemorrhage).
  • Presents with mild abdominal pain, rectal bleeding, and bloody diarrhea. Patients do not appear severely ill.

Investigations

• Laboratory Studies:
  • Highly nonspecific. Normal laboratory values do NOT exclude acute mesenteric ischemia.
  • Findings: Marked leukocytosis, elevated hematocrit, metabolic acidosis, elevated lactate, and elevated serum amylase.
• Radiological Imaging:
  • Plain Radiograph: Early signs include thick-walled, distended, featureless bowel loops. Pneumatosis intestinalis (air in bowel wall) is a late sign indicating transmural necrosis.
  • CT Angiography (CTA): Primary diagnostic modality.
    • Embolus typically lodges 1–3 cm distal to the SMA origin (sparing proximal branches like the middle colic artery).
    • Thrombosis often shows severe calcific ostial stenosis at the SMA/Celiac origins.
    • Diagnosis of chronic ischemia requires high-grade stenosis in at least 2 of 3 major splanchnic arteries.
  • Catheter-Based Angiography (DSA): Traditional gold standard. Retained for equivocal cases or for therapeutic access (intra-arterial papaverine/thrombolysis).
• Endoscopy: Colonoscopy is the procedure of choice for suspected colonic ischemia.

Management

• Initial Resuscitation (All Acute Cases):
  • Gastrointestinal decompression (NPO/NG tube).
  • Aggressive fluid resuscitation & hemodynamic support.
  • Avoid vasopressors (exacerbates ischemia).
  • Broad-spectrum antibiotics and supplemental oxygen.
  • Systemic anticoagulation (under most circumstances).
• Etiology-Specific Management:
  • Arterial Embolism: Early open laparotomy with embolectomy, OR catheter-directed thrombolysis (if high surgical risk and no peritonitis). Long-term: VKA or DOACs.
  • Arterial Thrombosis / Chronic Ischemia: Surgical bypass OR endovascular angioplasty/stenting. Long-term: Antiplatelet therapy and statins (lifelong anticoagulation is not indicated here).
  • Venous Thrombosis (MVT): Primarily conservative. Systemic anticoagulation and bowel rest. Surgery strictly reserved for overt bowel infarction.
  • NOMI: Reverse the underlying cause (sepsis, heart failure, stop pressors/cocaine) and intra-arterial infusion of vasodilators (e.g., papaverine) into the SMA.
• Colonic Ischemia: Generally self-limiting and managed medically (supportive care).

Relevant Guidelines

• Diagnostic Rule: Any patient with acute abdominal pain and a metabolic acidosis has intestinal ischemia until proven otherwise.
• Hypercoagulability Workup (for MVT): Should include Protein S, Protein C, Antithrombin III, Factor V Leiden, APC resistance, and Anticardiolipin/Antiphospholipid/Lupus antibodies.

Operative / Procedural Notes

• Patients with signs of peritonitis or obvious infarction must bypass advanced imaging and proceed directly to exploratory laparotomy.
• Intra-op Bowel Viability Assessment:
  • Reassess after perfusion is restored.
  • Check color, distension, peristalsis, mesenteric arterial pulsations, and bleeding from cut edges.
  • Adjuncts: Handheld Doppler over the serosa; Intravenous fluorescein dye evaluated under a Wood's lamp (viable bowel fluoresces green).
  • Marginally viable bowel should be left in situ for a planned "second-look" operation (24-48 hours later).

Complications / Prognosis

• Overall Mortality: Highly lethal, exceeding 60%. Time to diagnosis is the paramount determinant of survival.
• Requiring advanced bowel resection is associated with a 15-fold increase in mortality.
• Etiology-Specific Prognosis:
  • Venous thrombosis has the best prognosis.
  • NOMI has the worst prognosis (70–90% mortality rate).
• Survivors of Massive Resection: Frequently develop Short Bowel Syndrome, requiring lifelong Total Parenteral Nutrition (TPN).

Past-Paper High Yield

• Most common cause of acute mesenteric ischemia: Arterial embolism (responsible for ~50% of cases), typically from a cardiac source (AFib) lodging in the SMA. (Arterial thrombosis = ~25%, NOMI = ~20%).
• Visceral Artery Aneurysms: The splenic artery is by far the most common site, accounting for ~60% of all cases. (Hepatic, SMA, celiac, IMA aneurysms are much less common).
• Gastroduodenal Artery Bleeding: Runs directly posterior to the 1st part of the duodenum. A posteriorly penetrating duodenal ulcer classically erodes this artery, causing massive life-threatening upper GI hemorrhage.
• Celiac vs. Aortic Origins: Celiac trunk trifurcates into the common hepatic, splenic, and left gastric arteries. The SMA, IMA, renal, and gonadal vessels branch directly off the aorta.
• Duodenal Surgical Anatomy: The 3rd part of the duodenum passes posterior (not anterior) to the SMA and SMV.
• Chronic Mesenteric Ischemia Misconceptions: It is an atherosclerotic arterial disease treated with bypass/stenting and antiplatelets. It does not require lifelong anticoagulation (which is the treatment for mesenteric venous thrombosis).

Memory Pearls

• Arterial vs. Venous Anticoagulation Rules: Lifelong anticoagulants = Venous clot or cardiac embolus. Antiplatelets/Statins = Arterial atherosclerotic plaque (Thrombosis/Chronic).
• Pain out of proportion = Ischemic bowel until proven otherwise.
• Food fear + Weight loss = Chronic mesenteric ischemia ("Intestinal angina").
• Wood's Lamp + Fluorescein = Intra-op viability check to save maximum bowel length.

Small bowel tumors

Core Concepts

• Epidemiology: Rare tumors accounting for only 1–2% of all GI malignancies (100 times less frequent than in the stomach, esophagus, or colorectum). Equal incidence in men and women.
• Distribution Rule of Thumb: Benign lesions are more common distally; Adenocarcinomas are more common proximally.
• Tumor Origins:
  • Epithelium: Adenomas, adenocarcinomas, carcinoids.
  • Lymphatic tissue: Lymphomas.
  • Mesenchymal/Neural: Gastrointestinal stromal tumors (GIST), leiomyomas, lipomas, hemangiomas, neuromas, sarcomas.
• Risk Factors for Small Bowel Tumors:
  • Familial adenomatous polyposis (FAP): 24–93% develop small intestine polyps; 2–12% develop duodenal cancer.
  • Hereditary nonpolyposis colorectal cancer (HNPCC).
  • Peutz-Jeghers syndrome.
  • Crohn’s disease: Associated with ileal adenocarcinoma.
  • Celiac disease (gluten-sensitive enteropathy): High risk for GI lymphoma.
  • Biliary diversion (e.g., previous cholecystectomy).

Diagnosis / Clinical Features

• General Presentation: Typically present in the 6th and 7th decades.
• Benign Neoplasms: Often asymptomatic (47–60%) and found incidentally. When symptomatic, present with acute GI hemorrhage, anemia, intermittent obstruction, or vague abdominal pain.
• Malignant Neoplasms: Almost always symptomatic.
  • Abdominal pain is the most common symptom (62–83%).
  • Other features: weight loss (38–55%), nausea/vomiting, anemia, acute hemorrhage, or palpable abdominal mass.
  • Obstruction occurs in 15–35% of patients (due to tumor, adhesions, or infiltration).
• Carcinoid Tumors:
  • Arise from enterochromaffin (argentaffin) cells.
  • Characteristically yellow-colored, slow-growing, submucosal/serosal lesions.
  • Most common in the ileum (last two feet). Pain is the most common presentation.
  • Carcinoid Syndrome: Vasomotor (flushing), GI (diarrhea, abdominal cramps), respiratory (wheezing), and cardiac (right heart failure) manifestations. Triggered by systemic circulation of peptides (serotonin/5-HT). Requires large tumor burden bypassing the liver or, most commonly, liver metastases.
• Crohn's-associated Adenocarcinoma: Occurs in the ileum, presents ~20 years younger than sporadic cases, has a strong male preponderance (70%), and carries a very poor prognosis.

Investigations

• Imaging: CT / MRI Enterography, Small bowel follow-through (contrast studies showing filling defects/luminal narrowing).
• Endoscopy: Enteroscopy, Capsule endoscopy (especially for occult bleeding).
• Angiography: Useful for highly vascularized lesions (e.g., prominent tumor blush in GIST or carcinoids).
• Laboratory: 24-hour urinary 5-HIAA (high-performance liquid chromatography) is highly specific but not sensitive for carcinoid tumors.

Management

• Adenomas (True, Villous, Brunner's gland): Excision/biopsy and follow-up. Malignant potential increases with size, site (periampullary = higher risk), and number.
• Adenocarcinoma: Segmental resection including regional lymph nodes. Chemotherapy is generally of little help.
• Carcinoid Tumors:
  • Local disease: Resection including draining lymph nodes.
  • Metastatic disease: Tumor debulking, hepatic artery embolization/chemoembolization, radiofrequency ablation, or cryotherapy.
  • Systemic therapy: Somatostatin analogs (Octreotide, Lanreotide). Cytotoxic chemotherapy is ineffective.
• GI Lymphoma: Treatment is primarily medical (systemic chemotherapy/radiotherapy).
• GIST: Surgical excision. Imatinib (tyrosine kinase inhibitor) used in advanced cases (can achieve 50% tumor shrinkage). Lesions are typically radio-resistant.

Relevant Guidelines

• Carcinoid Tumor Metastatic Risk & Management Stratification:
  Metastatic potential correlates directly with tumor size:
  • < 1 cm: 20–30% risk of metastases to LN/liver. Adequately treated with local excision.
  • 1–2 cm: 60–80% LN risk, 20% liver risk.
  • > 2 cm: 80% LN risk, 40–50% liver risk.
• GIST Prognostic Stratification (Low Risk):
  • Tumor size < 2 cm.
  • Mitotic rate < 5 per high-power field (HPF).

Operative / Procedural Notes

• Adenocarcinoma / Larger Carcinoids (>1 cm): Require wide segmental resection of the involved bowel along with the mesentery to ensure radical regional lymphadenectomy.
• GIST: Lymphatic spread is uncommon. Surgery requires complete excision with negative margins; routine lymphadenectomy is not typically required.
• GI Lymphoma: Surgery is explicitly reserved ONLY for acute complications (bleeding, perforation, or obstruction).

Complications / Prognosis

• Adenocarcinoma: Overall 5-year survival is 20–30%. If node-negative at operation, survival increases to 50–70%.
• Carcinoid Tumors: May cause local complications like small bowel obstruction, intense mesenteric fibrosis, and ischemia. Most patients already have lymph node or liver metastases at presentation.
• GIST: Small bowel GISTs carry a worse prognosis compared to stomach or esophageal GISTs.
• GI Lymphoma: Favorable overall, with localized disease 5-year survival generally > 50%.

Past-Paper High Yield

• Carcinoid Multifocality: Small bowel carcinoids are multifocal (multicentric) in 30–40% of cases. Do not fall for the trap stating they are rarely multiple or only multiple in 3% of cases.
• Carcinoid Metastatic Potential: Midgut carcinoids (specifically of the ileum) have the highest propensity for malignancy and metastasis (to nodes and liver) compared to those in the appendix, rectum, stomach, or bronchus.
• Carcinoid Syndrome Physiology: Syndrome only occurs when vasoactive substances (e.g., serotonin) bypass hepatic metabolism. This means it classically requires the presence of liver metastases. The tumors arise from enterochromaffin cells and secrete serotonin.
• GI Lymphoma Paradigm: It is highly tested and FALSE that GI lymphomas cannot be treated with chemo/radiotherapy. They are primarily treated with systemic chemotherapy (e.g., R-CHOP) and radiotherapy. Surgery is not universally necessitated and is strictly reserved for complications.
• GI Lymphoma Epidemiology: The GI tract is the most common extra-nodal site for lymphoma. The vast majority are Non-Hodgkin B-cell type. The stomach is the most frequent site overall, followed by the small bowel (specifically the ileum).

Memory Pearls

• Malignancy distribution: Proximal = Adenocarcinoma (usually); Distal (Ileum) = Carcinoids & Lymphomas.
• Mesenchymal standout: GIST = No lymphatic spread (do not need routine LN dissection). Liver/peritoneal mets are common.
• Rule of 50s for Carcinoids: >2cm tumors have ~50% (40-50%) chance of liver mets.

Acute appendicitis

Core Concepts

• Anatomy:
  • The appendix is a true diverticulum of the cecum located at the base of the cecum near the ileocecal valve.
  • Blood supply: The appendiceal artery is a terminal branch of the ileocolic artery.
• Epidemiology:
  • Peaks in the second and third decades of life (highest incidence in the 10-19 age group).
  • Male to female ratio is 1.4:1.
• Pathogenesis:
  • Classic Surgical Teaching: Luminal obstruction is the primary initiating pathophysiological event and is a mandatory prerequisite for acute appendicitis to develop.
  • Causes of obstruction vary by age:
    • Young patients: Lymphoid follicular hyperplasia (often secondary to infection) is the most common cause.
    • Older patients: Fibrosis, fecaliths (hard fecal masses), or neoplasia (carcinoid, adenocarcinoma, mucocele).
    • Endemic areas: Parasites.
• Pathophysiological Cascade:
  • Luminal obstruction → increased luminal and intramural pressure → thrombosis/occlusion of small vessels → lymphatic/vascular stasis → ischemia → necrosis.
  • Bacterial overgrowth: Aerobic organisms predominate early; mixed infections are common late in the course.
• Pain Referral Pathway:
  • Early: Engorgement stimulates visceral afferent nerves (T8-T10) leading to vague central/periumbilical pain.
  • Late: Inflammation involves the parietal peritoneum leading to well-localized somatic right lower quadrant (RLQ) pain.

Diagnosis / Clinical Features

• Classic Presentation:
  • Abdominal pain is the first symptom (periumbilical migrating to RLQ in 50-60% of cases).
  • Followed by anorexia, nausea, and vomiting.
  • Fever occurs later in the illness course.
• Atypical Presentations:
  • Generalized malaise, indigestion, flatulence, bowel irregularity, or diarrhea.
  • Anatomical variation heavily influences symptoms:
    • A pelvic appendix or pelvic abscess can irritate the rectum, presenting as new-onset diarrhea.
• Physical Examination Signs:
  • McBurney’s Point Tenderness: Maximal tenderness 2/3 of the distance from the umbilicus to the anterior superior iliac spine (ASIS).
  • Rebound Tenderness (Blumberg Sign): Pain upon sudden release of abdominal pressure.
  • Rovsing's Sign: Palpation of the left lower quadrant (LLQ) elicits pain in the RLQ.
  • Psoas Sign: RLQ pain with passive right hip extension. Indicates a retrocecal appendix lying against the psoas muscle.
  • Obturator Sign: RLQ pain with flexion and internal rotation of the right hip. Indicates a pelvic appendix lying against the obturator internus muscle (low sensitivity, rarely performed).

Investigations

• Laboratory Findings:
  • Mild leukocytosis (WBC >10,000 cells/microL) with a "left shift" is present in ~80% of patients.
  • Elevated serum C-reactive protein (CRP).
• Imaging Studies:
  • Ultrasound: Accurate for diagnosis if appendiceal diameter is >6 mm.
  • CT Abdomen/Pelvis (with contrast): The modality of choice for equivocal cases. Key findings include:
    • Enlarged appendiceal diameter >6 mm with an occluded lumen.
    • Appendiceal wall thickening (>2 mm) and wall enhancement.
    • Periappendiceal fat stranding.
    • Appendicolith (seen in ~25% of patients).
  • Plain Radiographs: Generally not helpful for establishing the diagnosis.
• Routine Pathological Examination:
  • Every surgically removed appendix must be carefully labeled and sent for routine histopathology.
  • Clinical Importance: Confirms appendicitis and is mandatory to rule out unexpected pathologies (e.g., carcinoid tumors, adenocarcinoma, Crohn's disease). Discarding the specimen is considered malpractice.

Relevant Guidelines

Alvarado Score (Used to rule in/out acute appendicitis)

• 1 Point Parameters:
  • Migratory RLQ pain
  • Anorexia
  • Nausea or vomiting
  • Rebound tenderness in RLQ
  • Fever >37.5°C (>99.5°F)
• 2 Point Parameters:
  • Tenderness in RLQ
  • Leukocytosis (WBC >10 × 10⁹/L)
• Interpretation & Pathway:
  • <4 Points: Appendicitis unlikely; evaluate for other diagnoses.
  • 4 to 6 Points: Equivocal. Perform CT (or US if available). If non-diagnostic, observe for 12 hours and reassess. If score drops <4, evaluate other diagnoses. If score rises ≥ 4, proceed to laparoscopy/appendectomy.
  • ≥ 4 Points (General): Evaluate further via imaging (CT/US).
  • >6 Points: High probability. Warrants surgical exploration (laparoscopy/appendectomy).

Management

• Uncomplicated (Non-perforated) Appendicitis:
  • Definitive Treatment: Immediate appendectomy (within 12 hours), typically laparoscopic.
  • Supportive Care: IV fluids, pain control, and pre-operative IV antibiotics.
  • Contraindication: Colonoscopy is absolutely contraindicated due to the risk of organ rupture. Medical management (oral antibiotics + discharge) or indefinite observation is inappropriate.
• Complicated (Perforated) Appendicitis:
  • Unstable / Free Perforation / Generalized Peritonitis: Emergent appendectomy (laparoscopic or open) with irrigation and drainage of the peritoneal cavity. Post-operative IV antibiotics for 3-5 days.
  • Stable with Localized Abscess: Image-guided percutaneous drainage + intravenous antibiotics. Immediate surgery is an alternative only if the abscess is not amenable to drainage. Followed by discharge on oral antibiotics (7-10 days) and an interval appendectomy 6-8 weeks later.
  • Stable with Phlegmon: Intravenous antibiotics and observation. Repeat imaging to track resolution. If failure occurs, perform a rescue appendectomy.

Post-operative Care / Procedural Notes

• Post-operative Antibiotics: For an uneventful (uncomplicated) appendectomy, post-operative antibiotics are NOT indicated. Routine use for 3 days does not reduce hospital stay; it only increases resistance and cost.
• DVT Prophylaxis: Early mobilization significantly reduces the risk of post-operative deep vein thrombosis (DVT).
• Surgical Site Infection (SSI): Wound swelling and purulent discharge post-operatively are classic signs of SSI.
• Intra-operative Dilemmas: If clinical suspicion is extremely high but imaging is non-diagnostic/unavailable, surgical exploration is warranted. Frozen sections of the appendix are not routinely indicated unless intra-operative malignancy is overtly suspected.

Associated High-Yield Surgical/GI Concepts

(Mapped directly from GI rotation past-papers)

• Hepatic Abscesses:
  • Pyogenic Liver Abscess: The most common cause today is ascending biliary tract infection (cholangitis), often secondary to gallstones or strictures. (Appendicitis via pylephlebitis is a less common historical cause). Almost always requires drainage.
  • Amebic Liver Abscess: Patients present with a travel history to endemic regions + Entamoeba histolytica. Responds rapidly to medical therapy alone (metronidazole followed by paromomycin). Avoid routine percutaneous/surgical drainage as first-line therapy due to the high risk of secondary bacterial superinfection; drain only if rupture is imminent or antibiotics fail.
• Primary Iliopsoas Abscess: Standard first-line management is image-guided percutaneous drainage combined with targeted systemic antibiotics. (Do not observe, do not use antibiotics alone, do not immediately do open debridement).
• Child-Pugh Classification: Assesses chronic liver disease prognosis based on 5 parameters. It uses Prothrombin Time (PT) or INR to assess synthetic coagulation function, not Partial Thromboplastin Time (PTT). Parameters: Bilirubin, Albumin, PT/INR, Ascites, Encephalopathy.

Past-Paper High Yield

• Pathophysiology Trap: You must recognize luminal obstruction as a mandatory prerequisite for acute appendicitis. Stating it is "not a must" is false.
• Specimen Protocol: You must send every uncomplicated appendix to histology. Never discard it, give it to the family, or send it exclusively for culture.
• Antibiotic Trap: For a simple appendectomy, do not prescribe a 3-day post-op course of IV antibiotics.
• Classic Presentation vs. Anatomy Trap: Remember that an inflamed pelvic appendix can present with new-onset diarrhea due to direct rectal irritation.
• Management Dilemmas: For a clinically certain appendicitis, surgery is definitive. For equivocal cases (Alvarado 4-6), utilize CT imaging. Never send a clear-cut case home on oral antibiotics, and never perform a colonoscopy during an acute attack.
• Abscess Management Rules:
  • Appendiceal/Iliopsoas Abscess → Image-guided percutaneous drainage + systemic antibiotics.
  • Pyogenic Liver Abscess → Drainage + antibiotics (most commonly from biliary tree).
  • Amebic Liver Abscess → Medical therapy ONLY (metronidazole + paromomycin). Routine drainage is highly contraindicated!
• Child-Pugh Trap: The scoring system uses PT/INR, not PTT.

Diverticular diseases

Core Concepts

• Definition: Diverticular disease involves the acquired herniation of the mucosa and submucosa through the muscular wall of the colon.
• True vs. False Diverticulum:
  • False (Pulsion) Diverticulum: Contains only mucosa and submucosa herniating through a defect in the muscularis layer. Colonic diverticula, Zenker's, duodenal, jejunal, and epiphrenic diverticula are all false.
  • True Diverticulum: Contains all three layers of the bowel wall (mucosa, submucosa, and muscularis propria). A classic example is Meckel's diverticulum.
• Pathophysiology of Colonic Diverticula:
  • Herniation occurs at a point of anatomical weakness between the mesenteric and antimesenteric taenia, specifically where penetrating vasa recta blood vessels traverse the muscularis propria.
  • Etiology: A low-fiber diet results in smaller stool volumes, requiring high colonic wall tension and high intraluminal pressure for propulsion. This chronic contraction leads to muscular hypertrophy and "segmentation" (the colon acts as separate segments rather than a continuous tube).
  • Irreversibility: Diverticulosis involves permanent structural changes. While a high-fiber diet can prevent complications, it cannot reverse the anatomical pouches.
• Epidemiology & Anatomic Distribution:
  • Highly prevalent in Western populations; age-related (50% of people >50 years; 65% >85 years).
  • Left colon / Sigmoid (90%): Most common site overall, especially in Western populations, due to having the highest intraluminal pressure.
  • Right colon (5–15%): More common in Asian populations.
• Gross Morphology: Characterized by thickening and shortening of the bowel (due to muscular hypertrophy), luminal narrowing, and extensive pericolic fat deposition.

Diagnosis / Clinical Features

• Disease Spectrum:
  • Diverticulosis: Asymptomatic presence of diverticula. The mortality rate of uncomplicated, asymptomatic diverticulosis is essentially 0%.
  • Symptomatic Uncomplicated Diverticular Disease (SUDD).
  • Uncomplicated Diverticulitis: Localized inflammation (phlegmon) driven by a microperforation.
  • Complicated Diverticulitis: Abscess, free perforation, fistula, or obstruction.
• Acute Diverticulitis:
  • Left-sided: Classic triad of localized left lower quadrant (LLQ) tenderness, fever, and leukocytosis.
  • Right-sided: Presents with acute right lower quadrant (RLQ) pain, classically mimicking acute appendicitis.
• Diverticular Bleeding:
  • Pathogenesis: The vasa recta become stretched, displaced, and thinned over the dome of the diverticulum, making them highly vulnerable to mechanical trauma and erosion.
  • Presentation: Painless, bright red blood per rectum (macroscopic/overt bleeding). Not detected by Fecal Immunochemical Test (FIT), which is reserved for microscopic/occult blood (e.g., colon cancer screening).
  • Often originates from the right colon.
  • Diverticulosis and angiodysplasia are the most common causes of massive arterial lower GI bleeding in adults.
  • Crucial distinction: Uncomplicated colon cancer typically causes chronic, occult, low-grade mucosal bleeding leading to anemia, not massive, acute, life-threatening hemorrhage.

Investigations

• CT Scan of Abdomen/Pelvis (with contrast): The gold standard and preferred initial test for both acute diverticulitis and its complications (e.g., abscesses, fistulas).
  • Findings: Marked colonic wall thickening, mesenteric fat stranding, and air-filled outpouchings.
  • Highly sensitive for diagnosing colovesical fistulas (often reveals air in the bladder).
• Colonoscopy:
  • Mandatory after an episode of diverticulitis or bleeding to exclude underlying malignancy.
  • Contraindicated in acute settings (see Past-Paper High Yield).
• Contrast Enema (Barium/Water-soluble): Can be used to outline fistulas (e.g., colovesical extravasation) but is strictly avoided during acute inflammation.

Management

• Uncomplicated Diverticulitis: Conservative management with broad-spectrum IV antibiotics and bowel rest (clear liquid diet).
• Abscesses (Hinchey I & II):
  • Small abscess: IV antibiotics alone.
  • Large, walled-off pelvic/retroperitoneal abscess (Hinchey II): Image-guided (CT/US) percutaneous drainage + antibiotics.
• Bleeding: Typically stops spontaneously but has a high rebleeding rate. Managed with supportive care, endoscopic clipping/injection once stable, angiographic embolization, or colectomy for refractory massive bleeding.
• Obstruction: Occurs in ~10% of complicated cases secondary to luminal stenosis or extrinsic abscess compression. Treated with Hartmann’s procedure, primary anastomosis, or bridging stents.

Relevant Guidelines

• Hinchey Classification (Staging & Management)

• Indications for Elective Prophylactic Surgery
  • Traditional Criteria:
    • At least two documented attacks of diverticulitis.
    • A single attack in high-risk groups: Young patients (<50 years), immunocompromised patients, or if malignancy cannot be excluded.
  • Recent Updates: These guidelines have been increasingly questioned, as modern evidence suggests the risk of complications does not necessarily increase with recurrent disease.

Operative / Procedural Notes

• Hartmann’s Procedure: The standard emergency surgical intervention for Hinchey III/IV peritonitis or obstruction.
  1. Resection of the inflamed/diseased sigmoid colon.
  2. The distal rectal stump is oversewn and closed as a blind pouch in the pelvis.
  3. The proximal descending colon is brought out to the abdominal wall as a terminal end colostomy.
• Surgical Recurrence: Recurrence after definitive surgical resection is low (3%), but it is 4-fold higher if a colosigmoidostomy is performed instead of extending the resection down to healthy rectal tissue.

Complications / Prognosis

• Abscess: The most common complication of acute diverticulitis.
• Fistulas: Occurs in 5% of complicated cases.
  • Colovesical: Most common overall. More common in males. Presents with pneumaturia, urgency, and recurrent polymicrobial UTIs.
  • Colovaginal: Presents as passage of flatus/feces through the vagina. Most common in women with a prior hysterectomy.
  • Coloenteric: Secondary to abscess rupture into the small bowel; presents with chronic abdominal pain and diarrhea.
• Prognosis & Recurrence:
  • 50–70% of patients managed conservatively will have no further episodes.
  • Age factor: Young patients (under 50) have a higher rate of recurrence and a more aggressive disease course necessitating surgery compared to older patients.
  • Recovery rates decline sharply with subsequent attacks: >70% recover after the 1st attack, but only 6% remain complication-free after a 3rd attack.

Past-Paper High Yield

• STRICT CONTRAINDICATION: Diagnostic colonoscopy, flexible sigmoidoscopy, and barium enemas are absolutely contraindicated during acute diverticulitis. The inflamed, edematous colon wall is highly weakened, making the risk of iatrogenic perforation (from air insufflation and mechanical trauma) unacceptably high. Delay endoscopy for 6–8 weeks.
• Left vs. Right Discrepancy: Diverticulitis overwhelmingly affects the left (sigmoid) colon, but massive diverticular bleeding disproportionately originates from the right colon.
• Massive Bleeding Etiologies: In an adult with massive, acute, life-threatening lower GI bleeding, suspect diverticulosis or angiodysplasia. Do not suspect uncomplicated colon cancer (which causes chronic, occult bleeding).
• Meckel's Diverticulum distinction: As a true diverticulum, it causes painless lower GI bleeding (hematochezia/melena) in young patients due to ectopic gastric mucosa ulcerating the ileum. It does not cause hematemesis (which indicates an upper GI bleed).
• Amebic Liver Abscess Principle (GI differential): Amebic liver abscesses typically respond excellently to medical therapy (metronidazole). They should not be routinely drained unless they are huge, threatening to rupture, or failing medical therapy.

Memory Pearls

• Hinchey Progression: I = Pericolic, II = Pelvic, III = Purulent, IV = Putrid (Fecal).
• Rule of 2s for True/False: Colonic = False (2 layers herniate: mucosa + submucosa). True = All 3 layers (e.g., Meckel's).
• Diverticular Bleeding vs. Infection: They rarely happen at the same time. The patient is either bleeding (painless, overt) OR infected (pain, fever, leukocytosis).

Colorectal polyp

Core Concepts

• Definition: Mass lesions protruding from the intestinal mucosa toward the lumen or elevating the mucosa. They represent defects in normal mucosal cell proliferation, differentiation, or apoptosis.
• Classic Adenoma-Carcinoma Sequence:
  • Development of invasive carcinoma from a clean colon takes approximately 5 years.
  • APC (Adenomatous Polyposis Coli): Mutation and loss of function of this tumor suppressor gene is universally the earliest initiating event in the sequence.
  • KRAS: Intermediate mutation driving adenoma growth and progression.
  • TP53 & SMAD4: Late-event mutations driving the final transformation into invasive carcinoma.
  • (Note: BRAF mutations are characteristic of the alternative serrated pathway, not the classic adenoma-carcinoma sequence).
• Morphological Classification:
  • Sessile: Broad-based, flat, raised mucosal lesion.
  • Pedunculated: Anchored to the bowel wall by a distinct mucosal stalk/pedicle.
• Histological Classification:
  • Non-neoplastic Polyps:
    • Hyperplastic: The most common non-neoplastic colorectal polyp in clinical practice. They are benign and have NO malignant potential.
    • Inflammatory
  • Neoplastic Polyps (Premalignant):
    • Adenomas: Comprise two-thirds of all colon polyps. Classified by villous (glandular growth) content:
      • Tubular: 0–25% villous glands (Most common: 80–86% of adenomas).
      • Tubulovillous: 25–75% villous glands.
      • Villous: 75–100% villous glands (Highest malignant potential).
  • Hamartomatous Polyps: Juvenile polyps, Peutz-Jeghers polyps.

Diagnosis / Clinical Features

• Sporadic Polyps: Highly common; found in ~34.3% of asymptomatic screening colonoscopies. Mostly located in the left colon and most (87–89%) are <1 cm. More common in men.
• Familial Adenomatous Polyposis (FAP):
  • Genetics: Autosomal dominant inheritance caused by a germline mutation in the APC tumor suppressor gene on chromosome 5q21. (80% inherited, 20% de novo mutation).
  • Clinical: Hundreds of adenomatous colorectal polyps carpet the colon by the 2nd–3rd decade of life.
  • Extracolonic Features: Upper GI adenomas (95%), jaw osteomas (80%), Congenital Hypertrophy of the Retinal Pigment Epithelium or CHRPE (75%), epidermoid cysts (50%), fundic gland polyps (40%), unerupted teeth (17%), and desmoid tumors (15%).
• Juvenile Polyposis Syndrome:
  • Autosomal dominant condition characterized by 50–200 hamartomatous polyps in the rectum, colon, and stomach.
  • Presents around age 4 with blood around the stool. Carries a 30–50% risk of cancer.
• Solitary Juvenile Polyp:
  • Presents in infants/children as a bleeding, painful, prolapsing "cherry tumor" (bright red, glistening, pedunculated sphere).
  • Unique histology: Large mucus-filled spaces covered by cuboidal epithelium. Lacks smooth muscle (poor anchorage to bowel wall; may spontaneously amputate). Has no malignant potential.
• Peutz-Jeghers Syndrome:
  • Autosomal dominant condition presenting with mucocutaneous pigmentation (lips, perioral area) and gastrointestinal hamartomatous polyps. High risk for bowel obstructions and cancers.
• Risk Factors (Sporadic Polyps):
  • Increased risk: Age, low fiber/high fat diet, low folate, alcohol, smoking, physical inactivity, family history, acromegaly.
  • Decreased risk (Chemopreventive): Aspirin, NSAIDs.

Investigations

• Diagnostic Modalities for Screening:
  • FOBT: Cheap, noninvasive, but low specificity and requires 3 successive stools.
  • FIT: More sensitive and specific than FOBT; requires only 1 stool sample.
  • Multitarget Stool DNA: Highly sensitive but less specific than FIT.
  • Sigmoidoscopy: Highly sensitive for left colon lesions but misses proximal lesions.
  • Colonoscopy: Gold standard. Examines the entire colon, highly sensitive/specific, and therapeutic (polypectomy). Requires bowel prep and sedation; carries risk of perforation.
• FAP Diagnostics:
  • Diagnosis requires the presence of ≥100 colorectal adenomas OR a confirmed APC gene mutation.
  • If genetic testing is unavailable, the presence of CHRPE on ophthalmic exam can be used to screen affected families.

Management

• General Management:
  • Endoscopic polypectomy is standard and significantly reduces the long-term incidence of colorectal cancer.
• FAP Pharmacotherapy:
  • NSAIDs (Sulindac and Celecoxib) can cause regression of polyps but do not replace prophylactic surgery; they require frequent endoscopic surveillance.

Relevant Guidelines

BSG Guidelines (2002) for Surveillance Following Adenoma Removal

• Low Risk (Group A): 1–2 adenomas AND both are small (<1 cm).
  • Recommendation: No surveillance required OR follow-up colonoscopy at 5 years.
• Intermediate Risk (Group B): 3–4 small adenomas OR at least one adenoma ≥1 cm.
  • Recommendation: Follow-up colonoscopy at 3 years.
• High Risk (Group C): ≥5 small adenomas OR ≥3 adenomas with at least one ≥1 cm.
  • Recommendation: Follow-up colonoscopy at 1 year.

FAP Clinical Surveillance

• Lower GI: Annual flexible sigmoidoscopy starting at age 13–15. If no polyps are found, transition to colonoscopy at age 20. If no adenomas are present by age 30, FAP is highly unlikely.
• Upper GI: Endoscopic surveillance looking for duodenal polyps every 2 years starting after age 30.

Operative / Procedural Notes

• FAP Prophylactic Surgery: Carcinoma inevitably develops 10–20 years after polyp onset, necessitating prophylactic resection.
  • Total Proctocolectomy with Ileal Pouch-Anal Anastomosis (IPAA / RPC): The universal gold standard operation of choice.
  • Total Proctocolectomy and End Ileostomy: An alternative option.
  • Colectomy with Ileorectal Anastomosis (IRA): Generally not preferred as it leaves at-risk rectal mucosa intact.

Complications / Prognosis

• Determinants of Malignant Potential (High-Yield):
  1. Histological Type: Villous > Tubulovillous > Tubular.
  2. Size: >1 cm significantly increases risk (e.g., >1 cm tubular = 35% risk; 2 cm villous = 50% risk).
  3. Degree of Dysplasia: High-grade dysplasia equates to carcinoma limited to the epithelium.
  4. Site / Anatomical Location: Proximal (right-sided) polyps carry specific risk profiles.
  5. Multiplicity: A higher number of polyps increases the risk.
  • Note: Pedunculation (morphological shape) is NOT a primary prognostic factor.
• FAP Prognosis: Lifetime risk of malignant transformation in the colon is 100% without surgery. Risk of small bowel (duodenal) cancer is significantly elevated but is not 100%.
• Progression timeline: The estimated yearly rate of conversion from a 1 cm adenoma to carcinoma is 0.25%, accelerating over time (2.5% at 5 years → 8% at 10 years → 24% at 20 years).

Past-Paper High Yield

• Primary Prognostic Factors: Always remember that histology (adenomatous/villous), size (>1 cm), number, and site dictate malignant potential. Pedunculation does NOT heavily influence prognosis.
• Hyperplastic Polyps: These are the most common non-neoplastic polyps found in practice. They have no malignant potential. Do not confuse them with neoplastic adenomatous or serrated polyps.
• Genetics of FAP: Must know that FAP is caused by a germline mutation (not somatic) in the APC tumor suppressor gene located on chromosome 5 (5q21).
• FAP vs. HNPCC Genetics: FAP = APC gene. HNPCC (Lynch Syndrome) = MSH2 (or MLH1/MSH6/PMS2) mismatch repair genes.
• Adenoma-Carcinoma Sequence Initiator: The loss of the APC gene is the absolute earliest event. KRAS comes later. TP53/SMAD4 are final-stage events.
• General GI Pharmacology (Laxatives): Lactulose is a synthetic, non-digestible sugar that acts as an osmotic laxative. Contrast this with Psyllium (bulk-forming) and Senna / Bisacodyl / Sodium picosulfate (stimulant laxatives).

Memory Pearls

• Adenomatous Polyposis Coli (APC) mutation occurs on Chromosome 5 (Think: "APC" has 3 letters, but "Polyp" has 5 letters).
• Villous = Villainous: Villous adenomas are the most sinister (highest malignant potential).
• Cherry Tumor: Pathognomonic description for a solitary, benign juvenile polyp in a child presenting with rectal bleeding and prolapse.

Colorectal cancer

Core Concepts

• Epidemiology & Distribution:
  • Primarily a disease of the Western world; >90% of cases diagnosed in patients >50 years old.
  • Tumors are distributed predominantly in the left colon and rectum (50%), followed by the right colon (25%).
  • Synchronous lesions (multiple primary tumors presenting simultaneously) occur in 4–5% of cases.
• Aetiology & Genetic Pathways:
  • Sporadic (majority): Typically follows the Chromosomal Instability (CIN) pathway: Normal cell → APC mutation → Low-level polyp → KRAS mutation → Mid-level polyp → DCC loss → High-level polyp → p53 loss → Carcinoma.
  • Inherited (5-10%):
    • Lynch Syndrome (HNPCC): Driven by Microsatellite Instability (MSI) via germline mutations in mismatch repair (MMR) genes (MLH1, MSH2, MSH6, PMS2).
    • Familial Adenomatous Polyposis (FAP): Driven by germline mutations in the APC gene.
  • Serrated Pathway: Associated with CpG Island Methylation Pathway (CIMP), KRAS, and BRAF mutations.
• Risk Factors:
  • Age, family history, African American race, obesity, smoking, alcohol, and diets high in red/processed meats, animal fat, and sugar.
  • Predisposing medical conditions: Longstanding IBD (Ulcerative Colitis and Crohn’s disease), history of cholecystectomy, post-gastrectomy/vagotomy, and ureterosigmoidostomy (direct urinary diversion to the sigmoid colon).
  • Protective Factors: Physical exercise, dietary fiber, calcium, garlic, non-starchy vegetables, and Aspirin/NSAIDs (proven to decrease the incidence of colonic adenomas and colorectal cancer).
• Polyp Biology:
  • Hyperplastic polyps: Most common non-neoplastic polyps; small distal ones rarely become malignant.
  • Hamartomatous polyps: Composed of disorganized normal native tissue elements.
  • Adenomas: Villous histology, large size, and high-grade dysplasia dictate a high risk for malignant transformation.

Diagnosis / Clinical Features

• Presentation: Ranges from asymptomatic (detected on screening) to elective symptomatic presentations or surgical emergencies (obstruction, perforation).
• High-Risk Symptoms:
  • Rectal bleeding + change in bowel habit (to looser stools/increased frequency) >6 weeks (all ages).
  • Change in bowel habit without rectal bleeding >6 weeks (age >60).
  • Persistent rectal bleeding without anal symptoms (age >60).
  • Palpable right-sided abdominal mass or rectal mass (all ages).
  • Unexplained iron deficiency anemia (all ages).
• Low-Risk Symptoms: Transient bowel habit changes, rectal bleeding with obvious external anal causes (e.g., fissure), or abdominal pain as an isolated symptom without other signs.

Investigations

• Endoscopy: Colonoscopy is the gold standard (diagnostic and therapeutic; mandatory to rule out synchronous tumors).
• Imaging:
  • CT Colonography: Less invasive diagnostic alternative; carries risks of radiation and contrast nephrotoxicity.
  • Barium Enema: Classic "apple-core" lesion (annular constricting carcinoma with overhanging mucosal edges/shouldering). Mostly historical but high-yield for imaging recognition.
  • Pelvic MRI & Endorectal Ultrasound: Crucial for local staging of rectal cancer.
  • PET-CT: Limited routine role; primarily used when surgical resection of metastases is being considered.
• Tumor Markers (Systemic Review for Exams):
  • CEA: Used for CRC surveillance and detecting recurrence/metastases (not screening).
  • CA 19-9: Most sensitive and commonly used for pancreatic/biliary adenocarcinoma.
  • AFP: Classic biomarker for screening and monitoring Hepatocellular Carcinoma (HCC).
  • CA 125: Ovarian cancer.
  • PSA: Prostate cancer.
  • FOB/FIT tests: Exclusively screening tools for CRC.

Relevant Guidelines

• Indications for Postoperative Chemotherapy (High-Risk Features):
  • Lymph node positive (N+ disease).
  • Lymphovascular invasion (LVI).
  • Obstruction or Perforation at presentation.
  • Peritoneal involvement.
  • Poorly differentiated histology.
• Rectal Adenocarcinoma Treatment Algorithm:
  • Stage I (T1-2, N0, M0): Radical resection. (Transanal excision considered if high surgical risk or patient refuses radical resection).
  • Stage II (T3-4, N0, M0) & Stage III (Node positive): Neoadjuvant chemoradiation → Restage → Radical resection (if no metastases).
  • Stage IV (Metastatic):
    • Asymptomatic primary: Chemotherapy → Restage → Consider resection if a single metastatic site is resectable; continue chemo if multiple/unresectable sites.
    • Symptomatic primary: Chemoradiation vs. palliative procedures (stent, laser, ablation, stoma, or palliative resection).

Management

• Antibiotic Prophylaxis: Colorectal surgery carries a high risk of surgical site infections. Regimens must cover both aerobic Gram-negative bacilli (e.g., E. coli) and anaerobes (e.g., B. fragilis).
  • Standard: 3rd-generation cephalosporin + metronidazole, or a single broad-spectrum agent like cefoxitin. Monotherapy with just a cephalosporin or just metronidazole is inadequate.
• Surgical Oncology Principles:
  • Achieve local control with microscopically free margins.
  • En bloc excision of draining lymph nodes along named vessels.
  • Ensure viable bowel is left behind with a safe anastomosis.
  • Standardization techniques: Complete mesocolic excision (CME) for colon and total mesorectal excision (TME) for rectal cancer.
• Appendiceal Carcinoid Tumors (Surgical Correlate):
  • Simple Appendectomy: Sufficient for tumors < 1–2 cm located at the appendiceal tip without concerning features.
  • Right Hemicolectomy: Mandatory for tumors > 2 cm, or any tumor involving the base of the appendix, to ensure complete oncologic clearance and node sampling.

Operative / Procedural Notes

• Anatomical Definitions of the Rectum: The exact starting point varies clinically but is defined by: 15 cm from the anal verge, 11-12 cm from the anal verge, fusion of the taenia coli, or the level of the 3rd sacral vertebra.
• Vascular Anatomy & Ligation:
  • Midgut (Right Colon): Supplied by Superior Mesenteric Artery (SMA) branches (ileocolic, right colic, middle colic).
  • Hindgut (Left Colon/Rectum): Supplied by Inferior Mesenteric Artery (IMA) branches (left colic, sigmoid branches, superior rectal).
  • Major named vessels (SMA/IMA root branches) require secure mechanical ligation (clips/staples), whereas smaller arcades and mesorectal vessels may be sealed with energy devices (e.g., LigaSure).

Complications / Prognosis

• Spread Patterns:
  • Lymphatic: Spreads from paracolic nodes along main vessels to para-aortic nodes. 30% can skip a tier of nodes. 15% of tumors confined strictly to the bowel wall already have LN metastases.
  • Hematogenous: The liver is the most common site of metastasis (up to 37% have occult liver mets at operation), followed by the lung.
• Prognostic Factors:
  • Lymph Node Status: Assuming no distant metastases (Stage IV), the presence and number of involved regional lymph nodes (N stage) is the single most important prognostic factor for long-term survival.
  • Poor Prognosticators: Signet ring histology, vascular invasion, obstructing presentation, and bowel perforation all indicate aggressive biology and poor outcomes.
  • Note: Right-sided colon cancer in itself is not universally considered a poor prognostic factor relative to left-sided disease.
• Surveillance: 80% of recurrences occur within the first 3 years; intense follow-up (laboratory, radiological, and endoscopic) is required during this period.
• 5-Year Survival Rates: Stage 1 (~90-96%), Stage 2 (~65-77%), Stage 3 (~25-77% depending on node burden), Stage 4 (~15-19%).

Past-Paper High Yield

• Prognosis Trap: Right-sided colon cancer is NOT inherently a poor prognostic factor compared to left-sided, whereas perforation, obstruction, signet ring histology, and vascular invasion definitively are.
• Most Important Prognostic Factor: Nodal involvement (N-stage) is the most critical determinant of survival in non-metastatic CRC.
• Tumor Marker Panel Recognition: CEA = Colon; CA 19-9 = Pancreas; AFP = Liver (HCC); CA 125 = Ovary; PSA = Prostate. Do not mix these up.
• Fistula Diagnosis: The most accurate imaging modality for diagnosing a colovesical fistula is a CT scan of the abdomen and pelvis with oral or rectal contrast, typically demonstrating air within the bladder.
• Antibiotic Prophylaxis Trap: Monotherapy with Metronidazole alone or Cephalosporin alone is always the wrong answer for elective colorectal cases. You must select the combination covering both Gram-negatives and anaerobes.
• Chemoprevention Fact: Aspirin and NSAIDs decrease the risk of colonic adenomas and CRC—they do not increase it.
• Appendix Carcinoids: Carcinoid is the most common primary tumor of the appendix. Do not blindly select right hemicolectomy for all appendiceal carcinoids; tumors <1.5 cm at the tip are cured with simple appendectomy.

Memory Pearls

• CIN vs. MSI: CIN = sporadic, classic adenoma-carcinoma sequence (APC, KRAS, p53). MSI = Lynch syndrome, defective mismatch repair (MMR).
• High-Risk Chemo Triggers: "The Bad LOPP" = Lymph nodes/LVI, Obstruction, Perforation, Poorly differentiated/Peritoneal spread.

Hemorrhoids & fissures

Core Concepts

• Anal Canal Anatomy:
  • The dentate (pectinate) line is located 1.5–3 cm from the anal verge and serves as a critical anatomical landmark for epithelium, venous drainage, and innervation.
  • Anoderm: The sensitive skin below the dentate line; drains to the superficial inguinal lymph nodes.
• Hemorrhoidal Anatomy:
  • Hemorrhoids are not varicose veins. Everyone has physiological anal cushions composed of erectile blood vessels, smooth muscle (Treitz’s muscle / musculus submucosae ani), and elastic connective tissue.
  • Their primary function is to act as a conformable plug maintaining continence (~15–20% of resting pressure) and allowing sensory discrimination (anal sampling).
  • Etiology: Disruption and downward sliding (shearing) of these cushions due to aging, constipation, straining, diarrhea, and pregnancy.
  • High-Yield Fact: Hemorrhoids are no more common in patients with portal hypertension than in the general population.
  • Classic anatomical sites (in lithotomy position): Left lateral (3 o'clock), Right posterolateral (7 o'clock), and Right anterolateral (11 o'clock).
• Femoral Hernia Anatomy (Exam Distractor / Board Pearl): A defining anatomical feature of a femoral hernia is that it presents as a bulge BELOW the inguinal ligament, passing through the femoral canal (unlike inguinal hernias, which are above).
• Laxative Pharmacology: Ispaghula husk (psyllium) is a natural bulk-forming laxative that absorbs water to form a viscous gel, promoting peristalsis without causing massive secretory/osmotic diarrhea (unlike PEG or bisacodyl).

Diagnosis / Clinical Features

• Internal Hemorrhoids:
  • Located above the dentate line.
  • Painless (unless prolapsed/strangulated/thrombosed) due to visceral innervation.
  • Present with bright red bleeding at the end of defecation (dripping or squirting into the toilet bowl).
  • May cause prolapse, mucous leakage, pruritus, or perianal excoriation.
• External Hemorrhoids:
  • Located below the dentate line.
  • Highly sensitive due to somatic innervation (pudendal nerve branches).
  • Usually asymptomatic unless thrombosed, which presents as an abrupt, tense, bluish-purple, excruciatingly painful perianal mass. Pain peaks at 48 hours and typically subsides within 5 days.
• Anal Fissure:
  • Classic presentation: Severe, tearing pain during and after defecation, with occasional bright red blood streaks on the stool or paper.
  • Often associated with a hypertonic internal anal sphincter (high resting pressure).
  • Anatomical distribution:
    • Posterior midline: Most common site overall (both sexes).
    • Anterior midline: More common in females than males.
    • Lateral (off-midline): Atypical. Strongly suggests a secondary underlying pathology (Crohn’s disease, ulcerative colitis, tuberculosis, syphilis, HIV/AIDS, leukemia).

Investigations

• Physical Examination:
  • Inspection / Straining: Best for assessing prolapse, fissures, and skin tags.
  • Digital Rectal Exam (DRE): Uncomplicated internal hemorrhoids are SOFT and IMPALPABLE.
  • Anoscopy: Essential for directly visualizing and grading internal hemorrhoids.
• Flexible sigmoidoscopy or colonoscopy may be indicated to rule out proximal sources of bleeding (e.g., CRC).

Relevant Guidelines

• Classification of Internal Hemorrhoids:
  • Grade 1: Bulge into lumen; painless bleeding; do not prolapse.
  • Grade 2: Prolapse during defecation but reduce spontaneously.
  • Grade 3: Prolapse during defecation or spontaneously; require manual reduction.
  • Grade 4: Permanently prolapsed and irreducible; may become strangulated.
• Criteria for Chronic Anal Fissure:
  • History of symptoms lasting > 1 month.
  • Presence of the classic triad:
    1. Sentinel skin tag (distal).
    2. Deep ulcer exposing the internal sphincter muscle fibers in the base.
    3. Hypertrophied anal papilla (proximal).
  • Additional features: Fibrosis or submucous fistula.

Management

• Internal Hemorrhoids:
  • Initial/Medical (All Grades, especially 1 & 2): Diet optimization, bulk-forming agents (e.g., psyllium), warm Sitz baths, and topical protectants/analgesics.
  • Office Procedures (Grades 1, 2, and some 3):
    • Rubber Band Ligation (RBL): Highly effective, superior to sclerotherapy. Performed in-office without general anesthesia.
    • Sclerotherapy, Infrared photocoagulation (burns superior pedicle).
  • Operative (Grades 3 & 4 or failed minor procedures): Surgical excision (open/closed hemorrhoidectomy), Stapled hemorrhoidectomy (PPH), or Doppler-guided HAL.
• Thrombosed External Hemorrhoids:
  • Early (< 48 hours): May be managed with surgical incision and evacuation/excision of the clot.
  • Late (> 48 hours): Conservative management (local anesthetics, warm Sitz baths) as pain naturally minimalizes after the 4th day and the thrombus shrinks.
• Anal Fissure:
  • Acute Fissure: Conservative (Sitz baths, bulk agents). Pharmacologic sphincterotomy (Topical GTN, Calcium Channel Blockers, or Botulinum Toxin injection).
  • Chronic Fissure: Partial Lateral Internal Sphincterotomy (LIS) is the standard surgical gold standard. Alternatively, V-Y Anoplasty (advancement flap).

Operative / Procedural Notes

• Rubber Band Ligation (RBL): Forceps draw the mucosal apex of the hemorrhoid into the ligator drum. The band is deployed tightly at the vascular pedicle strictly above the dentate line to cause ischemic necrosis without somatic pain.
• Partial Lateral Internal Sphincterotomy (LIS): Under direct vision, the distal portion of the internal anal sphincter is isolated and divided to relieve chronic hypertonicity, allowing the fissure bed to heal.
• Stapled Hemorrhoidectomy (PPH): A circular purse-string suture is placed in the mucosa well above the dentate line. A circular stapler pulls redundant prolapsed tissue into its casing, excises a mucosal band, and staples the defect, repositioning the cushions proximally.
• V-Y Anoplasty: Used for chronic fissures. The chronic fissure/fibrotic tract is excised. A V-shaped distal skin flap is mobilized and advanced upward to cover the mucosal defect, sutured in a "Y" shape for tension-free coverage.

Complications / Prognosis

• Operative hemorrhoidectomy carries risks of pain, bleeding, and stricture, but can impair continence to infused saline because the physiological "plug" (anal cushions) is removed.
• Fissure complications include progression to abscess and fistula-in-ano.

Past-Paper High Yield

• Anatomy & Innervation distinction is heavily tested:
  • Internal Hemorrhoids: Arise from superior hemorrhoidal plexus → ABOVE dentate line → covered by transitional/columnar mucosa → VISCERAL innervation (painless) → drain to portal system.
  • External Hemorrhoids: Arise from inferior hemorrhoidal plexus → BELOW dentate line → covered by anoderm (squamous) → SOMATIC innervation (acutely painful) → drain directly to systemic caval system.
• Fissure location is a critical diagnostic clue: A lateral (off-midline) fissure is an atypical red flag that necessitates workup for underlying disease (e.g., Crohn's, TB, HIV, leukemia, syphilis). Classic benign fissures are posterior midline.
• Fissure vs. Hemorrhoid presentation: Severe, tearing pain on defecation with a spot of bright red blood = Fissure. Painless, dripping/squirting bright red blood = Internal Hemorrhoid.
• Rubber band ligation (RBL) concepts: RBL is superior to sclerotherapy for Grade I-III internal hemorrhoids and is performed in the office setting without deep general anesthesia.

Memory Pearls

• 3, 7, 11: The clock-face positions (lithotomy) of normal anal cushions.
• Internal = Insensitive: Above the dentate line, internal hemorrhoids lack somatic pain fibers.
• Lateral = Look further: Lateral fissures mean systemic disease.
• Triad of Chronic Fissure: Tag (distal), Tear (muscle exposed), and Tip (hypertrophied papilla proximal).

Perianal suppuration

Core Concepts

• Anatomy of Anal Glands:
  • Average of 6 glands (range 3–10) per normal anal canal.
  • Lined by stratified columnar epithelium with mucus-secreting goblet cells.
  • Originate at the dentate line (crypts of Morgagni) and pass into the submucosa.
  • Two-thirds continue into the internal sphincter; one-half penetrate into the intersphincteric plane.
• Cryptoglandular Theory: Most perianal suppuration originates from obstruction of these anal gland ducts (by feces, foreign body, or trauma) leading to stasis and infection.
• Avenues of Extension: Infection typically starts in the intersphincteric space and can track:
  • Downward to the perianal space.
  • Horizontally through the external sphincter into the ischioanal space.
  • Upward into the supralevator space or high ischioanal space.
  • Circumferentially via the deep postanal space to the contralateral side (horseshoe abscess).
• Chronicity & Fistula Persistence:
  • Chronicity is driven by the persistence of anal gland epithelium or non-specific epithelialization of the tract.
  • Pathophysiological principle: Epithelialization of a fistula tract prevents spontaneous closure. Destruction or excision of this epithelium is required for healing.
• Etiologies:
  • Most common: Cryptoglandular.
  • Specific/Secondary: Crohn’s disease, ulcerative colitis, Tuberculosis (TB), Actinomycosis, Lymphogranuloma venereum (LGV), foreign body, trauma (impalement, enemas, episiotomy), radiation, malignancy (carcinoma, lymphoma, leukemia), chronic anal fissure.
• Bacteriology: E. coli (22%), Bacteroides fragilis (20%), Enterococcus spp. (16%).

Diagnosis / Clinical Features

Acute Phase (Abscess)

• Symptoms: Acute severe pain (aggravated by sitting, moving, coughing, defecation), swelling, purulent anal discharge, bleeding, malaise, pyrexia.
• Signs: Tender induration, fluctuant mass, pus exuding from a crypt.
• Supralevator Abscess: May lack external perianal signs; presents as a tender pelvic mass on digital rectal/vaginal exam or with signs of peritoneal irritation on abdominal exam.

Chronic Phase (Fistula-in-Ano)

• History: Previous perianal abscess that burst spontaneously or required surgical drainage, leaving a small discharging sinus.
• Signs:
  • External opening visible as a red elevation of granulation tissue exuding purulent/serosanguinous discharge on compression.
  • Palpable cord: A superficial tract felt just beneath the skin leading to the anal canal.
  • Funnel / Herniation sign: Retraction of the involved crypt of origin due to fibrotic pull on the internal sphincter.
• Epidemiology: Male predominance (2:1 to 7:1); peak incidence in the 3rd to 5th decades.

Investigations

• Examination Under Anesthesia (EUA): Highly indicated for accurate assessment and simultaneous treatment.
• Fistula Tracking:
  • Do NOT force a metal probe through a blind tract, as it creates false passages (iatrogenic extrasphincteric extensions).
  • Diagnostic fluids (methylene blue, hydrogen peroxide, milk) can be injected into the external opening to identify the internal opening via a bivalve speculum.
• Imaging:
  • MRI (Pelvic/Endoanal): Gold standard for mapping complex, recurrent, or high fistulae non-invasively.
  • Endoanal Ultrasonography (EAUS): Highly effective for visualizing intersphincteric tracts and sphincter defects.
  • Fistulography: X-ray contrast study to outline complex branching tracts and pelvic extensions.
  • Anoscopy & Sigmoidoscopy: Essential to rule out underlying proctitis or proximal disease (e.g., Crohn's, malignancy).

Management

Abscess (Acute Phase)

• Primary Treatment: Incision and drainage (I&D) with deroofing (excising skin edges to prevent premature closure).
• Antibiotics: Generally unneeded for simple abscesses. Indications for Abx:
  • Systemic or significant local sepsis (e.g., cellulitis).
  • Immunocompromised host.
  • Prosthetic heart valves or other specific hardware.

Fistula (Chronic Phase)

• Surgical Principles:
  1. Identify the primary internal opening.
  2. Establish the relationship of the tract to the puborectalis/sphincter complex.
  3. Divide the least amount of muscle necessary to cure the fistula (preserving continence).
  4. Identify and treat all side tracts.
  5. Rule out underlying specific diseases (biopsy suspicious tracts).

Relevant Guidelines

Parks Classification of Fistula-in-Ano

• Intersphincteric (70% - Most Common): Tract runs entirely within the intersphincteric plane and opens on the perianal skin. Does not cross the external sphincter.
• Transsphincteric (23%): Tract crosses through both the internal and external sphincters into the ischioanal fossa.
• Suprasphincteric (5%): Tract passes superiorly in the intersphincteric space, loops over the puborectalis/levator ani, and descends through the ischioanal fossa.
• Extrasphincteric (2%): Tract extends from the perineal skin, up through the ischioanal fossa and levator ani, directly into the rectum (completely lateral to the sphincter complex).
• Superficial: Confined to the subcutaneous space.

Goodsall’s Rule (Predicting Tract Pathways)

• Draw a transverse line bisecting the anus.
• Posterior openings: Track in a curved path to a primary internal opening in the posterior midline.
• Anterior openings (< 3 cm from anal verge): Track in a straight radial path to the nearest crypt directly opposite the opening.
• Anterior openings (> 3 cm from anal verge): Exception to the rule; these track in a curved path to the posterior midline.

Supralevator Abscess Drainage Pathway Guidelines

• Incorrect drainage creates complex, high fistulas.
• If Intersphincteric origin: MUST be drained internally into the rectum. (External drainage through ischioanal fossa is contraindicated as it creates a suprasphincteric fistula).
• If Ischioanal origin: MUST be drained externally through the ischioanal fossa. (Internal rectal drainage is contraindicated as it creates an extrasphincteric fistula).

Operative / Procedural Notes

• Fistulotomy (Lay-open technique):
  • Indicated for simple, low fistulae. The tract over a probe is divided (electrocautery).
  • Marsupialization: Edges of the laid-open tract are sutured to adjacent skin. Reduces wound profile and prevents premature skin closure over the wound bed.
• Fistulectomy: The entire fistulous tract is cored out/excised intact.
• Complex Tract Interventions:
  • Setons: Non-absorbable loops passed through the tract.
    • Draining: Tied loosely to keep tract open, ensuring continuous drainage of pus and resolution of inflammation prior to definitive surgery.
    • Cutting: Gradually tightened to slowly fibrose and cut through the sphincter, preventing sudden retraction and incontinence.
    • Medicated: Used to induce fibrosis of the tract.
  • LIFT Procedure (Ligation of Intersphincteric Fistula Tract): Approach via the intersphincteric groove; the tract is isolated, suture-ligated near the internal and external openings, and divided, preserving all sphincter muscle.
  • Advancement Flaps (Endorectal or Dermal Island): A mucosal/submucosal flap is mobilized and advanced over the closed internal opening to isolate the high tract from the rectal lumen.
  • Horseshoe Abscess (Modified Hanley Procedure): Posterior midline incision divides the internal sphincter at the primary crypt, combined with bilateral lateral counter-drainage incisions over the ischioanal spaces, sparing the external sphincter.
  • Tissue Sparing Methods: Fibrin glue, Anal Plug (bioprosthetic scaffold), Laser closure (FiLaC - thermal ablation), Video-Assisted Anal Fistula Treatment (VAAFT).

Past-Paper High Yield

• Pathophysiology of Healing: Epithelialization of a fistula tract prevents spontaneous closure and promotes persistence. It requires surgical destruction/excision to heal.
• Most Common Variant: Intersphincteric fistulae are the most common anatomical type (~70%).
• Surgical Contraindications: Standard simple fistulotomy is contraindicated in high trans-sphincteric (or suprasphincteric) fistulae due to the unacceptably high risk of fecal incontinence resulting from extensive external sphincter division.
• Biopsy Indications: The fistulous tract should ideally be biopsied at operation if it is suspicious, atypical, or non-healing to rule out Crohn's disease or underlying malignancy (e.g., anal carcinoma).
• General Fistula Principles Trap (Pancreatic Pseudocysts): Exam questions testing generalized fistula principles often use pancreatic pseudocysts as a contrast. Remember that external (enterocutaneous) drainage of a pancreatic pseudocyst is generally avoided due to the high risk of creating a persistent pancreaticocutaneous fistula; internal drainage is preferred. Unlike perianal fistulae, pseudocysts lack a true epithelial lining and can resolve spontaneously.

Memory Pearls

• Parks Incidence: "ITSE" -> Intersphincteric (70%), Transsphincteric (23%), Suprasphincteric (5%), Extrasphincteric (2%).
• Goodsall's Dog: "Dog's nose points straight ahead (anterior = straight); tail wags all around to the back (posterior = curved to midline)."
• Distance = Complexity: The further the external opening is from the anal margin, the greater the likelihood of a complex, upward, or transsphincteric extension.
• Supralevator Drainage Rule: Drain it back to where it came from (Intersphincteric -> Rectum; Ischioanal -> Skin).

Surgical aspect of spleen

Core Concepts

• Anatomy & Location: The spleen is located posterolaterally in the left upper quadrant (LUQ) spanning the 9th to 11th ribs. Its size correlates with a person's height, weight, and sex (guided by the "rule of odd numbers").
• Peritoneal Status: The spleen is completely surrounded by peritoneum (except at its hilum), making it an entirely intraperitoneal organ.
  • Contrast: The kidneys and adrenal glands are primary retroperitoneal, while the pancreas is secondary retroperitoneal.
• Ligamentous Attachments: Gastrosplenic, splenorenal, splenophrenic, and spleno-colic ligaments.
• Blood Supply: The splenic artery arises from the celiac trunk and divides into 3 to 7 intraparenchymal segments. This terminal vascular branching makes selective partial splenectomy anatomically feasible.
• Physiology: Crucial for the antibody response against infection and the opsonization of encapsulated bacteria.
• Hematological Indications for Elective Splenectomy:
  • Immune Thrombocytopenic Purpura (ITP): First-line therapy is medical (corticosteroids/IVIG). Splenectomy is highly effective for refractory cases.
  • Hereditary Spherocytosis: Splenectomy is the definitive treatment; it is highly curative for anemia and prevents gallstones as the spleen is the primary site of abnormal RBC destruction.
  • Thalassemia: Splenectomy is not first-line (standard care is blood transfusions and iron chelation). It is reserved only for massive splenomegaly or severe hypersplenism.

Diagnosis / Clinical Features

• Splenic Trauma: The spleen and liver are the most commonly injured intra-abdominal organs in blunt trauma (e.g., motor vehicle collisions).
• Kehr Sign: Left shoulder pain that worsens with inspiration. It is a classic sign of splenic rupture caused by irritation of the phrenic nerve from blood adjacent to the left hemidiaphragm.
• ITP Physical Exam: In ITP, the spleen is generally not palpably enlarged. A massively palpable spleen in a thrombocytopenic patient should prompt investigation for other conditions (e.g., portal hypertension, leukemia, lymphoma).
• OPSI Presentation: Often presents initially as a non-specific flu-like illness that rapidly progresses to fulminant sepsis.

Investigations

• Hemodynamically Stable Trauma Patient: A CT scan of the abdomen with IV contrast is the standard of care to diagnose and grade the injury.
  • Identifies hemoperitoneum, parenchymal lacerations (hypodensities), and active bleeding.
  • Active contrast extravasation (blush) implies ongoing hemorrhage requiring urgent intervention.
• Hemodynamically Unstable Trauma Patient: FAST exam is the initial modality. A positive FAST (hypoechoic rim around the spleen) in an unstable patient mandates immediate laparotomy.
• Peripheral Blood Smear: Post-splenectomy, the presence of Howell-Jolly bodies is characteristically seen and confirms the absence of splenic function.

Management

• Splenic Abscess: A septated or multiloculated splenic abscess is best treated with splenectomy and antibiotics. Percutaneous drainage and antibiotics are inadequate and likely to fail due to the septations. Observation carries a high risk of fatal rupture.
• Non-Operative Management (NOM) for Trauma:
  • Indicated for hemodynamically stable patients lacking other abdominal injuries (e.g., peritonitis).
  • Consists of intensive monitoring, bed rest, and observation. Abandoned if ongoing hemorrhage occurs.
  • A 5-day observation period identifies >95% of patients who will fail NOM.
• Splenic Artery Embolization (SAE):
  • Used as an adjunct to NOM.
  • Distal (selective): Limits parenchymal infarction; used for specific contrast blushes.
  • Proximal: Lowers distal systolic pressure by ~40 mmHg to enhance healing.
• Prophylactic Antibiotics: Lifelong penicillin is not universally mandatory for all patients. It is indicated for children <5 years old, immunocompromised patients, or those with a history of severe encapsulated infections.

Relevant Guidelines

American Association for the Surgery of Trauma (AAST) Splenic Injury Scale

• Grade I: Subcapsular hematoma <10% surface area; Capsular tear <1 cm deep.
• Grade II: Subcapsular hematoma 10%–50% surface area or intraparenchymal <5 cm; Laceration 1–3 cm deep (not involving trabecular vessels).
• Grade III: Subcapsular hematoma >50% or ruptured/expanding; Laceration >3 cm deep or involving trabecular vessels.
• Grade IV: Laceration involving segmental or hilar vessels producing major devascularization (>25% of spleen).
• Grade V: Completely shattered spleen or hilar vascular injury completely devascularizing the organ.

Western Trauma Association (WTA) Algorithm for Blunt Splenic Injury

• Stable Patient: Resuscitate -> CT Scan of Abdomen/Pelvis with IV contrast.
  • Grade I, II, III without blush: Observation.
  • Grade I, II, III with blush: Angiography / Embolization.
  • Failure of observation: Operating Room.
• Unstable Patient: FAST or DPA.
  • Positive: Direct to Operating Room for laparotomy/splenectomy.
  • Negative: Look for other causes of instability.

Operative / Procedural Notes

• Vaccination Timing: For elective splenectomies, immunizations against encapsulated organisms (pneumococcal, meningococcal, Hib) must be administered 2-4 weeks prior to surgery for optimal immunologic response. For emergent trauma splenectomies, vaccinate post-operatively.
• Surgical Approach: Open splenectomy is preferred over laparoscopy when there is massive splenomegaly, cancer surgery requiring en-bloc resection, or a need to thoroughly search for accessory spleens. Failure to remove an accessory spleen can lead to disease recurrence in conditions like ITP or spherocytosis.
• Damage Control: In unstable trauma patients who are coagulopathic, hypothermic, or acidotic, total splenectomy is the safest option. Attempting splenic salvage (splenorrhaphy or partial splenectomy) is abandoned in the face of physiological collapse.

Complications / Prognosis

• Overwhelming Post-Splenectomy Infection (OPSI):
  • Pathogens: Primarily caused by encapsulated organisms. Streptococcus pneumoniae is the most common and most lethal cause. Haemophilus influenzae and Neisseria meningitidis are also notable.
  • Timing: The risk of OPSI is highest within the first 2 years post-operation.
  • Incidence: Following trauma splenectomy, the incidence is very low (0.1% to 0.5%), contrary to the 2% risk seen in patients undergoing splenectomy for hematologic malignancies.
  • Mortality: Carries a 50–80% mortality rate without rapid antibiotic treatment.
• Reactive Thrombocytosis: Physiologically expected postoperative response. Platelet counts typically peak between 7 and 20 days postoperatively before gradually normalizing.
• Splenosis: Iatrogenic or traumatic rupture of the spleen can cause fragments of splenic tissue to implant throughout the peritoneal cavity.
• Vascular Thrombosis: Postoperative DVT/PE risk is increased (~10%). Portal, mesenteric, and splenic vein thrombosis can also occur.

Past-Paper High Yield

• Septated Splenic Abscess: Always choose splenectomy + antibiotics. Do not choose percutaneous drainage, as septations cause it to fail.
• Vaccine Timing: Vaccines must be given 2 to 4 weeks BEFORE an elective splenectomy.
• Stable Trauma with Kehr Sign: Always choose CT abdomen as the next step. Laparotomy is the wrong answer for a hemodynamically stable patient.
• Most common cause of OPSI: Streptococcus pneumoniae.
• Thalassemia Trap: Splenectomy is NOT standard or first-line treatment for all beta-thalassemia patients; standard care is transfusions and chelation.
• Anatomical Trap: The spleen is intraperitoneal. The kidneys and adrenals are primarily retroperitoneal; the pancreas is secondary retroperitoneal.
• ITP Clinical Feature: The spleen is generally NOT palpably enlarged in ITP.
• OPSI incidence in trauma: Understand that the rate is much lower than 2% (typically 0.1% - 0.5%).

Memory Pearls

• Rule of Odds (1, 3, 5, 7, 9, 11): The spleen is roughly 1 x 3 x 5 inches in size, weighs about 7 ounces, and lies between the 9th and 11th ribs.
• Encapsulated bugs to vaccinate against (SHiN): Streptococcus pneumoniae, Haemophilus influenzae, Neisseria meningitidis.

Neuroendocrine tumors

Core Concepts

• Origin: Arise from pluripotent stem cells in the base of intestinal crypts or gastric glands (not mature pancreatic islets). They originate from APUD (Amine Precursor Uptake and Decarboxylation) cells, which constitute the diffuse endocrine system.
• Embryological Classification:
  • Foregut: Thymus, esophagus, lung, stomach, duodenum, pancreas.
  • Midgut: Appendix, ileum, cecum, ascending colon.
  • Hindgut: Distal colon, rectum.
• Epidemiology:
  • Second most prevalent GI tumor overall due to indolent course and long survival (median localized survival ~200 months). Over 60% of NETs are advanced at the time of diagnosis (median survival for advanced: 33 months).
  • Most common primary site: GI tract (58%), specifically rectum (17.2%) and jejunum/ileum (13.4%).
  • Geographic variance: In Middle East & Asia Pacific cohorts, the pancreas is the most common primary site (~49%).
• Pancreatic NETs (pNETs):
  • Account for 7% of all NETs and 1–2% of all pancreatic tumors.
  • Most common overall pNET: Non-functional tumors.
  • Most common benign functional pNET: Insulinoma.
  • Most common malignant functional pNET: Gastrinoma.

Diagnosis / Clinical Features

• Carcinoid Syndrome:
  • Occurs in 8–35% of patients with NETs. For midgut primary tumors, hepatic metastases are required to bypass liver clearance.
  • Pathophysiology: Symptoms are driven by the systemic release of serotonin, histamine, and tachykinins.
  • Manifestations: Episodic flushing (94%), diarrhea (78%), cramping, wheezing/bronchospasm, and potentially carcinoid heart disease (right-sided valvular lesions).
• Insulinoma (β cells):
  • Characterized by Whipple’s triad: 1) Symptoms of hypoglycemia, 2) Plasma glucose < 45 mg/dL (< 2.2 mmol/L), 3) Relief of symptoms with glucose.
  • Often presents with weight gain. 90% are benign and solitary.
• Gastrinoma / Zollinger-Ellison Syndrome (γ cells):
  • Presents with severe, refractory peptic ulcers (often non-healing despite PPI therapy), abdominal pain (70%), diarrhea (70%), and heartburn.
  • 60% malignant. 25% are associated with Multiple Endocrine Neoplasia Type 1 (MEN-1).
• VIPoma (δ cells):
  • Produces WDHA Syndrome (Verner-Morrison Syndrome): Watery Diarrhea (secretory), Hypokalemia, Achlorhydria (or hypochlorhydria).
  • Associated with profound hypovolemia and acidosis. 2/3 are malignant.
• Glucagonoma (α cells):
  • Typically presents with the 4D Syndrome: Dermatitis (Migratory necrolytic erythema—blistering/scaly lesions with central clearing), Diabetes, Diarrhea, DVT.
  • Nearly all are malignant; mostly located in the body and tail of the pancreas.
• Somatostatinoma (δ cells):
  • Usually located in the pancreatic head. 70–90% malignant.
  • Unpredictable presentation but typically includes gallstones (59%), mild diabetes (75%), steatorrhea, and diarrhea.

Investigations

• Biomarkers:
  • Chromogranin A (CgA): Best general biomarker for diagnosis (elevated 80–100% of the time). Correlates with tumor progression. Present in secretory granules.
  • Synaptophysin: Excellent for identifying poorly granulated or poorly differentiated NETs that may be CgA negative (expressed independently of secretory granules).
  • Urinary 5-HIAA: Used to diagnose carcinoid syndrome; it is the inactive metabolic breakdown product of serotonin.
• Insulinoma Workup:
  • 72-hour fasting test: Diagnostic if serum glucose < 45 mg/dL, insulin > 5 µU/L, C-peptide > 0.7 ng/mL, and proinsulin > 6.5 pmol.
  • Localization: Endoscopic ultrasound (EUS) has 77% sensitivity; Intraoperative US (IOUS) has 90% accuracy. Selective calcium angiogram with portal venous sampling (ASVS) yields 90% accuracy.
• Gastrinoma Workup:
  • Fasting Serum Gastrin: > 150 pg/mL (requires cessation of PPI for 1 week).
  • Basic Acid Output (BAO): > 15 mmol/h.
  • Secretin Provocative Test: Confirmatory if gastrin paradoxically rises by ≥ 200 pg/mL.
• Imaging Modalities:
  • CT/MRI for staging.
  • Endoscopic ultrasound (EUS) is primary for pancreatic and duodenal localizations.
  • Somatostatin-receptor scintigraphy (Octreoscan™) or DOTA-TOC FDG/PET is highly effective for primary tumors and metastases (e.g., localizes 91% of VIPomas).

Management

• VIPoma: Urgent correction of metabolic abnormalities (vigorous rehydration, potassium replacement) followed by Octreotide to halt secretory diarrhea.
• Surgical Excision: The mainstay of curative intent for localized tumors (ranges from EMR for small rectal NETs to major resections/enucleation for pNETs).

Relevant Guidelines

• Diagnostic Algorithm (Stepwise Approach):
  1. Morphology & Neuroendocrine markers (Differentiate NET vs. non-NET).
  2. Structure + Grade (Differentiate NET vs. Neuroendocrine Carcinoma [NEC]).
  3. Mitoses & Ki67 Index (Assign Grade 1, 2, or 3).
  4. Size & Invasion (Assign TNM Stage I–IV).
• WHO 2010 Classification of the Digestive System:
  • Premise: All neuroendocrine neoplasms have malignant potential. The term "carcinoid" is a misnomer regarding benign nature and should strictly be reserved for clinical "carcinoid syndrome".
  • Differentiates between Neuroendocrine Tumours (Grade 1/2), Neuroendocrine Carcinomas (Grade 3), and Mixed Adenoneuroendocrine Carcinoma (MANEC).
• ENETS/WHO/AJCC Grading of GEP-NETs:

• ENETS/AJCC TNM Staging Proposal:
  • Stage I/II: Localized (T1–T3, N0, M0) → Median survival is high and stable over 200 months.
  • Stage III: Regional nodal involvement (Any T, N1, M0) → Median survival drops to ~50% at 150 months.
  • Stage IV: Distant metastasis (Any T, Any N, M1) → Median survival drops below 40% by 100 months.

Operative / Procedural Notes

• Passaro's Gastrinoma Triangle: The anatomical region where up to 90% of gastrinomas are located. Bounded by:
  1. Junction of the cystic and common hepatic ducts.
  2. Junction of the second (D2) and third (D3) parts of the duodenum.
  3. Junction of the neck and body of the pancreas.
• Insulinoma Localization: Tumors are distributed evenly across the pancreas (1/3 head, 1/3 body, 1/3 tail). They are highly vascular, well-circumscribed, and usually enucleated if benign and superficially located.

Complications / Prognosis

• Delayed Diagnosis: NETs can be undetected for years; over 60% are advanced at the time of diagnosis.
• Carcinoid Heart Disease: Chronic exposure to elevated systemic serotonin leads to right-sided heart valvular fibrotic lesions, eventually resulting in heart failure.

Past-Paper High Yield

• Anatomical Site of Gastrinoma: The duodenum is the single most common anatomical site for a gastrinoma, accounting for 50-70% of cases (usually within Passaro's gastrinoma triangle). Do not select the stomach antrum or head/body of the pancreas if the duodenum is an option.
• MEN-1 vs. Zollinger-Ellison (ZES) alone: A patient presenting with a refractory peptic ulcer (gastrinoma) and hypercalcemia has MEN-1. ZES alone lacks hypercalcemia; primary hyperparathyroidism (causing the elevated calcium) is the key differentiator for MEN-1.
• Mechanism of Carcinoid Syndrome: Systemic manifestations (flushing, diarrhea, bronchospasm) are caused by the release of serotonin, histamine, and tachykinins. Exam trap: 5-HIAA does not cause symptoms; it is an inactive breakdown product measured in the urine for diagnosis.
• Ulcer Classification trap: Type I benign gastric ulcers (most common, lesser curvature) are due to decreased mucosal defenses with normal/low acid. Do not confuse them with ZES ulcers, which are characterized by profound hypergastrinemia and marked acid hypersecretion.

Memory Pearls

• Whipple's Triad (Insulinoma): Low glucose, Hypoglycemic symptoms, Relief with glucose.
• WDHA Syndrome (VIPoma): Watery Diarrhea, Hypokalemia, Achlorhydria.
• 4 D's of Glucagonoma: Dermatitis (Migratory necrolytic erythema), Diabetes, Diarrhea, DVT.
• Gastrinoma Triangle Landmarks: Duct junction (Cystic/Hepatic) → Duodenum junction (D2/D3) → Pancreas junction (Neck/Body).

Breast

Exam Map

• Diagnostic Algorithms & Next Steps:
  • Triple Assessment: Mandatory for any symptomatic lump (Clinical, Imaging, Pathology).
  • Cyst Management: Fine Needle Aspiration (FNA) is the diagnostic and therapeutic first step for symptomatic, palpable cysts.
  • BI-RADS Actions: BI-RADS 3 = repeat imaging in 6 months. BI-RADS 4 (even if non-palpable microcalcifications) = stereotactic core needle biopsy. Do not choose 6-month follow-up or open excision for BI-RADS 4.
• Recurring Clinical Presentations:
  • Nipple Discharge: Bloody = Intraductal papilloma; Thick green/brown with slit-like inversion = Duct ectasia / periductal mastitis.
  • Nipple Skin Changes: Bilateral/itchy/intact nipple = Eczema; Unilateral/destructive/underlying mass = Paget's disease.
  • Lactational Abscess: Drainage is required, but the heavily tested principle is that patients must continue breastfeeding/pumping to prevent stasis.
• Staging Rules & Clinical Traps:
  • T-Stage Calculation: Determined strictly by the size of the invasive component. Always ignore the in situ size when determining the T-stage.
  • T4 vs. Regional Disease: Skin dimpling (Cooper's ligaments), peau d'orange (dermal lymphatics), and pectoral fixation are direct local T4 signs. Arm edema is a regional axillary node complication, not a T4 sign.
  • Premalignant Risk: Atypical Ductal Hyperplasia (ADH) carries the highest risk (4-5x) for subsequent malignancy compared to other benign conditions.
• Operative Decision Points:
  • Early-Stage Disease (Node-Negative): Standard of care is Breast-Conserving Surgery (lumpectomy) + Sentinel Lymph Node Biopsy (SLNB) + Radiotherapy. Never perform an upfront formal ALND if the SLNB is negative.
  • Inflammatory Breast Cancer (T4d): Upfront surgery is strictly contraindicated. The operative sequence must be: Neoadjuvant Chemotherapy → Modified Radical Mastectomy → Radiotherapy.
• Post-Operative Complications:
  • ALND Morbidity: Ipsilateral upper extremity lymphedema is the most common and significant chronic complication of formal axillary dissection.
  • Nerve Injuries: Know the anatomical associations: Intercostobrachial nerve (medial upper arm numbness) and Long Thoracic nerve (winged scapula).

Breast introduction & benign breast disorders

Core Concepts

Anatomy & Boundaries

• Structure: Modified sweat gland lying in the deep pectoral fascia.
• Boundaries:
  • Superior: Clavicle
  • Inferior: Inframammary fold
  • Medial: Sternum
  • Lateral: Lateral border of the latissimus dorsi muscle
• Glandular Pathway: Acini (within lobules) → Ducts → Ampulla (lactiferous sinus) → Nipple.
• Blood Supply: Perforating branches of internal mammary (thoracic) artery, lateral thoracic artery, thoracoacromial artery, and posterior intercostal arteries.
• Lymphatic Drainage: >75% of ipsilateral breast drainage goes to the axillary lymph nodes. Other pathways include supraclavicular and internal mammary chains.
• Axillary Anatomy: The Long Thoracic Nerve (nerve of Bell) runs vertically along the lateral chest wall on the serratus anterior muscle. Injury during axillary clearance causes a "winged scapula."

Physiology & Embryology

• Hormonal Regulation:
  • Prolactin: Acts on luminal epithelial cells to stimulate milk secretion into the alveolus.
  • Oxytocin: Acts on basal myoepithelial (contractile) cells to trigger milk ejection.
• Embryology (The Milk Line): The mammary ridge develops from the axilla down to the groin.
  • Incomplete regression: Leads to accessory breast tissue (polymastia) or accessory nipples (polythelia) anywhere along this path.
  • Failure of development: Leads to complete absence of breast tissue (amastia).

Diagnosis / Clinical Features

Clinical Presentation & Differentials

• Painless Lump: Carcinoma, cyst, fibroadenoma, fibroadenosis.
• Painful Lump: Fibroadenosis, cyst, periductal mastitis, abscess (usually postpartum/lactational), occasionally carcinoma.
• Nipple Discharge:
  • Unilateral, Bloody: Intraductal papilloma (most common), Ductal carcinoma-in-situ (DCIS), invasive ductal carcinoma.
  • Thick, Multicolored (creamy/green/brown): Duct ectasia / Periductal mastitis.
• Nipple/Areola Changes: Duct ectasia (slit-like inversion), carcinoma, Paget's disease, eczema.

Benign Breast Disorders

• Fibroadenoma: Most common in ages 15–55. Presents as a smooth, rubbery, well-circumscribed, highly mobile mass ("breast mouse").
• Intraductal Papilloma: Benign papillary neoplasm within the milk ducts. Unpalpable or soft peri-areolar swelling; classically presents with bloody nipple discharge.
• Periductal Mastitis / Duct Ectasia: Dilatation of mammary ducts filled with inspissated debris (macrophages/chronic inflammation). Features include green/thick discharge, slit-like nipple inversion, and potential for subareolar abscess leading to a mammillary fistula.
• Breast Cyst: Sudden onset, tender, fluctuating, perimenopausal (40–55 years). Often multiple.
• Phyllodes Tumor: Fibroepithelial tumor presenting as a firm, mobile, rapidly growing mass (similar to a fibroadenoma clinically). ~10-25% are malignant. Exhibits leaf-like epithelial-lined spaces histologically. High local recurrence rate if inadequately excised.
• Gynecomastia (Male):
  • True Gynecomastia: Benign glandular proliferation. Responsive to hormone modulation (e.g., testosterone replacement for primary hypogonadism). Induced by medications like spironolactone. Prevalence increases with advancing age (declining testosterone / increased aromatization). Does not increase male breast cancer risk.
  • Pseudo-gynecomastia (Lipomastia): Accumulation of subareolar adipose tissue without glandular tissue. Unresponsive to anti-estrogen therapies (e.g., tamoxifen).

Differentiating Eczema vs. Paget's Disease of the Nipple

• Pathogenesis of Paget's: Malignant cells (from underlying DCIS or invasive cancer) migrate up the lactiferous ducts to infiltrate the nipple epidermis.

Comparison of Common Breast Lumps

Investigations

Triple Assessment For any symptomatic patient, diagnosis mandates all three components:

1. Clinical: History and physical examination.
2. Imaging: Mammography and/or Ultrasound.
3. Pathology: Fine Needle Aspiration Cytology (FNAC) or Core Needle Biopsy.

Imaging Modalities

• Mammography: Most sensitive overall, but sensitivity decreases in young women (dense glandular breasts). Standard views: Craniocaudal (CC) and Mediolateral Oblique (MLO; captures axillary tail and pectoralis).
• Ultrasound: Highly useful for differentiating solid vs. cystic lesions, guiding biopsies, and assessing young/dense breasts. Cysts appear as well-circumscribed, anechoic structures with posterior acoustic enhancement. Sens 75%, Spec 97% for malignancy.
• Ductogram (Galactogram): Used for pathological nipple discharge; reveals contrast filling defects (e.g., intraductal papilloma).

Pathological Tissue Sampling

• FNAC: Uses syringe/needle to aspirate cells (cytology). Rapid and minimally invasive. Diagnostic and therapeutic for cysts.
• Core Needle Biopsy: Extracts a tissue cylinder (histology). Preserves tissue architecture, distinguishing in-situ from invasive disease, and allows receptor testing (ER/PR/HER2). Essential for solid masses.

Management

• Symptomatic Simple Cyst: The most appropriate initial step is Fine Needle Aspiration (FNA). It is both diagnostic and therapeutic, providing immediate symptomatic relief. If fluid is non-bloody and the cyst completely collapses, no further intervention is needed.
• Lactational Breast Abscess: Most commonly Staphylococcus aureus, ascending via a macerated/cracked nipple.
  • Treatment: Requires drainage (US-guided aspiration or open I&D).
  • Crucial principle: Do NOT discontinue breastfeeding. Continued feeding/pumping prevents milk stasis and promotes resolution. If unresolved despite antibiotics/drainage, a biopsy is indicated to rule out inflammatory breast cancer.
• Fibroadenoma: Can be managed with observation or surgical enucleation (circumareolar/submammary incision for cosmesis).
• Periductal Mastitis / Mammillary Fistula: Excision of the major terminal duct system (Hadfield's procedure) to cure chronic infection and close the fistula tract.

Relevant Guidelines

BI-RADS Mammographic Assessment Categories

Operative / Procedural Notes

• Hadfield's Operation (Major Duct Excision): Indicated for recurrent periductal mastitis or mammillary fistulae. Involves a circumareolar incision, deep dissection, and wide excision of the terminal major duct bundle behind the nipple-areola complex.
• Abscess Drainage: For severe fluctuant abscesses, an incision is made, and a corrugated rubber drain (Penrose drain) is inserted deeply to prevent premature skin closure, allowing the cavity to heal by secondary intention.
• Fibroadenoma Enucleation: Simple surgical "popping out" of the encapsulated mass from surrounding parenchyma.
• Clinical Breast Exam Patterns: Palpation should be methodical—radial (spoke-wheel), concentric circles, or vertical strips (lawnmower). Evaluate the axilla by supporting the patient's arm to fully relax the pectoralis muscles.

Complications / Prognosis

• Risk of Malignancy in Benign Breast Disease:
  • High Risk: Atypical ductal hyperplasia (ADH) carries a 4–5x increased relative risk for invasive breast cancer.
  • Slightly Increased Risk: Sclerosing adenosis (1.5–2x relative risk).
  • No Significant Risk: Duct ectasia, simple cysts, and fibroadenomas are non-proliferative and do not inherently increase cancer risk.
• Phyllodes Tumor Spread: Uniquely among malignant breast tumors, it characteristically spreads hematogenously (to lungs and bone). Lymph node metastasis is extremely rare (<5%), so axillary dissection is rarely needed.
• Locally Advanced Breast Cancer Signs: Tumor progression (T3/T4) causing local invasion leads to skin dimpling (fibrosis of Cooper's ligaments), nipple inversion (ductal fibrosis), peau d'orange (dermal lymphatic embolization), and pectoral muscle fixation. Note: Arm edema indicates regional advancement (axillary lymphatic obstruction), not direct local tumor invasion.

Past-Paper High Yield

• Intraductal papilloma is the most common cause of unilateral, bloody nipple discharge. (Do not confuse with duct ectasia, which produces thick, green/brown, multicolored discharge).
• Fine Needle Aspiration (FNA) is the first-line management for a symptomatic, painful, palpable cyst (even large, e.g., 4 cm). It is diagnostic and therapeutic; excisional biopsy or MRI are incorrect initial choices.
• Lactational Abscess: Always encourage the patient to continue breastfeeding or pumping to prevent stasis. Surgical drainage is mandatory if fluctuant. If a presumed abscess fails to resolve, you must biopsy to rule out inflammatory carcinoma.
• Phyllodes Tumors spread hematogenously (lungs, bone) rather than via lymphatics. They present like fast-growing fibroadenomas and require wide excision due to high local recurrence rates.
• Atypical Ductal Hyperplasia (ADH) is the benign proliferative condition carrying the highest risk (4-5x) for subsequent breast malignancy.
• Polymastia/Polythelia results from incomplete regression of the mammary ridge (milk line). Amastia is failure of the ridge to develop.
• Gynecomastia: True gynecomastia is responsive to hormonal shifts (e.g., spironolactone use, testosterone replacement for hypogonadism, advancing age). Pseudo-gynecomastia (lipomastia) is pure fat and completely unresponsive to anti-estrogens like tamoxifen.
• Arm edema is a sign of extensive regional axillary lymph node disease, whereas peau d'orange, dimpling, and pectoral fixation are signs of a locally advanced primary tumor.

Memory Pearls

• "Breast mouse" → Fibroadenoma (highly mobile).
• Bloody nipple discharge → Intraductal papilloma.
• Slit-like nipple inversion + Green discharge → Duct ectasia / Periductal mastitis.
• Winged Scapula post-axillary dissection → Long thoracic nerve injury (Serratus anterior).
• Eczema vs. Paget's → Eczema is bilateral/itchy/no lump; Paget's is unilateral/destroys nipple/underlying mass.

Breast cancer overview

Core Concepts

• Triple Assessment Approach: The gold standard for evaluating breast masses involves three pillars:
  1. Clinical Evaluation (focused history + standardized examination)
  2. Imaging (Mammography, Ultrasound, or MRI)
  3. Cytology or Histology (FNA or Core Needle Biopsy)
• Risk Factors:
  • Advancing age is the single most significant risk factor for sporadic breast cancer (excluding female sex).
  • Note: 70% of women diagnosed have no identifiable risk factors.
  • Other factors: Female gender (100:1 ratio), Caucasian race, obesity (BMI >30), exogenous hormones, nulliparity, early menarche.
  • Family history: One 1st-degree relative doubles risk; two 1st-degree relatives triple risk.
  • Genetics: BRCA1, BRCA2, p53 account for only 5–6% of all breast cancers.
• Receptor Subtypes & Targeted Therapies:
  • ER-positive / HER2-negative: Treated with endocrine therapies (tamoxifen, aromatase inhibitors).
  • HER2-positive: Treated with targeted monoclonal antibodies (e.g., Trastuzumab, which directly targets the HER2/neu receptor). Amplification of HER2/neu is an indicator of aggressive tumor biology and poor prognosis.
  • Triple-negative (Basal-like): Lacks ER, PR, and HER2. Often associated with BRCA1 mutations and medullary histology.

Diagnosis / Clinical Features

• Classic Malignant Mass: Typically hard, irregular, and painless (only 10–15% are painful).
• Direct Local Invasion (T4 Signs): Occurs via contiguous invasion of the primary tumor into surrounding tissue.
  • Skin dimpling/tethering: Caused by the tumor's desmoplastic fibrotic reaction shortening and tethering Cooper's suspensory ligaments.
  • Nipple retraction/inversion: Pathologic fibrosis and contracture of the major subareolar lactiferous ducts.
  • Peau d'orange: Edema and "orange-peel" pitting of the skin caused by tumor emboli blocking dermal lymphatics.
  • Pectoral fixation: Deep fixation to the pectoral fascia or muscle (best assessed clinically by having the patient press hands into hips to contract the pectoralis major).
  • Skin ulceration & satellite nodules.
• Regional Disease (Nodal Spread):
  • Arm edema (Lymphedema): A sign of regional lymphatic obstruction from extensive metastatic axillary lymph nodes. Crucial exam point: It is a regional complication, not a direct local T4 extension of the breast mass.
• Nipple Discharge: Spontaneous, single-duct, bloody or serosanguineous (watery) discharge is highly suspicious for intraductal pathology (e.g., papilloma or DCIS).
• Paget's Disease of the Nipple:
  • Characterized by intraepithelial spread of malignant adenocarcinoma cells (Paget cells) into the nipple epidermis. Represents carcinoma in situ.
  • Presents as an erythematous, eczematous, scaling, crusting, or ulcerating lesion of the nipple-areolar complex. Highly associated with underlying invasive or in situ carcinoma.

Investigations

• Mammography:
  • Standard views: Craniocaudal (CC) and Mediolateral Oblique (MLO). MLO captures the maximum tissue amount, including the axillary tail (Tail of Spence).
  • Suspicious signs: Irregular, spicular masses causing architectural distortion, and clustered pleomorphic microcalcifications (classic for early DCIS/invasive cancer).
  • Limitations: Sensitivity is significantly reduced in young women due to dense fibroglandular tissue. In older women with fatty breasts, mammography is highly sensitive and accurate for tumor extent.
• Ultrasound:
  • Essential for differentiating solid vs. cystic lesions (e.g., cysts show eggshell calcifications on mammogram and are fluid-filled on US).
  • Guides focal biopsies (FNA or core needle).
• MRI (Magnetic Resonance Imaging):
  • Indications: Screening high-risk young women (e.g., BRCA mutations), evaluating occult primary tumors in patients with positive axillary nodes, and assessing disease extent in invasive lobular cancer.
  • Kinetic curves: Type I (progressive = benign); Type II (plateau = indeterminate); Type III (rapid early enhancement followed by rapid wash-out = 90% malignant).
  • Contraindication/Limitation: Not a substitute for biopsy. In older women with fatty breasts, routine MRI does not outperform mammography and causes false positives.
• Biopsy Techniques:
  • Core Needle Biopsy (CNB): The standard of care. High sensitivity (100%), distinguishes between in situ and invasive cancer (unlike FNA).
  • FNA: Cannot distinguish in-situ from invasive disease. Ideal for simple cyst aspiration.
  • Stereotactic Image-Guided Biopsy: The mandatory next step for non-palpable mammographic findings (e.g., clustered microcalcifications detected only on a screening mammogram).
• Metastatic Workup (Stage IV):
  • Symptoms direct imaging: Bone scan for skeletal complaints, CT chest/abdomen for visceral spread.
  • Labs: LFTs, Renal function, CBC (anemia from bone marrow infiltration), Tumor marker CA 15.3.

Relevant Guidelines

American Cancer Society (ACS) Breast Screening Guidelines

(Screening continues as long as life expectancy is >10 years)

BI-RADS Classification & Management Algorithm

AJCC TNM Staging Framework

• T (Tumor): Calculated strictly by the size of the invasive component (ignore in situ component).
  • Tis: Carcinoma in situ
  • T1: < 2 cm
  • T2: 2–5 cm
  • T3: > 5 cm
  • T4: Any size, but extends to skin or chest wall
• N (Nodes):
  • N0: None
  • N1: Movable same-side axillary nodes
  • N2: Fixed or matted same-side axillary nodes
  • N3: Same-side internal mammary nodes
• M (Metastasis):
  • M0 = None, M1 = Distant (Brain, Lungs, Liver, Bones)
• Stage Grouping Pearls:
  • Stage I: T1N0M0 (85% 5-year survival).
  • Stage II: e.g., T2N1M0.
  • Stage III: e.g., T2N2M0 (T2 with matted/fixed nodes).

Nottingham Histological Grading System

• Based on Glandular/tubular differentiation, Nuclear pleomorphism, and Mitotic count.
  • Grade 1 (Well-diff): >75% gland formation, uniform cells, <7 mitoses.
  • Grade 2 (Moderate): 10–75% glands, moderate variability.
  • Grade 3 (Poorly-diff): <10% glands, highly pleomorphic, >16 mitoses.

Operative / Procedural Notes

• Breast Conserving Surgery (BCS): Wide local excision/lumpectomy with clear margins. Combined with radiation therapy, it offers equivalent survival to mastectomy for early-stage disease.
  • Oncoplastic techniques: Use local flaps and parenchymal pillars to prevent severe cosmetic deformities and contour collapse.
• Mastectomy Approaches:
  • Radical Mastectomy: Removes breast, nodes, and pectoralis major/minor. Rarely done today; results in shoulder instability and severe cosmetic deformity.
  • Modified Radical Mastectomy: Removes breast and Level I/II axillary nodes but preserves the pectoralis major muscle.
  • Skin-sparing Mastectomy: Preserves the skin envelope (nipple-areola excised), allowing for immediate prosthetic/implant reconstruction.
• Reconstructive Flaps:
  • TRAM Flap (Transverse Rectus Abdominis Myocutaneous): Pedicled from the abdomen.
  • Latissimus Dorsi Flap: Pedicled from the back. Good for volume deficits, but the transplanted muscle will eventually atrophy, and there is a loss of latissimus function.
• Axillary Management:
  • Sentinel Lymph Node Biopsy (SLNB): Injection of blue dye/radiotracer to identify the first draining axillary lymph node. If negative, complete axillary lymph node dissection (ALND) is avoided, significantly reducing the risk of lymphedema.

Complications / Prognosis

• Recurrence:
  • Most breast cancer recurrences (especially in triple-negative or HER2+ tumors) happen within the first 5 years.
  • Exception: ER-positive tumors are notorious for late recurrences (10 to 20 years later).
• Metastatic Pathways:
  • Breast cancer frequently hematogenously metastasizes to the axial skeleton (vertebral column) via the valveless Batson's vertebral venous plexus.
• Histological Variants:
  • Invasive Ductal Carcinoma (IDC): Most common. The presence of surrounding DCIS does not adversely affect the prognosis of the invasive component.
  • Medullary Carcinoma: Often large and triple-negative, with dense lymphocytic infiltrates, no desmoplastic stroma, and pushing borders. Paradoxically associated with a better prognosis than standard IDC, even with node involvement.
  • Invasive Lobular Carcinoma (ILC): Associated with a higher incidence of bilateral and multicentric disease.
  • Mucinous (Colloid) Carcinoma: A rare variant, making up only 2–3% of breast cancers.
  • Mixed tumors: Clinical behavior is driven by the worst/most aggressive component.

Past-Paper High Yield

• BI-RADS 3 vs 4 Trap: BI-RADS 3 = repeat imaging in 6 months. BI-RADS 4 (even if non-palpable and only clustered microcalcifications on screening) = Stereotactic Core Needle Biopsy. Do not choose reassurance, 6-month follow-up, or open excision as the first step for BI-RADS 4.
• T-Stage Calculation Trap: The T-stage is determined strictly by the size of the invasive component. If a question stem gives a "3.2 cm carcinoma in situ with an invasive component of 0.9 cm," the tumor is a T1.
• T4 vs Regional Disease Trap: A question will ask which physical finding is not a sign of direct local T4 invasion. Arm edema is the answer. Arm edema is a regional lymphatic complication of the axilla, whereas peau d'orange, skin tethering, and chest wall fixation are direct local T4 extensions.
• Staging Trap: A 4 cm mass (T2) + matted/fixed nodes (N2) is automatically pushed into Stage III, regardless of tumor size.
• Carcinoma in Situ Distinctions: Paget's disease, Bowen's disease (skin SCC), Erythroplasia of Queyrat (penis SCC), and Hutchinson's freckle (melanoma) are all in situ. Basal cell carcinoma is locally invasive, NOT in situ.
• Receptor Nuance: BRCA2 mutations are more likely to be ER-positive (unlike BRCA1 which is triple-negative). Endocrine therapy is only effective for ER+ tumors.
• MRI Limitations Trap: Recognize that MRI does not significantly outperform mammography in older women with fatty breasts; routine MRI here causes false positives.

Memory Pearls

• Cooper's Ligaments = Skin Dimpling.
• Dermal Lymphatics blocked = Peau d'orange.
• Subareolar Duct Fibrosis = Nipple Retraction.
• Batson's Plexus = Spine Metastasis.
• Medullary Carcinoma = Looks bad (Grade 3/triple negative), acts good (good prognosis).
• Microcalcifications only = Stereotactic biopsy.
• HER2 = Trastuzumab (Herceptin) target; implies worse tumor biology.

Breast cancer management

Core Concepts

• Multimodal Treatment: Cancer management relies on single or combined modalities: Surgery, Radiotherapy, Chemotherapy, and Hormonal Therapy.
• Surgical Oncology Objectives: Prevention, diagnosis, treatment of primary tumor, resection of metastasis, management of oncologic emergencies (e.g., hemorrhage, abscess), palliation, reconstruction, and cytoreduction.
• Principles of Oncologic Resection: Achieve adequate resection margins, prevent tumor spillage, and utilize minimal manipulation of the tumor during excision.
• Breast-Conserving Therapy (BCT): Lumpectomy followed by whole-breast radiation therapy is as effective in terms of survival as a modified radical mastectomy for appropriately selected patients.

Diagnosis / Clinical Features

• Clinical Evaluation: Relies on history, physical examination (clinical breast exam), and assessing the involved system for late symptoms/signs.
• Inflammatory Breast Cancer (T4d): A highly aggressive, locally advanced breast cancer. Clinically presents as an edematous, erythematous breast (peau d'orange) due to dermal lymphatic invasion by tumor cells.
• Locally Advanced Breast Cancer (T4): Involves direct extension to the chest wall or skin, or presents as inflammatory breast cancer.

Investigations

• Fine Needle Aspiration Biopsy (FNAB):
  • Simple outpatient procedure extracting tissue for cytological examination.
  • Major limitation: A negative result does not reliably rule out cancer.
• Incisional Biopsy: Removes only part of the tumor. Usually reserved for very large tumors or special circumstances; rarely performed today.
• Excisional Biopsy: Most common biopsy procedure. The entire lump is removed. If histological margins are negative, this can serve as a definitive lumpectomy.
• Surgeon's Biopsy Responsibilities:
  • Select the appropriate biopsy method and site.
  • Specimen Orientation: Must orient the specimen for the pathologist (e.g., placing a suture at the superior margin).
  • Ensure the integrity of the tissue plane and adequacy of the sample.
  • Communicate results and initial prognosis to the patient.

Management

• Early-Stage Invasive Breast Cancer (e.g., T1/T2, Clinically Node-Negative):
  • Standard of Care: Breast-conserving surgery (Wide Local Excision / Lumpectomy) + Sentinel Lymph Node Biopsy (SLNB) + Post-operative Radiotherapy.
  • Mastectomy is an option but not mandatory unless there are contraindications to radiation or if disease is multicentric.
• Locally Advanced / Inflammatory Breast Cancer (T4/T4d):
  • Upfront surgery is strictly contraindicated due to high risk of positive margins and rapid recurrence.
  • Standard Pathway: Neoadjuvant systemic chemotherapy (to downstage tumor and treat micrometastases) → Modified Radical Mastectomy → Post-mastectomy Radiotherapy.
• Surgical Resection Types:
  • Lumpectomy (Wide Local Excision): Excision of the primary tumor with a surrounding circumferential margin of normal healthy tissue.
  • Total (Simple) Mastectomy: Entire breast tissue is removed. Pectoral muscles and axillary lymph nodes are preserved. Indicated for early non-invasive cancers or as prophylactic surgery (e.g., BRCA mutations).
  • Modified Radical Mastectomy (MRM): Entire breast tissue is removed along with an axillary lymph node dissection (Level I-II). Pectoralis major and minor muscles are preserved.
  • Radical Mastectomy: Entire breast, axillary nodes, and both pectoralis major and minor muscles are removed. Obsolete and rarely performed; reserved only for massive tumors directly invading the chest wall musculature.
• Radiotherapy Principles:
  • Typical whole-breast doses are 4500–5000 cGy (not <1000 cGy).
  • Primarily provides local control; does not eliminate the need for systemic chemotherapy in treating distant micrometastatic disease.
  • Strictly contraindicated during pregnancy (especially first trimester) due to high risk of fetal malformation and demise.
• Metastatic Disease Surgery:
  • Metastasectomy can improve 5-year overall survival (e.g., 16% survival benefit for resection of breast cancer metastases).
• Supportive Surgery: Placement of subcutaneous venous access catheters (Port-a-cath) allows for repeated chemotherapy infusions, avoiding damage to peripheral veins.

Relevant Guidelines

• Criteria for Metastasectomy:
  • The primary tumor is controlled or controllable.
  • Evidence that metastasectomy is associated with clinical benefits.
  • Tumor doubling time is sufficiently long.
  • No significant co-morbid factors.
• Indications for Primary Surgical Prophylaxis:
  • Breast: BRCA mutations (bilateral prophylactic mastectomies)
  • Colon: Familial Adenomatous Polyposis (FAP) and HNPCC
  • Thyroid: MEN II syndrome

Operative / Procedural Notes

• Axillary Lymph Node Dissection (ALND):
  • Formal clearance of level I-III axillary nodes.
  • Contraindication: Do NOT perform a complete ALND in a patient with an early-stage cancer (e.g., T1) and a pathologically negative SLNB, regardless of tumor quadrant. It adds unnecessary morbidity.
  • Indications: Clinically palpable/matted nodes, positive SLNB with massive extranodal extension, failure of SLNB mapping to identify nodes, or inflammatory breast cancer (where SLNB is contraindicated).

Complications / Prognosis

• Lymphedema (ALND Complication): The most common, dreaded, and significant long-term complication of a complete ALND (occurring in 20-30% of patients) due to the permanent disruption of lymphatic drainage.
• Nerve Injuries Post-Axillary Dissection:
  • Intercostobrachial Nerve: Provides sensory innervation to the axilla and medial upper arm. Frequently sacrificed or stretched during axillary clearance, leading to postoperative numbness and paresthesia in the inner arm.
  • Long Thoracic Nerve: Injury results in paralysis of the serratus anterior muscle (winged scapula deformity).
  • Thoracodorsal Nerve: Injury results in latissimus dorsi weakness (impaired adduction/internal rotation of the arm).
• Acute Radiation Dermatitis: A well-known acute side effect of breast radiotherapy characterized by skin erythema, edema, dry/moist desquamation, and occasionally ulceration. Prognosis: Transient; typically heals and resolves within a few weeks after completing treatment (rarely permanent).

Past-Paper High Yield

• SLNB vs. ALND Trap: Exam questions frequently test the overtreatment of clinically node-negative early-stage breast cancer. The correct approach is always Wide local excision coupled with a sentinel lymph node biopsy. Never choose a complete ALND for a negative SLNB, as it is contraindicated.
• Identifying Lymphedema: Know that lymphedema of the ipsilateral upper extremity is the most common chronic complication of a formal level I-III ALND. Winged scapula and brachial plexopathy are comparatively rare.
• Nerve Deficits: Medial upper arm numbness post-mastectomy = Intercostobrachial nerve injury.
• Inflammatory Breast Cancer Trap: If a question describes a patient with an edematous, erythematous breast and a biopsy proving carcinoma, do NOT choose upfront surgery or antibiotics for cellulitis. The definitive key is Multimodal therapy: Chemotherapy → Surgery → Radiotherapy.
• Radiotherapy Side Effects: Remember that post-radiation skin erythema is expected and usually resolves within a few weeks; it is not a permanent fixture.

Memory Pearls

• Simple Mastectomy: Breast out, nodes in, muscles in.
• Modified Radical Mastectomy: Breast out, nodes out, muscles in.
• Radical Mastectomy: Breast out, nodes out, muscles out.
• T4d (Inflammatory) Treatment Order: Chemo → Mastectomy → Radiation (CMR).

Endocrine

Exam Map

• The Biopsy Hierarchy (Crucial Exam Trap): Never select "excisional/incisional biopsy" as the initial step for a parotid mass or a suspicious lateral cervical node in an adult/smoker. FNA is always the mandated first step to preserve surgical and lymphatic planes (preventing SCC or salivary tumor seeding).
• Thyroid Algorithmic Decision Points: FNA cannot differentiate a benign follicular adenoma from a malignant follicular carcinoma. The absolute exam-tested next step for Bethesda 4 (Follicular Neoplasm) is a diagnostic hemithyroidectomy (lobectomy).
• Post-Operative Neck Emergencies: Neck hematoma is universally tested as the most lethal immediate complication post-thyroidectomy/parathyroidectomy, causing rapid airway loss and requiring emergent bedside wound opening.
• Adrenal Perioperative Safety: The preoperative preparation for pheochromocytoma is a heavy favorite: *Alpha-blockade (phenoxybenzamine) must strictly precede beta-blockade* to prevent massive unopposed vasoconstriction and heart failure.
• Strict Surgical Criteria: Memorize the NIH guidelines for asymptomatic primary hyperparathyroidism. Age strictly < 50, Serum Ca >1.0 mg/dL above normal, T-score ≤ -2.5, or renal impairment are the absolute triggers for surgery.
• Diagnostic Lab Profiles: Be prepared to differentiate primary hyperaldosteronism (Conn's) characterized by hypernatremia, hypokalemia, and crucially low/suppressed renin, from secondary causes (high renin).
• MEN Syndromes & Tumor Markers: Rapidly distinguish MEN-1 (3 Ps) from MEN-2A/2B (Pheochromocytoma + Medullary Thyroid Cancer). Remember that Medullary cancers require a prophylactic central neck node dissection and secrete calcitonin.
• "Rules of Thumb" to Memorize: The Salivary "Rule of 80s" (Parotid is 80% benign, minor glands are 80% malignant) and the Pheochromocytoma "Rule of 10s" (though remember pediatric cases specifically break this rule, with 25% being bilateral/extra-adrenal).

Disorders of parathyroid glands

Core Concepts

Anatomy & Embryology

• Structure: Typically 4 glands located behind the thyroid, embedded between the posterior border of the thyroid and its fibrous capsule. Normal dimensions: 6 x 4 x 2 mm; weight: 25–40 mg each.
• Variation: Normal function is maintained with at least 2 glands. Up to 15-20% of glands may be ectopic (e.g., intrathyroidal, deep neck, or mediastinal); total number can vary from 4 to 6.
• Embryology:
  • Superior parathyroid glands: Develop from the 4th branchial pouch. Located dorsal to the recurrent laryngeal nerve (RLN) at the level of the cricoid cartilage.
  • Inferior parathyroid glands: Develop from the 3rd branchial pouch. Located ventral to the RLN.
• Vascular Supply: Primarily from the inferior thyroid artery. (The superior thyroid artery supplies ~20% of the upper glands).
• Venous Drainage: Ipsilaterally via the superior, middle, and inferior thyroid veins.
• Histology: Composed of chief cells and oxyphil cells within an adipose stroma. Both synthesize parathyroid hormone (PTH). Oxyphil cells derive from chief cells and increase with age. Note: They do not contain follicular or C cells (which are thyroid).

Physiology of Calcium & PTH

• Plasma Calcium Distribution: Total plasma calcium (~9.5 mg/dL) is divided into:
  • 50% Free ionized (biologically active): Strictly regulated by PTH and active Vitamin D.
  • 40% Protein-bound: 80% to albumin, 20% to globulins.
  • 10% Complexed: With small anions (citrate, phosphate).
• Corrected Calcium Formula: Corrected Ca = Measured Ca (mg/dL) + 0.8 * (4.0 - Albumin g/dL). This differentiates true hypercalcemia from factitious hypercalcemia due to hyperalbuminemia.
• PTH Synthesis & Secretion:
  • Synthesized as preproparathyroid hormone → proparathyroid hormone → active PTH (84 amino acids).
  • Extremely short half-life of 2 to 4 minutes (crucial for intraoperative monitoring).
  • Metabolized in the liver into an active N-terminal and inactive C-terminal fraction.
• Mechanism of Action: Calcium-sensing receptors (CASR) on parathyroid cells detect low serum ionized calcium, triggering PTH release, which increases serum calcium via three targets:
  1. Bone: Increases bone resorption (demineralization).
  2. Kidney: Enhances calcium reabsorption, decreases phosphate reabsorption (causing phosphaturia), and stimulates 1-α-hydroxylase.
  3. GI Tract (Indirect): 1-α-hydroxylase converts Vitamin D to its active form (1,25-dihydroxyvitamin D3), which increases intestinal absorption of both calcium and phosphate.

Diagnosis / Clinical Features

Primary Hyperparathyroidism (1° HPT)

• Pathology: Autonomous overproduction of PTH independent of calcium levels. Accounts for 90% of hypercalcemia cases alongside malignancy.
  • Single Adenoma: 80–85% of cases (Most common cause).
  • Hyperplasia: 10–15% of cases (All 4 glands enlarged).
  • Carcinoma: ~1% of cases.
• Epidemiology: Occurs in 0.1–0.3% of the population; highly female predominant (1:500 women vs 1:2000 men).
• Clinical Presentation: Often an incidental finding of hypercalcemia. However, detailed history reveals symptoms in ~70%. Classically summarized as:
  • Stones: Nephrolithiasis (calcium phosphate and oxalate stones). Polyuria (nephrogenic DI secondary to hypercalcemia, not oliguria) and polydipsia.
  • Bones: Bone pain, osteopenia, osteoporosis, and osteitis fibrosa cystica (advanced disease marked by "brown tumors" or osteoclastomas).
  • Groans: Abdominal pain, severe peptic ulcer disease (PUD), pancreatitis, constipation.
  • Moans (Psychic): Depression, anxiety, florid psychosis, obtundation, coma.
  • Fatigue Overtones: Generalized severe fatigue and muscle weakness.

Secondary vs. Tertiary Hyperparathyroidism

• Secondary HPT: An appropriate physiological response to chronic hypocalcemia.
  • Cause: Most commonly Chronic Renal Failure (loss of renal tissue leads to decreased 1-α-hydroxylase, low 1,25-Vit D, and decreased GI calcium absorption).
  • Biochem: Low or low-normal calcium, High PTH.
• Tertiary HPT: Long-standing secondary HPT leading to autonomous parathyroid hyperfunction, typically seen post-renal transplant.
  • Biochem: High calcium, High PTH.

Parathyroid Carcinoma

• Aggressive disease with a poor prognosis. 15% present with lymph node metastases, 33% with distant metastases.
• Intraoperative Findings: Large, gray-white to gray-brown firm tumor strongly adherent to or invading surrounding neck structures.

Hypoparathyroidism

• Causes:
  • Surgical: Most common (post-thyroidectomy or neck exploration). Results from inadvertent removal or devascularization.
  • Idiopathic: Genetic/autoimmune forms (e.g., MEDAC or HAM syndromes, DiGeorge syndrome).
  • Functional: Secondary to severe hypomagnesemia (magnesium is required for both PTH release and peripheral PTH action).
• Clinical Features:
  • Neuromuscular hyperactivity: Tetany, perioral paresthesias, muscle cramps, hyperreflexia.
  • Cardiac: Prolonged QT interval, hypotension, resistance to digitalis, refractory heart failure.
  • Other: Posterior lenticular cataracts.

Investigations

Biochemical Evaluation of Primary HPT

• Serum Calcium: Elevated (corrected or ionized).
• Intact PTH: Elevated (>0.5 mg/L) or inappropriately normal relative to hypercalcemia.
• Serum Phosphate: Decreased (due to PTH-induced renal wasting).
• Serum Chloride: Elevated (PTH causes a mild hyperchloremic metabolic acidosis).
• Chloride to Phosphate Ratio (Cl:PO4): > 33.
• Alkaline Phosphatase: Normal or elevated (if increased bone turnover/disease is present).
• Urine: Normal or high 24h urinary calcium (>250 mg/24h).
• Calcium to Creatinine Clearance Ratio: > 0.02 (Differentiates 1° HPT from Familial Hypocalciuric Hypercalcemia [FHH], which has a ratio < 0.01).

Pre-Operative Imaging (Localization)

• Technetium-99m Sestamibi Scan: The most specific and sensitive (85-95%) functional imaging modality for localizing a parathyroid adenoma. The radiotracer concentrates in mitochondria-rich tissue; parathyroid adenomas exhibit delayed washout compared to normal thyroid tissue.
• Sestamibi-SPECT (Single-Photon Emission CT): Excellent for deep neck or ectopic (mediastinal) glands.
• High-Resolution Ultrasound: 65-85% sensitivity. Good adjunct, but user-dependent and limited by short thick necks, multinodular goiters, or ectopic mediastinal glands.

Management

Primary Hyperparathyroidism

• Definitive Therapy: Surgical parathyroidectomy. (Medical observation is reserved for asymptomatic patients with mildly elevated calcium, older age, or extensive comorbidities).

Secondary Hyperparathyroidism

• Primarily treated medically (address the underlying cause, vitamin D analogues, phosphate binders).
• Indications for Surgery in 2° HPT: Intractable bone pain, severe pruritus, Calcium-Phosphate product ≥ 70, Serum Ca > 11 mg/dL with markedly high PTH, calciphylaxis, or severe soft-tissue calcification.

Tertiary Hyperparathyroidism

• Operative intervention is required if symptomatic disease or if autonomous PTH secretion persists >1 year after successful renal transplant. Treatment is subtotal parathyroidectomy or total parathyroidectomy with autotransplantation.

Hypoparathyroidism Emergency Management

• Acute Tetany/Hypocalcemia: Immediate IV Calcium supplementation until stable, followed by oral calcium and active Vitamin D analogues.
• Chronic: Oral calcium, Vitamin D, and dietary phosphate restriction.

Relevant Guidelines

Surgical Indications for Asymptomatic Primary HPT (NIH Guidelines) Surgery is indicated if any of the following criteria are met:

• Serum Calcium: > 1.0 mg/dL above the upper limit of normal (Often operationalized as > 11.5 mg/dL depending on lab normal values; Note: an isolated finding of 11.1 mg/dL does not strictly meet the >1.0 threshold if ULN is 10.5).
• Renal Impairment: Decreased creatinine clearance.
• Renal Stones: Presence of nephrolithiasis.
• Bone Density: Markedly reduced cortical or cancellous bone density (T-score ≤ -2.5 at any site) or history of fragility fracture.
• Age: < 50 years old.

WHO Diagnostic Criteria for Osteoporosis (DEXA Scan Results)

Operative / Procedural Notes

Surgical Approaches